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 Abstract 
The inferior colliculus (IC) is an integral centre of auditory processing. Neuronal 
processing of sound within IC is well established, as are its afferent and efferent 
projections. The IC is a complex structure that can be divided into sub-regions that 
undertake different aspects of processing. The central nucleus (CNIC) - a primary 
central auditory processing sub-region, the lateral cortex (LCIC) which is involved in 
polysensory integration, and the dorsal cortex (DCIC) which is involved in plasticity and 
processing descending signals from the auditory cortex. How processing is regulated 
within these sub-regions, and how non-neuronal cells, such as glia, contribute to local 
processing, is unclear. In other regions of the brain, astrocytes and microglia contribute 
to synaptic processing, but little is known of their morphology or variability throughout 
IC. Therefore, this thesis combines anatomical, physiological and molecular biological 
approaches to investigate astrocytic and microglial interrelationships with neuronal 
somata and synapses. Specifically, the morphology and colocalisation of microglial and 
astrocytic processes have been contrasted between sub-regions of IC in young guinea 
pig. Interestingly, analysis revealed that Iba1+ microglia, not GFAP+ astrocytes, make 
numerous abutments with GAD67+ somata (putative inhibitory neurons) throughout 
the IC parenchyma, and microglia were more ramified and interacted with more 
putative excitatory synapses (colocalised with synaptophysin and Homer1) in DCIC 
than other sub regions. As the IC was hypothesised to be an unexplored locus of 
pathology in neurodegeneration, a measurement of how markers of microglia, 
astrocytes and neurons were modified in theTgF344-AD (Tg) rat model of Alzheimer’s 
disease, from 6- to 18-months was conducted. This produced evidence for little 
neuronal loss up to 18-months in CNIC and other brain regions, but there was a 
considerable increase in GFAP+ expression, which mirrored results observed in the 
CA3 region of hippocampus. However, astrocytes in hippocampus demonstrated age-
dependent increases in astrocyte ramification length and number, but this was not 
found in any sub-region of IC. Furthermore, there were increased maximal respiration 
 rates in isolated synaptosomes from 15-month Tg IC, which matched findings from 
hippocampus. Scanning electron microscopy revealed putative synaptosomes were 
reduced in size in 15-month Tg IC and hippocampus. QRT-PCR found a trend for a 
reduction in the expression of GAD65, SV2a, Iba1 and synaptophysin mRNA in the 15-
month Tg model, suggesting loss of synapses and microglia precedes loss of neurons 
in this model. These findings show that microglia differentially contribute to processing 
between sub regions of young adult IC, and multiple hallmarks of hippocampal 
dysfunction in Alzheimer’s disease are found at the same time points in the Tg model. 
Collectively, these findings reveal novel roles for glia in the IC and suggest potential 
links between IC dysfunction and Alzheimer’s disease. 
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Chapter 1 – General introduction  
1.1 – Overview  
After centuries of neuroscientific study and technological advancements, substantial 
discoveries have been made into understanding brain anatomy and physiology. It is well 
established that the regions of the brain are made up of neurons, synapses, microglia and 
astrocytes. However, the individual and interdependent roles each of these components play 
from region to region across the brain is far from clear. One of these brain regions is an integral 
nucleus within the auditory pathway, the inferior colliculus (IC), of which there is a particular 
paucity of study regarding the glial cells therein, and is consequently the main target of this 
thesis.  
There is emerging evidence that hearing loss is associated with the development of dementia. 
Therefore, this Chapter will first lay the foundation of how sounds are processed along the 
auditory pathway, with a focus on how they project to the IC, as this is the model auditory 
nucleus employed in this thesis to identify mechanisms between hearing loss and dementia. 
This will be followed by contextualising background on astrocytes, microglia and synapses, 
and an introduction to each of the brain regions studied in this thesis, with particular focus on 
the IC, setting the stage for the findings presented in Chapter 3. This will be followed by an 
outline of the physiological effects of aging, dementia, Alzheimer’s disease (AD) and the link 
between hearing loss and dementia, which are of direct relevance to the studies presented in 
Chapters 4 and 5. To this end, the two animal models used in this thesis will be discussed. 
Finally, this Chapter will culminate by highlighting pertinent gaps in our understanding that 
are addressed in this thesis. 
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1.2 – The auditory pathway  
The auditory pathway is a complex system that can be divided into the peripheral and central 
components. The peripheral pathway processes sound stimuli outside the head, along the 
external, middle and inner ear (Figure 1.1), detecting changes in air pressure waves and 
mediating transfer of these signals toward the central component, where auditory signals enter 
the brain and are processed by the central auditory pathway (Figure 1.2). Structures along the 
central auditory pathway are based on a tonotopic organisation - i.e. a frequency place map, 
first established in the inner ear, and found throughout the auditory system. The numerous 
structures along the central auditory pathway allow the determination of fundamental 
parameters of auditory perception, such as sound level (perceived as loudness) and 
azimuthal/vertical position (perceived as location). This section will provide a brief outline of 
the structures along the peripheral and central auditory pathways. 
 
Figure 1.1. Image displaying the location of the cochlea in the inner ear with respect to the 
structures of the middle and extrnal ear the peripheral auditory pathway from Brownell (1997). 
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Figure 1.2. Image displaying the structures that make up the central auditory pathway and 
their location within the brain from Graven and Browne (2008). Note the key location of the IC 
within the ascending and descending pathwys.
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1.2.1 – External ear  
The external ear is comprised of the pinna, concha and auditory canal and is the first point of 
contact for air pressure along the auditory pathway. The pinna is a corrugated structure, which 
directs the air molecules based on their elevation, amplitude and frequency through the 
concha towards the auditory canal. Sound molecules oscillate down the length of the auditory 
canal and impinge upon the tympanic membrane. Depending on the elevation, amplitude and 
frequency of the air molecules determines the angle at which they interact with the tympanic 
membrane (eardrum).  
1.2.2 – Middle ear 
The middle ear is composed of an air-filled environment, separated from the external 
environment by the tympanic membrane (Sade et al., 1995). Figure 1.3 provides a 
representation of the anatomy of the middle ear. The tympanic membrane is composed of the 
pars flaccida and pars tensa, which are involved in maintaining the pressure within the middle 
ear and converting air molecules into specific vibrations respectively (Stenfors et al., 1979, 
Milazzo et al., 2017). Attached to the pars tensa is the malleus, which transduces vibrations of 
the tympanic membrane (Mason, 2016). These vibrations then pass to the incus, then the 
stapes. These three bones are the smallest in the body and collectively form the ossicles.  
The stapes is attached to a footplate that connects to the membrane of the oval window. Here, 
the vibrations displace the fluid within the inner ear. The malleus incus and stapes form the 
ossicular chain, which together amplify the pressure exerted upon the tympanic membrane 
and result in increased detection of signals.  
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Figure 1.3 Image depicting the structures of the middle ear (Mason, 2016). Sound waves 
directed from the outer ear impinge upon the fibrous pars flaccida and pars tensa. At the pars 
tensa the sounds waves are converted into vibrations which are passed to the malleus. The 
malleus then directs the vibrations through the incus, then stapes. The vibrations are then 
directed across the stapes footplate, which is attached to the oval window of the bony 
labyrinth. 
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1.2.3 – Inner ear 
The inner ear consists of the bony labyrinth and within it the membranous labyrinth, which are 
composed of three main constituents, including the cochlea, vestibule and the three semi-
circular canals (Figure. 1.4A). The membranous labyrinth is surrounded by perilymphatic fluid 
and filled with endolymphatic fluid. Vibrations across the oval window disrupt the endolymph 
within the vestibule and here signals diverge into the cochlea and semi-circular canals. Signals 
that traverse the semi-circular canals are important in vestibular processing and the cochlea is 
important in auditory processing. The vestibular system is beyond the scope of this thesis, but 
has been reviewed by Angelaki and Cullen (2008).  
The membranous structures within the cochlea include the scala vestibuli and scala tympani 
which are separated by the cochlear duct (Figure 1.4B). Along the scala tympani lies the basilar 
membrane, which forms part of the organ of Corti, and lies in opposition to the tectorial 
membrane. The basilar membrane enlarges along the axial border, and resonates according 
to its size, producing a frequency dependent map of maximal displacement in response to 
sound stimuli. The organ of Corti is populated by inner and outer hair cells, with protruding 
stereocilia. The displacement of the basilar membrane in opposition to the tectorial membrane 
causes mechanotransduction of the vibrations to an electrical signal by disrupting the 
stereocilia of hair cells, which in turn innervate spiral ganglion fibres (Hudspeth, 1989).  
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Figure 1.4 (A) Composition and bilateral anatomical positioning of the bony labyrinth from each ear. The bony labyrinth is subdivided into three 
semi-circular canals, the cochlea and the vestibule from Ekdale (2016). (B) An example image illustrating the composition within the cochlea from 
Jenison (2001). The cochlea is where mechanical signals are converted into electrical signals in spiral ganglion fibres. This transduction process 
occurs at the organ of corti, which is located above the basilar membrane and below the tectorial membrane. These structures are encased within 
the scala tympani and scala vestibule, which surround, and are sealed from, the scala media. 
8 | P a g e  
 
1.2.4 – Cochlear nucleus 
Auditory spiral ganglion nerve fibres enter the brain and branch to innervate divisions of the 
cochlear nucleus (Benson and Brown, 2004). Two main divisions that comprise the cochlear 
nucleus include the dorsal cochlear nucleus (DCN) and ventral cochlear nucleus (VCN). The 
VCN can be further sub-divided into posterior (PVCN) and anterior (AVCN) regions (Figure 
1.5). Spiral ganglion fibres from the cochlea tonotopically innervate neurons within the 
cochlear nucleus and these signals bifurcate and innervate the AVCN and PVCN. Neurons are 
innervated in line with their source of innervation from hair cells on the basilar membrane 
(Lorente de Nó, 1979, De No, 1981, Osen and Roth, 1969). Low frequency signals relayed into 
the CN are processed ventrally, while higher frequency signals are processed dorsally (Evans 
and Nelson, 1973, Rose et al., 1959).  
The PVCN is made up of stellate and octopus neurons and stellate neurons can be further 
classified as T and D stellate cells (Oertel et al., 1990). T stellate cells signal through the nucleus 
of the trapezoid body and project to the contralateral IC, while D stellate cells signal with the 
DCN. Octopus cells are found within the most caudo-medial region of the PVCN and are found 
perpendicular to auditory nerve fibres. T stellate neurons in PVCN are tonotopically arranged, 
in line with the AVCN. T and D stellate cells also populate the AVCN, in addition to bushy cells.  
Here, T stellate and bushy cells in parallel form the tonotopic pathway, whereby bushy cells 
project to the superior olivary complex and the T-stellate cells project to the IC, forming a 
major source of afferent input (Blackburn and Sachs, 1990, Frisina et al., 1990, Joris et al., 1994, 
Cant and Benson, 2003).  
The DCN has three layers, including the molecular, fusiform and deep layers. The DCN is 
predominantly composed of fusiform neurons with apical dendrites protruding to the glia-
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limtans border with basal dendrites directed towards the deep layer (Blackstad et al., 1984). 
The apical dendrites of the fusiform neurons extend into the molecular layer. Fusiform cell 
bodies populate the fusiform layer and their basal dendrites enter the deep layer. Other 
neuronal cell types that populates the deep layer are giant cells (Ryugo and Willard, 1985) and 
unipolar brush cells (Bauer et al., 2013). These two cell types are involved in projecting to the 
contralateral IC (Adams, 1979, Ryugo and Willard, 1985). The DCN receives afferent projections 
from the PVCN and the present fusiform and giant cells are oriented tonotopically. The DCN 
is involved in filtering self-made sounds (Singla et al., 2017), responding to spectral cues and 
integrating signals with vestibular and somatosensory systems through parallel fibre inputs 
similar to cerebellar circuits (Singla et al., 2017). 
 
Figure 1.5. The CN is subdivided into the AVCN, PVCN and DCN. Each region of CN is 
organised tonotopically, with high frequency signals processed dorsally and low frequencies 
ventrally from Bahmer (2007). 
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1.2.5 – Superior olivary complex 
The superior olivary complex (SOC) is comprised of numerous nuclei that are located in close 
proximity within the ventral pons. The SOC is the second target in the ascending auditory 
pathway, receiving afferent tonotopic projections from both sides of the CN. The SOC is a 
primary source of excitatory projections to the central nucleus of the IC (CNIC) (Oliver et al., 
1995). Nuclei of the SOC are the first sites in the auditory pathway where signals from both 
ears converge. The SOC is subdivided into the lateral-superior olive (LSO), medial-superior 
olive (MSO), the medial nucleus of the trapezoid body (MNTB) and numerous periolivary 
nuclei. Schofield and Cant (1991) classified up to eleven different subtypes of periolivary nuclei, 
including the lateral and ventral nucleus of the trapezoid body, though these are thought to 
vary between species. Tonotopy is also found throughout SOC, whereby high frequency 
signals in LSO are processed in the medial portion and low frequency signals are processed 
laterally. In MSO, high frequency signals are processed ventrally and low frequencies dorsally 
(Goldberg and Brown, 1968) and in MNTB high frequency signals are processed ventromedially 
and low frequencies are processed dorsolaterally (Figure 1.5) (Guinan et al., 1972). This 
tonotopic organisation is reflected in the locations within the IC to which respective neurons 
project. 
The MSO is located centrally within the SOC and receives bilateral projections derived from 
bushy cells from the cochlear nucleus (Harrison and Irving, 1966, Osen and Roth, 1969). Central 
MSO is populated by fusiform cells, whereby their dendrites are orientated perpendicular to 
the plane and protrude towards the lateral borders. In addition, there are a smaller proportion 
of marginal neurons, with dendrites branching towards the centre of the nucleus, as well as 
multipolar cells that are distinct from marginal cells. Some marginal neurons are located 
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centrally with others located rostro-caudally (Schwartz, 1977). The MSO receives ascending 
bilateral projections from both ipsilateral and contralateral AVCN, enabling the integration of 
signals. The main source of afferent excitatory synaptic endings projected from neurons in the 
MSO can be found in the CNIC (Oliver et al., 1995). 
The LSO has a number of fusiform cells lining the central band, which have polar dendrites 
oriented perpendicular to the arching nature of the nucleus, and in opposition has a number 
of marginal cells populating the border. The main sources of afferent auditory signals to the 
LSO are from the ipsilateral AVCN and MNTB and the LSO projects bilaterally to the lateral 
lemniscus and IC. Projections to the IC from the LSO are a primary source of glycinergic 
processing, which is a major source of inhibitory input. This inhibition may modify the 
representation of interaural level responses, in combination with excitatory projections from 
other sources (Saint Marie and Baker, 1990). In addition, the LSO has a significant number of 
excitatory synaptic endings found in the CNIC (Oliver et al., 1995), albeit less than the MSO.  
The MNTB is composed predominantly of principal, elongate and stellate neurons and is home 
to the largest synapses in the mammalian brain, the calyces of Held (Morest, 1968). Principal 
neurons are the most numerous and anatomically have dense dendrites, which innervate the 
calyces of Held. The elongated neurons are smaller than principal neurons and have four to 
five dendritic arbours that protrude dorsoventrally (Morest, 1968). Stellate neurons are located 
with principal and elongated neurons and have fewer dendrites that protrude in multiple 
directions. The MNTB is a relay between the AVCN and the LSO and the major projections 
from the MNTB are relayed tonotopically to the ipsilateral LSO. The MNTB also has ascending 
connections with the lateral lemniscus and IC. Determination of interaural time differences and 
interaural level differences are processed across various regions of the SOC. Collectively, these 
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nuclei interact to distinguish binaural interaural time and level differences via excitatory and 
inhibitory inputs, which are further processed in the IC, after traversing through the lateral 
lemniscus (Kelly et al., 2009). 
Figure 1.6. The parcellation of the main subdivisions of the SOC from (Kulesza and Berrebi, 
2000). Each subdivision is tonotopically organised. The LSO has high frequencies medially and 
low frequencies laterally. High frequencies in MSO are processed ventrally and high 
frequencies dorsally. In MNTB, high frequencies are processed ventromedially and low 
frequencies dorsolaterally. 
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1.2.6 – Lateral Lemniscus 
Afferent projections from neurons in CN and SOC are sent to each side of the lateral lemniscus. 
The lateral lemniscus is essential in relaying ascending auditory information from the CN and 
SOC to the IC (Kelly et al., 2009). There is conflicting literature as to how many subdivisions of 
lateral lemniscus there are. Some research suggest there is three (Adams, 1979, Zook and 
Casseday, 1982), some suggest two (Brunso-Bechtold et al., 1981, Glendenning et al., 1981) 
and others one (Saint Marie and Baker, 1990, Willard and Martin, 1983). In rat there is a 
subdivision termed the intermediate nucleus of the lateral lemniscus that has been found to 
project to the ipsilateral CNIC (Kelly et al., 2009). However, it is generally considered that there 
are two different groups of neurons that project to distinct regions. These groups include the 
ventral nucleus of the lateral lemniscus (VNLL) and the dorsal nucleus of the lateral lemniscus 
(DNLL) (Figure 1.7). These regions have distinct neuronal types; the VNLL is comprised of oval 
neurons, multipolar and horizontal cells (Adams, 1979). On the other hand, DNLL is comprised 
of four types of neurons including, i) ovoid multipolar neurons with dark Nissl labelling, ii) 
large bipolar with dark Nissl labelling, iii) medium sized ovoid neurons and iv) small round 
neurons with light Nissl labelling (Bajo et al., 1993). 
The VNLL predominantly sends afferent signals to the ipsilateral CNIC (Saint Marie and Baker, 
1990, Tanaka et al., 1985) and sends fewer projections to the medial geniculate body of the 
thalamus, the DNLL (Whitley and Henkel, 1984), the periolivary nuclei and the ventral nucleus 
of the trapezoid body (Whitley and Henkel, 1984). As a result of the predominant signals 
projected to the IC, the topographic orientation of VNLL neurons mirror the orientation of 
projections to the CNIC (Benson and Cant, 2008). Tonotopic organisation of nuclei in the VNLL 
is a concept of controversy. Guinan et al. (1972) suggests in cats that there is no tonotopic 
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organisation, however, Covey and Casseday (1991) showed tonotopically organised neurons 
in bat. These results may underpin evolutionary differences across species and provide insight 
into the relationship between frequency hearing ranges and shaping VNLL tonotopy, which 
will ultimately shape IC structure. Similarly, to VNLL, neurons in the DNLL have been found to 
project afferent signals to distinct regions of the CNIC, which are organised tonotopically (Kelly 
et al., 2009). DNLL also sends afferent signals to regions of the contralateral DNLL and superior 
colliculus (SC), in addition to transmitting descending projections to the periolivary regions of 
the SOC (Bajo et al., 1993).  
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Figure 1.7. Micrographs labelled with the inhibitory GAD65 mRNA using in situ hybridisation 
(A) sagittal (B) coronal. Subsequent masks of micrographs (located adjacent to respective 
micrograph) taken from (Riquelme et al., 2001). The DNLL and VNLL can be separated based 
on neuronal densities. 
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1.2.7 – Medial geniculate body 
Of the structures comprising the auditory pathway, there is the least amount of literature 
surrounding the medial geniculate body (MGB). What is known is that the MGB is located 
laterally from the midline, at the caudal end of the thalamus (Winer and Wenstrup, 1994). 
Anatomically, it is evident that the MGB is an essential relay point along the afferent auditory 
pathway, receiving projections from the IC. The MGB is subdivided into three subdivisions 
including the medial division of MGB (mMGB) dorsal MGB (dMGB) and ventral MGB (vMGB) 
(Morest, 1964).  
Afferent tonotopic auditory signals, transmitted from the IC, are processed in the MGB prior 
to processing in the auditory cortex. Neurons within the mMGB are medium-sized including 
radiate, tufted elongate dendrites small stellate and large neurons, which are weakly tufted 
(Winer and Morest, 1983). The ramification of neuronal dendrites within the dMGB are much 
finer than in the other sub-regions. In addition, the dMGB is involved in projecting descending 
signals to the lateral cortex of the IC (LCIC) creating a thalamo-collicular connection (Kuwabara 
and Zook, 2000). The vMGB is defined by tufted neuronal dendrites, and the neurons follow a 
tonotopic fibrodendritic laminated structure and projections from IC accordingly course in 
parallel (Morest, 1964, Clerici et al., 1990). This maintained structure between the IC and MGB 
suggests that if the IC was afflicted, that it would also influence processing in the MGB. to The 
vMGB is involved in the rapid transmission of afferent signals and is sharply tuned to fast 
modulations of sounds (Edeline, 1999), in contrast to the dMGB which has slower 
responsiveness (Bartlett, 2013), demonstrating functional differences related to variations in 
cellular anatomy.  
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1.2.8 – Auditory cortex 
The auditory cortex is located within the neocortex and is comprised of six layers based from 
the outermost layer to the deepest layer (Rakic, 2009) at the apex of the auditory pathway. 
What defines the borders of auditory cortex is challenging, as the anatomy and physiology 
differ substantially between animals within a species, and more so between species (Kaas, 
2010). Winer (1984) characterised in the tonotopically-organised layer IV, a variety of different 
sub-types of neurons in primary auditory cortex. The majority of neuronal types include small, 
medium and large tufted neurons, with inward facing axons. Albeit less numerous, there are 
also sporadically located large multipolar, double bouquet, and spiny stellate cells throughout. 
In layer V of auditory cortex, projections from the IC comprise large pyramidal neurons that 
have dendrites that project extensively into layer II (Games and Winer, 1988). The majority of 
auditory cortex signals have been found to project predominantly to the dorsal cortex of the 
IC (DCIC), with a significantly lower number being projected to the CNIC (Winer et al., 1998). 
Auditory cortex receives afferent signals from the vMGB, which terminate in layers III and IV, 
this information is then relayed to influence non-auditory cortical regions (Webster, 1992). A 
large proportion of neurons from layers II and III, and to a lesser extend IV and V have been 
found to relay signals via the white matter tract, the corpus callosum, to the contralateral 
auditory cortex (Rouiller and Welker, 1991).  
1.3 – Brain regions of interest to this thesis 
The previous section introduced the auditory pathway as it forms the major sources of afferent 
and efferent connections of IC to demonstrate its integrative nature. Other brain regions of 
interest used throughout this thesis were selected as regions independent of the auditory 
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pathway, with important roles pertinent to each Chapter. An overview will be provided here, 
and their more specific roles will be introduced in each respective results Chapter. 
The results Chapters of this thesis focus primarily on IC. The first of these investigates 
interrelationships of glial cells and putative GABAergic neurons and synapses, and also 
investigates how these vary across different sub regions of IC (Chapter 3). The next Chapter 
builds upon Chapter 3, by looking at the interrelationships of glial cells across sub regions of 
IC and how they compare to other regions of the brain in an ageing transgenic model, in 
addition to measuring neuronal counts (Chapter 4). The final Chapter investigates synaptic 
functioning and gene expression, along with measuring glial gene expression, in an ageing 
transgenic model and how it compares to other regions of the brain (Chapter 5). Therefore, 
these brain regions will now be introduced, with preeminent focus on the IC.  
1.3.1 – The inferior colliculus anatomy and physiology 
The IC is located in the midbrain, rostral to the cerebellum, caudal to SC, and ventral to visual 
cortices (Figure 1.8A). The IC is made up of two egg shaped structures, which are connected 
by a commissure that is involved in integrating bilateral signals and contribute to the neural 
representation of azimuthal sound location (Orton and Rees, 2014).  Ascending afferent signals 
reaching the IC are predominantly received from the contralateral DCN and VCN. Fewer, but 
significant projections to IC originate from the ipsilateral ventral nucleus of the trapezoid body, 
VNLL and the deep layers of SC. Furthermore, projections from nuclei on both sides of the 
midline are received from the MSO, DNLL and auditory cortex (Willard and Martin, 1983).  
Morest and Oliver (1984) defined each sub-region of IC to be tegmental or tectal based on 
neuronal dendritic morphology. The tectal regions predominantly receive afferent signals from 
the auditory pathway and tegmental regions receive input generally from other sources. They 
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classified the three main subdivisions that comprise the IC including, the CNIC, dorsal cortex 
(DCIC) and lateral cortex (LCIC), which is often referred to in the literature as the external cortex 
(Coote and Rees, 2008). Recently, Bielefeld et al. (2008) expanded upon the work of Morest 
and Oliver (1984), uncovering that the CNIC predominantly receives ascending input rather 
than descending. Additionally, they found that neurons in the cortices could be classified into 
two groups: i) primarily receiving ascending auditory projections and ii) receive a multitude of 
descending projections, neuromodulatory nuclei and projections from the contralateral IC.  
1.3.1.1 – Central nucleus, lateral cortex and dorsal cortex inferior colliculus 
The CNIC is defined by its fibrodendritically laminated neuronal layout with the neuropil, 
mainly populated by disk-shaped neurons, with dendritic fields in parallel with terminating 
afferent laminated myelinated axons, intermingled with less numerous stellate cells, which 
have radiating dendritic fields that span across laminae (FitzPatrick, 1975). This is in contrast 
to the cortices, which are comprised of neurons that are orthogonal to in the CNIC, but lack 
disc-shaped neurons (Chen et al., 2018). Other methods that allow sub regions to be discerned 
include implementing histological methods such as using immunohistochemistry for calcium-
binding proteins, including parvalbumin, calretinin and calbindin (Tardif et al., 2003). Neurons 
in CNIC are predominantly parvalbumin positive, with sparse calretinin and calbindin positive 
neurons; however, this reverses in the cortices, whereby calretinin and calbindin comprise the 
largest concentration of neurons (Figure 1.8B). Differing densities of calcium-binding proteins 
provides insight into the signalling properties across the IC sub regions, one feature being that 
the CNIC is more GABAergic than the cortices which are more glutamatergic (Gritti et al 2003). 
Numerous studies have revealed that the DCIC resembles LCIC with smaller neurons and a 
fibrous outer layer (Ito et al., 2009, Rockel and Jones, 1973). The border of the DCIC, adjacent 
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to the CNIC is clearly separated by neurons in CNIC, lining the fibrodendritic laminae and 
neurons within DCIC lack clear orientation (Morest and Oliver, 1984). The LCIC is located 
relative to the low frequency processing region of CNIC and is defined by a fibrous outer layer 
and an adjacent layer with a low number of neurons (Morest and Oliver, 1984). More details 
specific to each sub region are introduced within each results Chapter.
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Figure 1.8. (A) Micrograph displaying staining for NeuN, which labels nonspecific ubiquitous neurons throughout the IC. (B) Example drawings 
illustrating the densities of GAD67+, parvalbumin+, calbindin+ and calretinin+ neurons across the sub regions of IC, from (Ouda et al., 2012). 
Contrasting (A) and (B) illustrates the high proportion of GABAergic (GAD67+) cells within the IC. How GABAergic neurons are distributed across 
the sub regions of IC and their interrelations with other cell types is covered in Chapter 3. In addition, notice the higher density parvalbumin+ 
neurons in the CNIC in comparison to the cortical regions. Also, notice the lack of calbindin+ and calretinin+ neurons within the CNIC.
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1.3.1.2 – Inhibitory processing 
Inhibition within the IC is mainly regulated by glycinergic and GABAergic transmission (Koch 
and Grothe, 1998). GABAergic projections to the IC are primarily received from the DNLL 
(Adams and Mugnaini, 1984) and less so from LSO and the VNLL. Glycinergic projections are 
received from the VNLL, LSO, periolivary nuclei and CN (Saint Marie and Baker, 1990). 
Approximately 25% of neurons within IC are GABAergic and these neurons differ in the number 
of synaptic inputs onto non-GABAergic neurons across subdivisions (Merchán et al., 2005). In 
addition, GABAergic neurons projecting from the MGB to IC can be classified based on 
synaptic inputs, or lack thereof (Beebe et al., 2016).  
The mechanism in IC that is involved in regulating interaural time differences and enabling 
signals from both ears to be perceived together is regulated by inhibitory processing (Fujita 
and Konishi, 1991). The nature of inhibitory processing in IC led (Ingham and McAlpine, 2005) 
to postulate that GABAergic inhibition is involved in regulating neuronal gain, which is a 
phenomenon that is hypothesised to be a crucial mechanism involved in the development of 
tinnitus (Brotherton et al., 2015).  
1.3.1.3 – Glial cells 
Glial cells will be introduced briefly here regarding the IC. A more in-depth introduction to 
astrocytes and microglia will be provided in section 1.4. In addition to the high density of 
GABAergic neurons, Hafidi and Galifianakis (2003) demonstrated that the IC develops a dense 
oligodendrocyte network in mature gerbil. They also showed that astrocyte cell bodies 
equidistantly populate the IC sub-nuclei from birth using the marker S100. Using the reactive 
marker of astrocytes GFAP there were no labelled cells throughout. Microglia are widely 
distributed in IC across all sub regions (Lawson et al., 1990), but little research has been 
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conducted into the anatomy of microglia in IC. A recent study by Rosskothen-Kuhl et al. (2018) 
looking at the role of glial cells in IC auditory processing compared normal hearing to 
neonatally deafened rats concluded that growth and activity of astrocytes and microglia are 
essential for regulating excitatory and inhibitory processing, which highlights using the IC as 
a model for understanding contributions glia make to inhibitory neuronal processing.  
1.3.1.4 – Metabolic functioning 
Among all other brain regions, the IC is by far the most metabolically active nucleus within the 
brain (Sokoloff et al., 1977a). Correspondingly, the IC also has the highest blood volume and 
influx of glucose and amino acids in the brain (Cremer and Seville, 1983) along with the highest 
levels of cerebral blood flow (Landau et al., 1955, Sakurada et al., 1978). A study by Gross et al. 
(1987) revealed that the capillary density was substantially higher in the CNIC in contrast to 
the cortices. These findings strongly suggest the possibility of IC being susceptible to 
metabolic decline. Consequently, Clerici and Coleman (1987) observed remodelling of pure-
tone metabolic evoked response detection to compensate for age-related reductions in 
afferent signals from the cochlea. In addition, during acoustical stimulation of IC, trafficking of 
glucose, lactate and amyloid-beta results in clearance into the interstitial fluid that could have 
implications in IC dysfunction (Ball et al., 2010). More details on the IC pertinent to the findings 
of this thesis will be presented in each results Chapter, as pertinent to the respective data 
found therein.   
1.3.2 – Hippocampus 
The hippocampus is one of the most studied parts of the brain, due to it largely being involved 
in memory and learning (Anand and Dhikav, 2012). The hippocampus is located between the 
mesencephalon and the medial portion of temporal lobe (Destrieux et al., 2013). Hippocampus 
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is a large sub-cortical brain region that is subdivided into two parts, the Cornu ammonis (CA) 
and dentate gyrus (Anand and Dhikav, 2012). The regions of the CA are respectively termed 
CA1, CA2, CA3 and CA4 and are based on a pathway of pyramidal neurons that curve around 
the hippocampus starting at the dentate gyrus (Parekh et al., 2015) (Figure 1.9A). The 
subdivisions of hippocampus receive signals from cortical, limbic and sub-cortical regions, 
specifically from the subiculum and entorhinal cortex (Rajmohan and Mohandas, 2007). 
Dentate gyrus is the initial site for incoming neuronal activity from the entorhinal cortex via 
the perforent path, which then projects to the CA3, CA2 and CA1 regions (see Figure 1.9B). 
Neuronal anatomy differs substantially across hippocampal sub-regions. The dentate gyrus is 
composed of a dense granule cell layer with mossy fibres that innervate CA3 pyramidal cells 
(Amaral et al., 2007). The pyramidal cells of the CA3 region, in turn excite the pyramidal 
neurons of CA1. After passing along the hippocampal pathway, the CA1 region directs efferent 
signals back to sub-cortical regions, entorhinal cortex and subiculum.  
Synapses in hippocampus are primarily glutamatergic (Fonnum, 1984), but also demonstrate 
extensive local inhibition (Pelkey et al., 2017) and measures of long-term potentiation at 
synapses have revealed that stimulating the entorhinal cortex results in feedforward 
stimulation of CA3 and CA1 (Yeckel and Berger, 1990). The ratio of neurons to glia is higher in 
the hippocampus than in neocortex (Christensen et al., 2007) and glial cells have been shown 
to directly influence neuronal and synaptic activity by interaction and releasing glutamate 
(Angulo et al., 2004). 
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Figure 1.9. (A) Drawing of a sagittal view looking at the anatomy of the hippocampus adopted 
from (Achten et al., 1995), illustrating the differences between CA1,  CA2 , CA3 and CA4 regions 
and the granule layer of the dentate gyrus is depicted in red. (B) Micrograph labelled with 
NeuN demonstrating the distribution and density of neurons across the different regions of 
hippocampus. Notice the thick granule layer in dentate gyrus and the transition in neuronal 
distribution between CA3 and CA1.
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1.3.3 – Striatum 
Striatum is subdivided into the dorsal striatum and the ventral caudoputamen. The dorsal 
striatum is pertinent to this thesis, so will be referred to as striatum hereafter. The striatum is 
a sub-cortical brain region located in the basal ganglia of the forebrain, rostrally adjacent to 
the lateral ventricle across from hippocampus and ventrally to somatosensory cortex. Striatum 
is an essential region involved in mediating responses based on reward-circuitry, hence 
influencing decision-making (Lauwereyns et al., 2002). This is in addition to being involved in 
motor initiation and motor function (Montgomery and Buchholz, 1991). The predominant 
neuronal cell type within the striatum are medium spiny GABAergic (Ade et al., 2008) and these 
cells receive substantial glutamatergic projections from cortical regions and dopaminergic 
projections from the midbrain (Centonze et al., 2001). Lovinger (2010) reviewed synaptic 
neurotransmission in striatum and discusses how glutamatergic synaptic long-term 
potentiation and depression is important in habitual learning. Astrocytes in striatum 
demonstrate significantly less connections with excitatory synapses than in hippocampus (Chai 
et al., 2017) and also astrocytes have been found interacting with specific neuronal types, 
suggestive of heterogeneous astrocyte activity (Martin et al., 2015).  
1.3.4 – Prefrontal cortex 
The frontal cortex consists of the premotor, primary motor and prefrontal cortices. The 
prefrontal cortex is the region of the frontal cortex that regulates working memory and this is 
a critical function that deteriorates as a result of numerous neurological conditions including 
Alzheimer’s disease (Sampath et al., 2017). Therefore, this thesis only focuses on the prefrontal 
cortex. The prefrontal cortex occupies the most rostral component of the forebrain. Amongst 
all animals, the prefrontal cortex is the most developed in humans, which hampers the 
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interpretability when experimenting on other mammals (Kolb et al., 2012). This does not 
however, disrepute studying prefrontal cortex in other mammals, as mammalian prefrontal 
cortex has evolved from similar ancestors and the cell types are not dissimilar (Teffer and 
Semendeferi, 2012). There are substantial differences in prefrontal cortex anatomy to 
understand when comparing rodents to humans. Primates have a lateral prefrontal cortex, 
which is not as developed in rodents (Preuss, 1995).  
The rodent prefrontal cortex is subdivided into the medial and orbital regions, which can be 
further subdivided into dorsal medial and ventral medial prefrontal cortices that are also 
present in primates (Ongur and Price, 2000, Cholfin and Rubenstein, 2008). The prefrontal 
cortex is essential in distinguishing between autonomic functioning and goal-directed 
responses in humans (Perret, 1974, Cohen and Servan-Schreiber, 1992). Synaptic dendritic 
spine formation in frontal cortex is higher than in any other region of the brain with the lowest 
level of corresponding elimination (Elston et al., 2010), which likely relates to cognitive 
capacity.  
1.3.5 – Superior colliculus 
The superior colliculus is an integral centre within the visual pathway and is co-member of the 
corpora quadrigemina shared with the IC, located ventrally to the visual cortex in the tectum 
(Paxinos and Franklin, 2019). Superior colliculus is a layered brain region composed of deep 
and superficial layers and the number of layers are different across species, which are 
separated in mammals from other species such as birds and reptiles, in that they signal with 
cerebral cortex and other sub-cortical regions (Huber and Crosby, 1943, Karten, 2015). The 
superior colliculus is tasked with integrating visual stimuli into responding with movement (Jay 
and Sparks, 1987, Marino et al., 2015). The auditory and visual system are linked by specific 
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auditory signals processed in the IC being relayed to the SC, which produces autonomic 
saccadic eye movements in response to stimuli (Jay and Sparks, 1987). Glial cells in superior 
colliculus have been found to support neuronal functioning and influence afferent input 
(Barradas et al., 1989), which is similar to the response observed in IC (Rosskothen-Kuhl et al., 
2018). 
1.3.6 – Cerebellum 
The cerebellum is different from the other brain regions, having a much higher neuronal 
number and receives significant indirect input from the cerebral cortex (Coffman et al., 2011). 
It is subdivided into three main regions, consisting of the flocculonodular lobe, anterior lobe 
and posterior lobe. Cerebellum regulates motor movements, including maintaining posture 
and balance by regulating muscle activity (Takakusaki, 2017). The cerebellum has five main 
types of neuronal cells including the main Purkinje cells, granule, Golgi, Lugaro and brush cells, 
which based on their distribution can provide insight into cross-species cerebellar functioning 
(Sultan and Glickstein, 2007). Glutamatergic brush cells in cerebellum are also found in the 
DCN (Kalinichenko and Okhotin, 2005) and are strongly linked to vestibular function, likely 
being a source of the connection between hearing and balance. Cerebellum is well integrated 
with cortical regions, whereby its effects are regulated by individual regions and dysfunction 
could potentially present as forms of learning difficulties (D'Angelo and Casali, 2012). There is 
a wealth of literature investigating long term synaptic potentiation and depression in 
cerebellum, all that conclude that synaptic remodelling is essential for learning (Hansel et al., 
2001, D'Angelo and Casali, 2012, Ito, 1989, Armano et al., 2000). One type of astrocyte 
described in cerebellum are called Bregmann glia (Chan-Palay and Palay, 1972), which are 
involved in granule cell development (Rakic, 1971) and interacting with neurons (Grosche et 
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al., 2002). Distributions of microglia are substantially lower in cerebellum and less ramified in 
morphology in contrast to microglia in cortical regions (Stowell et al., 2018). 
1.4 – Roles of astrocytes and microglia in the brain 
A major focus of this thesis are glial cells in the IC, particularly astrocytes and microglia. 
Therefore, these cell types will be introduced here. 
1.4.1 – Astrocytes 
Astrocytes are one of the most abundant cell types within the brain (Sofroniew and Vinters, 
2010). They are important in a large range of roles including facilitating neurotransmission, 
regulating neuroinflammation and maintaining homeostasis (Matias et al., 2019). They have 
been recognised as intermediary cells forming tripartite connections between pre- and post-
synapses of neurons, underpinning their role in mediating neurotransmission (Perea et al., 
2009). Two main types of astrocytes were classified by Miller and Raff (1984) including 
protoplasmic and fibrous astrocytes.  
Protoplasmic astrocytes were described as widely ramified with bushy processes and 
numerous in grey matter, they have been found to interact with synapses (Rothstein et al., 
1996) and line the glial-limitans border (Alvarez et al., 2013). Fibrous astrocytes differ from 
protoplasmic astrocytes substantially in anatomy, as they possess rarely ramified, long 
processes, and are predominantly found in the white matter.  Astrocytes demonstrate different 
morphologies across the brain (Miller, 2018), which suggests that they could be targeted to 
provide insight into functioning within separate brain regions.  
A common method to identify and investigate astrocytes is by implementing 
immunohistochemistry. The most widely used marker is anti-glial fibrillary acidic protein 
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(GFAP), which labels intermediate filaments most commonly found in astrocytes (Pekny and 
Pekna, 2014). The identification of GFAP+ astrocytes was first derived from plaques developed 
in multiple sclerosis (Eng and Dearmond, 1982), but now is used to label astrocytes throughout 
the brain. Another commonly used astrocyte marker is S100B, which is a less specific marker 
of astrocytes demonstrates high specificity in grey matter regions, but in white matter labels 
predominantly oligodendrocytes (Streitburger et al., 2012).  When labelling regions of the 
brain with a large proportion of myelinated fibres, S100B demonstrates high levels of non-
specific labelling, whereas GFAP is much more specific (Steiner et al., 2007). In contrast, in the 
healthy central nervous system, many astrocytes are not detected by GFAP, but under 
pathological conditions all astrocytes are thought to be labelled (Pekny and Pekna, 2004).  
Under pathological conditions, astrocytes are key regulators of the immune response as they 
have been found to become reactive when responding to stress (Pekny and Pekna, 2014). 
Throughout pathology, astrocytes have been observed to increase in expression and adapt 
their morphology by becoming more ramified (Dossi et al., 2018). It has also been noted that 
depending on the stressor, brain region, animal model and a range of different contexts, 
astrocyte activity can be detrimental and can exacerbate inflammation and damage to tissue 
(Sofroniew and Vinters, 2010). Therefore, by understanding how astrocytes are distributed 
across the brain under pathological conditions could provide novel insight into how certain 
diseases progress.  
1.4.2 – Microglia 
Microglia are abundantly distributed throughout the brain parenchyma and account for 
approximately 10% of all cells within the brain (Kettenmann et al., 2011), they are 
mononucleated cells, which are derived from a mesodermal origin (Rezaie and Male, 2002). 
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Microglial function is essential to maintain homeostasis within the brain under normal and 
pathological conditions (Perry et al., 2010). Microglial phenotypes are interdependent with 
their surrounding environment, changes in the environment can drastically alter microglial 
morphology. By monitoring and characterising microglial morphology provides insight into 
the pathological state of the brain. Broadly, microglia have been classified into two types based 
on extreme changes in morphology. Microglia are generally considered to have a resting and 
activated state. These states include a healthy ‘resting’ state, where microglia have widely 
ramified processes radiating from the somata (Streit, 2001). They also have a pathological 
‘activated’ state, which is when the microglia respond to subsequent stressors, whereby they 
lose their ramified morphology by withdrawing their processes into the somata (Lynch, 2009). 
These changes between states is a key component in understanding neurological disease, 
which is currently poorly understood.  
Lawson et al. (1990) utilised the macrophage specific plasma membrane glycoprotein marker 
F4/80 as a marker of microglial cells identified the distribution of microglia throughout the 
‘resting’ brain. They identified that microglia are distributed differently depending on brain 
region, but also present various morphologies throughout. This suggests that microglia have 
different functions depending on where they are situated in the brain under healthy 
conditions, mirroring astrocytes in this respect. However, there is a paucity of evidence 
regarding region dependent roles and variations of microglia across the health central nervous 
system. 
Within the healthy brain, microglia are constantly surveying the parenchyma making 
significant interactions with neurons and synapses (Nimmerjahn et al., 2005, Wake et al., 2009). 
Microglia have been identified to shape neuronal circuits by phagocytosing synapses with 
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weak connections and injured synapses (Schafer et al., 2012). They have also been found to 
contribute to the formation of synapses and dendritic spines (Parkhurst et al., 2013, Miyamoto 
et al., 2016). Not only are microglia involved in regulating neurotransmission, they are also 
involved in active neurotransmission. Tremblay et al. (2010) revealed that microglia adapt their 
morphology under healthy conditions whereby removing the light exposure to mice for 6-10 
days caused microglia within the visual cortex to retract their processes, and when the light 
exposure was re-introduced for 12-hour light/dark cycles, returned the processes to their 
previous state. Therefore, identifying regions of the brain with more ramified processes could 
uncover a sub-discipline of neurotransmission. 
Under pathological conditions, microglia are among the first cells to react in the event of an 
immune response (Rock et al., 2004). Microglia have been observed to increase in number, by 
activating and responding to the areas of interest (Sarlus and Heneka, 2017). In AD, there is an 
increased accumulation of activated microglia, which may contribute to neurodegeneration 
(Solito and Sastre, 2012). Taking into account that microglia demonstrate different 
morphologies across the brain, one would suggest that their response to neuropathological 
triggers may be region dependent. 
1.5 – Age related changes within the brain 
Ageing, the process of passing time (Lopez-Otin et al., 2013) is associated with senescence, a 
term used to describe the process that living organisms undergo with age (Tchkonia et al., 
2013). The extent to the effects that ageing has on the brain are so numerous that it would be 
unfeasible to cover all aspects. Broadly, ageing in the brain results in declining function of the 
vasculature, cell morphology, cognitive function, a decrease in neurotransmitter levels and a 
reduction in metabolism (Peters, 2006). Diseases that have increased in incidence with the 
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older population include cardiovascular disease (Olivieri et al., 2013), hearing loss (Gates and 
Mills, 2005) and dementia (Bhat et al., 2012). Importantly, these diseases are not solely because 
of ageing; all involve the interaction of genetic and environmental influences (Rodriguez-
Rodero et al., 2011).  
A specific mechanism that has been observed as a result of ageing incudes changes in cell 
morphology.  Neuronal morphology, density and subsequent dendrites have been found to 
change dependent on brain region, and in neurodegenerative diseases such as AD this is 
accelerated (Flood and Coleman, 1986). Another mechanism associated with age-related 
cognitive decline includes synaptic dysfunction and subsequent loss, which are particularly 
prominent in hippocampus and frontal cortex (Morrison and Baxter, 2012). Brain regions that 
are associated with executive cognitive functions, such as hippocampus and frontal cortex are 
particularly susceptible to age-related decline (Burke and Barnes, 2006).  
Ageing has been found to cause GFAP+ astrocytes in the mouse dentate gyrus and CA1 to 
increase substantially in size from 3-months to 24-months in contrast to entorohinal cortex 
that did not show any significant changes (Rodriguez-Arellano et al., 2016). These findings 
demonstrate astrocytes are affected differently depending on brain region as a result of 
ageing, highlighting the need to uncover how astrocytes are affected in other brain regions. 
Hippocampus does not demonstrate an age-dependent increase in microglia (Vanguilder and 
Freeman, 2011), however, the cerebral cortex demonstrates age-related reductions (Sharaf et 
al., 2013). Overall, the effects of ageing on the brain are not fully understood (Chinta et al., 
2015, Govoni et al., 2010), making it a tricky distinction to determine whether or not these 
signs of dysfunction are associated with pathology, or are signs of ‘normal’ ageing. The decline 
associated with ageing can broadly be classified into either a compensatory plastic response, 
34 | P a g e  
 
which is characteristic of continued normal cognitive functioning, or can enter a pathological 
state that results in accelerated decline (Harada et al., 2013). This thesis employs the IC as a 
target nucleus in different animal models to try and identify specific mechanisms that can 
provide insight into some of the changes that contribute to this pathological switch. 
1.6 – Dementia with a focus on Alzheimer’s disease 
Coincidently, many of the mechanisms associated with ageing, are also signs of dementia 
(Whalley, 2002). Therefore, what separates ‘normal’ ageing from dementia? The prevalence of 
dementia globally is between 5% and 7% of all adults aged over 60, where the likelihood of 
developing dementia doubles every 5 years (Prince et al., 2013). There are different forms of 
dementia, which have significantly different aetiologies and effects, including AD (Qiu et al., 
2009), Frontotemporal dementia (Warren et al., 2013), corticobasal degeneration 
(Svenningsson, 2019), dementia with Lewy bodies (Abe and Chiba, 2019) and Parkinson’s 
disease dementia (Eversfield and Orton, 2019, Jankovic and Aguilar, 2008). Dementia is broadly 
classified as a disorder of impaired cognitive ability, including memory loss and cognitive 
dysfunction, which progresses over time (Scott and Barrett, 2007). A stage of ageing commonly 
associated with ageing is termed mild cognitive impairment (Eshkoor et al., 2015), but is also 
considered an early stage of dementia (Knopman and Petersen, 2014). Therefore, what causes 
the transition between mild cognitive impairment and dementia? A focus of this thesis is on 
AD, so will be introduced in detail to try and understand the switch between mild cognitive 
impairment and AD. 
Around 60% of all dementia cases are attributed to AD (Rizzi et al., 2014).  Symptomology of 
AD is commonly associated with a progressive decline in cognition, and depending on disease 
stage, can present a wide repertoire of symptoms. Clinical diagnosis of AD is difficult as there 
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is significant overlap between the pathophysiologies across the different forms of dementia 
(Alves et al., 2012). However, AD is classically characterised by accumulation of insoluble 
amyloid beta protein (Aβ), tau associated neurofibrillary tangles, glial responses, synaptic loss, 
the accumulation of senile plaques and neuronal loss (Karantzoulis and Galvin, 2011, 
Mandelkow and Mandelkow, 1998, Iqbal and Grundke-Iqbal, 2010, Crews and Masliah, 2010). 
The clinical diagnosis of patients with AD usually surround the later stages of the disease, yet 
this occurs after a long prior prodromal stage of central mechanisms deteriorating (Petersen 
et al., 2009). Substantial techniques enable the identification of neuronal atrophy such as 
magnetic resonance imaging (Johnson et al., 2005). Others target amyloidosis and tauopathy 
by measuring rates of metabolic decline by utilising the radioactive tracer 
[18F]fluorodeoxyglucose and positron emission tomography (Nordberg, 2004). These 
techniques are critical to identifying the earlier stages of AD, yet they do not provide specific 
insight into components that initiate or drive AD development.  
The understanding that certain genes cause the early manifestation of AD led to developing 
transgenic models that emulate the pathophysiology that can be monitored by more invasive 
techniques (Spires and Hyman, 2005). This has enabled the monitoring of age-dependent 
pressures that AD genes exert on the brain and localise subsequent key anatomical and 
physiological adaptations (Jankowsky and Zheng, 2017). The most common transgenic models 
of AD are developed in mice (Hall and Roberson, 2012). Most AD models possess the mutant 
human familial APP gene that has been shown to independently cause the manifestation of 
AD in humans by causing an overproduction of insoluble Aβ (Goate and Hardy, 2012). Other 
genes that are expressed in transgenic models that independently cause AD in humans are the 
mutant presenilin genes (Levy-Lahad et al., 1995). Models based on these genes have provided 
36 | P a g e  
 
extensive knowledge into the pathophysiology preceding neuronal loss and cognitive 
impairment (Hall and Roberson, 2012).  
1.7 – Hearing loss and its association with dementia development 
Hearing loss is an umbrella term that covers numerous types and can be attributed to 
dysfunction that occurs at any point along the auditory pathway, which makes it difficult to 
diagnose (Brownell, 1997). A number of factors contribute to the development of hearing loss 
including with particular genetic predispositions such as otosclerosis that affects the middle 
ear (Cureoglu et al., 2010) and Usher's syndrome that causes cochlea dysfunction (Yan and Liu, 
2010). Alternatively, hearing loss can be acquired by the effects of environmental stimulus such 
as noise exposure (Le et al., 2017), certain antibiotics (Richardson et al., 1997), trauma (Zahnert, 
2011) and ageing (Fischer et al., 2016). These various causes have informed the categorisation 
of various hearing loss types.  
Conductive hearing loss is defined by damage or defects of the outer ear, or to the ossicles in 
the middle ear (Smith et al., 1993). Hearing loss associated with spiral ganglion fibres 
dysfunction is defined as sensorineural hearing loss (Kuhn et al., 2011). Dysfunction within the 
central auditory pathway is appropriately called, central auditory processing dysfunction 
(Atcherson et al., 2015). A combination of the above can occur, which is defined as mixed 
hearing loss. The most common form of hearing loss associated with ageing, is known as 
presbycusis (Huang and Tang, 2010). The prevalence of individuals with severe to profound 
hearing loss is 40% to 60% for individuals over the age of 60, which rises to 80% in people 
over the age of 85 (Humes et al., 2012). Presbycusis is characterised by a shift in audiometric 
threshold (Liu and Yan, 2007), and specific factors that contribute include mitochondrial 
damage and metabolic dysfunction (Lee, 2013).  
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Lin et al. (2011a), revealed that hearing loss was independently associated with all-cause 
dementia. This led to the comparison of risk factors, and it was uncovered that hearing loss 
has the most substantial effect on early-dementia development (Livingston et al., 2017). 
Presbycusis is generally associated with cochlea dysfunction resulting in a loss of afferent 
signals entering the central auditory pathway (Wong and Ryan, 2015). However, the 
mechanisms contributing to dementia development must occur within the brain (Shen et al., 
2018). This hypothesis is consolidated by Idrizbegovic et al. (2011) who identified that central 
auditory dysfunction is prevalent among AD patients. Significant losses of spiral ganglion 
auditory nerve fibres in the cochlea have been observed in contrast to hair cells in 3xTg-AD 
mice (Wang and Wu, 2015). Additionally, Omata et al. (2016) developed mutant mouse models 
Tg(Math1E-Aβ42)1Lt, Tg(Math1E-Aβ42Arc)1Lt, and Tg(MathE-MAPT)1Lt)) to over-produce Aβ 
and tau in the cochlea and found that overexpression of these genes were correlated with 
hearing loss. Additionally, Sinha et al. (1993) revealed that amyloid plaques and neurofibrillary 
tangles were distributed predominantly throughout the CNIC and MGB of AD patients, in 
contrast to the auditory cortex, which exhibited lesser pathology, and the CN that did not show 
any. These results implicate the IC as a primary target for auditory related AD, that could 
contribute to dysfunction. This hypothesis will be tested in Chapters 4 & 5 to identify the 
extensity of changes in the IC as an indirect measure of auditory dysfunction and its relation 
to AD development. This Chapter has provided indirect evidence for age resulting in cognitive 
decline, cognitive decline switching to pathological decline and hearing loss contributing to 
cognitive decline. There is broad evidence linking ageing, hearing loss and cognitive decline, 
but there are no bona fide mechanisms linking the three. This thesis aims to provide insight 
into some of the mechanisms characterising the conditions. 
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1.8 - Models of study employed in this thesis 
In this thesis, two different animal models will be used, guinea pigs and rats. Evolutionarily, 
guinea pigs and rats evolved from a common ancestor, making them closer to each other in 
phylogenetics than either to humans (Huchon et al., 2002). Therefore, when understanding the 
comparability between species, there will be substantive crossover. The first is the tricoloured 
guinea pig, which is used in auditory research due to its similarities in hearing to humans 
(Shera et al., 2002). Guinea pigs are an apt model to study central auditory processing, as they 
have a similar hearing frequency range to that of humans (Marquardt et al., 2007). Guinea pigs 
have recently being found to demonstrate monoaural and binaural integration which are key 
characteristics of IC processing, but also discriminate low frequency signals more similar to the 
human hearing range than mouse and rat models (Greene et al., 2018). 
Using guinea pigs to model AD genes would have been appropriate to understand auditory 
related changes. However, there are currently no transgenic guinea pig models that emulate 
AD. A suitable alternative is the transgenic Fischer 344 Alzheimer’s disease (Tg) rat model, 
which is the first viable AD model in rats. Rats are a good model to use opposed to mice, due 
to them having a closer number of synteny blocks to humans, which is a measure of similarity 
between two sets of chromosomes, demonstrating that they are closer in phylogeny (Bourque 
et al., 2004). The Tg rat model has been proposed to be useful in the studying the effects of 
causative human-familial AD genes (Cohen et al., 2013) and this thesis is exploring different 
approaches to try and consolidate this. In addition, the Fischer344 strain has been shown to 
demonstrate a moderate loss of hearing between 8 and 25 months (Simpson et al 1985), 
making it a good model to investigate age-dependent hearing loss with the AD genes. The 
genes include the human amyloid precursor protein Swedish mutation and presenilin-1, 
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excluding the nucleotides on the exon 9, gene mutations, which both independently result in 
the early manifestation of AD in humans, by producing excess abnormal amyloid beta in 
conjunction with an inability to cleave the protein into a soluble derivative. The Tg model in 
conjunction with guinea pigs provide a comprehensive approach to identifying factors 
associated with auditory processing and AD. 
 
1.9 – Issues this thesis attempts to address 
As introduced in the sections above, the different neuronal projections and regions of the 
brain that sounds undergo are well described. However, there is little to no information 
regarding the contributions that glial cells make to the processing of sounds. In addition, a 
correlational link between hearing loss and dementia has been found, with no information 
providing mechanistic data implicating the two conditions. Therefore, this thesis will address 
some outstanding questions surrounding neurons, glial cells and metabolic functioning within 
the IC, by providing data to try and better understand auditory processing and the potential 
link to dementia. 
1.9.1 – Gaps in our understanding 
• Astrocytes and microglia are known to be involved in regulating neuronal and synaptic 
processing in the brain (Sections 1.4.1 and 1.4.2 respectively). However, there is no 
research identifying how these cells contribute to processing across the sub regions of 
IC. Therefore, Chapter 3 aims to uncover how these cells contribute to processing in 
CNIC, DCIC and LCIC. 
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• Astrocytes and microglia are known to be differentially distributed across different 
regions of the brain and are involved in regulating the immune response and reacting 
to stimuli across the brain (Sections 1.4.1 and 1.4.2 respectively). However, there is no 
research identifying how these cells respond to ageing in the IC of the Tg model. 
Therefore, Chapter 4 aims to uncover age-dependent changes in the Tg model affects 
glial distributions across the CNIC, DCIC and LCIC. 
• Synaptic dysfunction and a reduction in metabolism are recognised outcomes of AD. 
However, there is no research identifying age-dependent changes in mitochondrial 
functioning in presynaptic nerve endings in IC of the Tg model. Therefore, Chapter 5 
aims to uncover mechanisms of metabolic synaptic dysfunction in the IC compared to 
other regions of the brain in the ageing Tg model. 
1.9.2 – Hypotheses 
• Astrocytes and microglia contribute to sub regional neuronal and synaptic processing 
across the guinea pig IC (Chapter 3). 
• There will be an age-dependent increase in astrocytes and microglia across the sub 
regions of IC in the Tg model (Chapter 4). 
• Age-dependent metabolic synaptic dysfunction will be more prominent in the IC than 
in other regions of the brain of the Tg model (Chapter 5). 
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Chapter 2 – General Methodology 
2.1 – Overview of Methodology 
This Chapter will present the general methodology employed across the Chapters. Full details 
pertinent to each specific results Chapter will be presented in those respective Chapters, as 
appropriate.  
2.2 – Animal Models 
All experiments were approved by the Faculty Research Ethics and Governance Committee at 
Manchester Metropolitan University. Adult guinea pig (Cavia porcellus) brains were provided 
by Professor Adrian Rees at Newcastle University, following transcardial perfusion with PBS 
and 4% PFA following regulations at Newcastle University. Wild type (n=and Tg rats were 
provided by Dr Herve Boutin at The University of Manchester following regulations at the 
University of Manchester. These rats were culled at The University of Manchester and 
transported on ice to Manchester Metropolitan University, where the brains were removed and 
processed (see Chapters 4 and 5). 
 
2.3 – Immunohistochemistry Protocols 
All sections were cut using a cryostat (Leica CM3050S) with an operating and chamber 
temperature of 18°C. Guinea pig sections were cut at 60µm, in the coronal plane and were 
placed free floating into a 3 x 4 well plates filled with PBS (0.9% NaCl in 0.01M phosphate 
buffer (ThermoFisher Cat# 003002)). Tg and wild type rat brains were cut into 10µm thick 
sections in the parasagittal plane and 4 sections were mounted onto Superfrost+ slides 
(ThermoFisher lot# 0120045). All experiments were conducted using i) no primary (no primary 
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antibody to determine secondary IgG autofluorescence) , ii) no secondary (no IgG control to 
determine the presence of debris associated with the primary antibody) and iii) no primary or 
secondary controls (to identify autofluoresce contributed through reagent contamination 
and/or human error).  
2.3.1 – Chapter 3 immunohistochemistry process 
Guinea pig tissue sections were labelled free-floating, starting with a wash in PBS (3 x 5 
minutes), then permeabilised and blocked in 0.05% Triton X-100 (to improve antibody invasion 
of desired cells) in PBS and 1% goat serum (to prevent the secondary antibody from binding 
to non-specific resident tissues or Fc receptors) (Vector cat# S-1000) (blocking solution) for 1 
hour at room temperature. The sections were then incubated in a cocktail of primary 
antibodies and left overnight at room temperature on a shaker plate (see Chapter 3 for specific 
antibodies). The next day, sections were washed (3 x 5 minutes) in PBS, followed by blocking 
solution for 1 hour, followed by incubation in the corresponding secondary antibodies for two 
hours at room temperature and washed (3 x 2-minutes in PBS) (see section 2.4.1 for specific 
antibody details). Sections were mounted onto positively charged slides, allowed to dry at 
room temperature followed by the addition of VectaShield H-1000 mounting medium (to 
minimise fading of the specific fluorophores) with 0.22x60x0.15mm coverslips (ThermoFisher 
Cat# 24X60-1.5). Once mounted, sections were stored at 4ºC until imaged. 
2.3.2 – Chapter 4 immunohistochemistry process 
Tg rat sections were washed (3 x 5 minutes) in PBS, then treated with a citrate antigen retrieval 
buffer (5mM sodium citrate dihydrate, 15mM Citric Acid, 500ml deionised H20, 6.0pH) at 80°C 
for 20 minutes. The slides were washed again (3 x 3 minutes), followed by an hour’s incubation 
in blocking solution at room temperature (as above). Sections were immersed into a cocktail 
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of primary antibodies overnight at 4ºC in a humidified chamber on a shaker to prevent 
evaporation (see section 2.4.2 for specific antibody details). Slides were then washed (3 x 5 
minutes) in PBS and immersed in blocking solution for 1 hour at room temperature. Sections 
were incubated in the corresponding secondary antibodies and left on a shaker plate at room 
temperature for 2 hours in a humidified chamber. Slides were washed 3 x 5 minutes and left 
to dry, then coverslipped in VectaShield H-1000 mounting medium and 0.22x60x0.15mm 
coverslips (ThermoFisher Cat# 24X60-1.5). Once mounted, sections were stored at 4ºC until 
imaged. 
2.4 – Details of primary antibodies used in this thesis 
All antibodies were stored at -20°C, except for when being used where they were kept at 4°C. 
See table 2.1 for a list of all details used throughout this thesis and sections 2.4.1 and 2.4.2 
describe details pertinent to each antibody in respect to each Chapter. Justification of each 
antibody is elaborated upon through the introduction of each results Chapter. 
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Antibody ID Antibody Name Target Antigen Clonality Host Organism Vendor Cat # 
AB_2278725 GAD67 GAD67 human, 
mouse, rat 
monoclonal 
antibody 
mouse Millipore MAB5406 
AB_477010 GFAP GFAP human, 
porcine, rat, 
human, pig, rat 
monoclonal 
antibody 
mouse Sigma-Aldrich G3893 
AB_839504 Iba1 Iba1 human, 
mouse, rat 
polyclonal 
antibody 
rabbit Wako 019-19741 
AB_2068336 Calbindin D-28K Calb1 human, rat, 
mouse 
polyclonal 
antibody 
rabbit Millipore AB1778 
AB_477523 Synaptophysin Synaptophysin 
human, porcine, 
rat, pig 
monoclonal 
antibody 
mouse Sigma-Aldrich S5768 
AB_2631222 Homer-1 Homer 1 human, 
rat, mouse 
polyclonal 
antibody 
chicken Synaptic Systems 160 006 
AB_2336492 GSL-1 N/A N/A N/A Vector 
Laboratories 
RL-1102 
AB_2298772 NeuN NeuN avian, 
chicken, ferret, 
human, mouse, 
pig, rat, 
salamander 
monoclonal 
antibody 
mouse Millipore MAB377 
AB_321301 CD11b CD11b rat monoclonal 
antibody 
mouse Bio-Rad MCA275G 
AB_10013382 GFAP GFAP cat, cow, 
dog, human, 
mouse, rat, sheep 
polyclonal 
antibody 
rabbit Agilent Z0334 
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Antibody ID Antibody Name Target Antigen Clonality Host Organism Vendor Cat # 
AB_2810980 Goat Anti-Chicken 
IgY H&L (Alexa 
Fluor 405) 
preadsorbed 
antibody 
IgY H&L chicken polyclonal 
antibody 
goat Abcam ab175675 
AB_2630356 Goat Anti-Rabbit 
IgG H&L (Alexa 
Fluor 488) 
antibody  
IgG H&L rabbit polyclonal 
antibody 
goat Abcam ab150077 
AB_2687594 Goat Anti-Mouse 
IgG H&L (Alexa 
Fluor 555) 
antibody 
IgG H&L mouse polyclonal 
antibody 
goat Abcam ab150114 
AB_2687948 Goat Anti-Mouse 
IgG H&L (Alexa 
Fluor 647) 
Antibody 
IgG H&L mouse polyclonal 
antibody 
goat Abcam ab150115 
Table 2.1 – Antibody table
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2.4.1 – Chapter 3 antibodies 
Mouse anti-GAD67 (1:500; monoclonal; clone 1G10.2; Cat# MAB5406; Millipore; RRID: 
AB_2278725) – according to the manufacturer, the immunizing antigen is a recombinant fusion 
protein containing unique N-terminus regions from amino acids 1-101 of GAD67. 
Immunoblotting detects a 67kDa protein in rat cerebellum and mouse microsomes; 
immunohistochemistry demonstrated labelling similar in distribution to in situ mRNA 
hybridization (Fong et al., 2005, Kotti et al., 2006, Ramirez et al., 2008). Use of this antibody has 
been published in guinea pig IC (Nakamoto et al., 2013, Foster et al., 2014, Beebe et al., 2016), 
as well as rat IC (Ito et al., 2009). 
Mouse anti-GFAP (1:500; monoclonal; clone G-A-5; Cat# G3893; Sigma; RRID: AB_477010) was 
used to detect astrocytes. According to the manufacturer, this antibody is raised against an 
epitope from the C-terminus of GFAP purified from pig spinal cord (Latov et al., 1979, Debus 
et al., 1983). The antibody has been shown to recognize a single band of approximately 50kDa 
and reacts with homologous, conserved residues across mammals (Lorenz et al., 2005). The 
use of this antibody has been demonstrated in many species, including mouse (Komitova et 
al., 2005), rat (Lennerz et al., 2008, Sanchez et al., 2009), tree shrew (Knabe et al., 2008), guinea 
pig (Kelleher et al., 2011, Kelleher et al., 2013) and human (Toro et al., 2006). Labelling in this 
thesis was consistent with these studies and the known morphology of astrocytes. 
Rabbit anti-Iba1 (1:1,000; polyclonal; 019-19741; lot# WDE1198; Wako; RRID: AB_839504) – 
according to the manufacturer, this affinity purified antibody was raised against a synthetic 
peptide corresponding to the C-terminus fragment of rat Iba1. Labelling via western blot was 
positive for a 17kDa band (Imai et al., 1996). We observed selective labelling of ramified 
microglia, matching similar reports in mouse (Bulloch et al., 2008), rat (Helfer et al., 2009) 
47 | P a g e  
 
(Fuentes-Santamaría et al., 2012), Japanese quail (Mouriec and Balthazart, 2013), macaque 
(Stanton et al., 2015) and chimpanzee (Rosen et al., 2008). We observed labelling consistent 
with these previous reports. 
Rabbit anti-calbindin D-28k (1:1,000; polyclonal; Cat # AB1778; Millipore; RRID: AB_2068336) 
antibody recognises a single band at 28kDa in human, mouse, and rat brain tissues, according 
to the manufacturer. This antibody does not bind to calretinin and pre-adsorption of diluted 
anti-serum with calbindin removed all labelling in human brain (Huynh et al., 2000). Previous 
work demonstrating labelling of mouse olfactory bulb (Kotani et al., 2010), rat piriform cortex 
(Gavrilovici et al., 2010) and guinea pig enteric nervous system (Liu et al., 2005) all showed 
highly selective cytoplasmic labelling of neurons. In this thesis, labelling was consistent with 
previous reports. 
Mouse anti-synaptophysin (1:500; monoclonal; Cat# S5768; Sigma; RRID: AB_477523) antibody 
targets a pre-synaptic synaptosome antigen derived from rat retina, producing a 38kDa band 
in rat brain extracts, according to the manufacturer. Labelling in this thesis demonstrated 
punctate labelling, as previously reported in mouse (Wiedenmann and Franke, 1985), rat 
(Zelano et al., 2009), guinea pig (Glueckert et al., 2008), and human (Jaafari et al., 2008). 
Chicken anti-homer1 (1:500; polyclonal; Cat# 160026; SySy; RRID: AB_2631222) IgY antibody 
is specific for residues 1-196 of human homer1, including splice variants a-d (Soloviev et al., 
2000). These residues are highly conserved, with reactivity for mouse and rat. Homer1 has been 
shown to bind selectively to glutamate receptors (Brakeman et al., 1997) and can be 
considered a marker of glutamatergic synapses when colocalized with synaptophysin (Ciruela 
et al., 2000, Sala et al., 2001, Lee et al., 2019. This antibody has recently been validated in mouse 
models of Alzheimer’s disease via colocalization with synaptophysin {Reichenbach, 2018 #121). 
48 | P a g e  
 
Blood vessels were labelled with rhodamine conjugated Griffonia (Bandeiraea) Simplicifolia 
Lectin 1 (GSL1) (1:100; RL-1102; Vector; lot# S0926RRID: AB_2336492), which binds to 
glycoproteins lining the inner lumen. 
Secondary antibodies included: goat anti-chicken IgY H&L (Alexa Fluor 405) preadsorbed 
antibody (1:250; polyclonal; Cat# ab175675; Abcam; RRID: AB_2810980), goat anti-rabbit H&L 
(Alexa Fluor 488) antibody (1:250; polyclonal; Cat# ab150077; Abcam; RRID: AB_2630356), goat 
anti-mouse IgG H&L (Alexa Fluor 555) antibody (1:250; polyclonal; Cat# ab150114; Abcam; 
RRID: AB_2687594) and goat anti-mouse IgG H&L (Alexa Fluor 647) antibody (1:250; 
polyclonal; Cat# ab150115; Abcam; RRID: AB_2687948) – the manufacturer does not disclose 
information pertinent to the immunogens within for all secondary antibodies. However, each 
secondary is well cited in the recent literature (Ionescu et al 2019; Goussakov et al 2019; Ding 
et al 2019; Yi et al 2019). 
2.4.2 – Chapter 4 antibodies 
Mouse anti-NeuN (1:500; monoclonal; Cat# MAB377; Millipore; RRID: AB_2298772) antibody 
reacts with most neuronal cell types throughout the brain, according to the manufacturer’s 
instructions. This IgG antibody recognizes 2-3 bands in the 46-48 kDa range in mouse brain. 
Labelling in this thesis demonstrated nuclear labelling similar to as previously reported in rat 
spinal cord (Kim et al 2006) and motor nucleus (Pang et al 2009) and mouse olfactory bulb 
(Panzanelli et al 2007) and hippocampus (Litvinchuk et al 2018). 
Mouse anti-CD11b, clone OX-42 (1:500; monoclonal; Cat# MCA275G; Bio-Rad; RRID: 
AB_321301) antibody is a 1,151 amino acid single pass type 1 transmembrane glycoprotein 
possessing a single vWFA domain and multiple FG-GAP repeats. CD11b is expressed on most 
macrophages, including resident and activated peritoneal macrophages and Kupffer cells, and 
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labels dendritic cells, granulocytes and microglia (Robinson et al 1986). Labelling in this thesis 
demonstrated cellular structures similar to previous reports in rat cochlear nucleus (Fuentes-
Santamaria et al 2013) and mouse spinal cord (Jiang et al 2017). 
Rabbit anti-GFAP (1:500; polyclonal; Cat# Z0334; Agilent; RRID: AB_10013382) – according to 
the manufacturer the antibody is a 50 kDa intracytoplasmic filamentous protein that 
constitutes a portion of the cytoskeleton in astrocytes. Labelling in this thesis appeared similar 
to previous reports in the dorsal vagal complex (Pecchi et al 2007) and striatum of rats (Yang 
et al 2008) and prefrontal cortex of chimpanzee (Rosen et al 2008), whereby the labelled cells 
were cellular with protruding processes. 
Secondary antibodies included: goat anti-rabbit H&L (Alexa Fluor 488) antibody (1:250; 
polyclonal; Cat# ab150077; Abcam; RRID: AB_2630356), goat anti-mouse IgG H&L (Alexa Fluor 
555) antibody (1:250; polyclonal; Cat# ab150114; Abcam; RRID: AB_2687594) and goat) – the 
manufacturer does not disclose information pertinent to the immunogens within. However, 
each secondary is well cited in the recent literature (Ito et al 2018; Hao et al 2018). 
2.5 – Confocal Microscopy 
All micrograph imaging of immunohistochemical labelling was acquired using a Leica SP5 
confocal microscope. Extensive steps of optimisation were taken in the Leica LAS AF software. 
Species-specific epitopes of interest were bound with complementary secondary antibody 
fluorophores exciting at the wavelengths 405, 488, 555 and 647 nanometres. Labelled sections 
were briefly observed using the mercury bulb and anomalous sections were not included 
(sections with missing brain regions, freezer damage, too many artefacts, abnormal 
autofluorescence or negligible labelling that would produce unrepresentative results).  
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Of the included sections, the strongest and the weakest labelled sections were identified, then 
to produce fair comparisons, settings were optimised in-between and implemented 
consistently throughout all experiments. This process was the same for images taken using the 
40x and 63x objectives. Overall laser power was set at 30% for all experiments. A hybrid 
detector (HyD3) combining a vacuum tube and a semiconductor was used to reduce the 
variability of the lasers baseline point of contact, ultimately improving the consistency of the 
beam intensity and reducing the levels of noise, increasing the clarity of high-powered images. 
Several modifiable methodological steps were taken in chronological order to ensure optimal 
signal representation. Initially, the peak of the emission spectrum was localised using the 
changeable emission spectrum to be detected by the laser and minimised to reduce non-
specific labelling and autofluorescence. Next, the minimal laser intensity was set in conjunction 
with altering the pinhole circumference, identifying the smallest diameter that produced the 
highest clarity of image (subjectively determined by minimal autofluorescence, clear definition 
at low resolution and the edges of structures are determinable). The optimal laser intensity 
was characterised by the lowest pinhole setting without bleaching the image, which provided 
the clearest representation of images (this was optimised on control tissue). This enabled reuse 
of the tissue, full representation across the z-plane of zoomed in images and subjective 
quantification of the quality of immunohistochemistry and specific markers used. Finally, the 
voltage of the gain setting was kept at its lowest, which kept the image acquisition as stable 
and clear as possible by minimising laser manipulation as minimal gain reduces beam 
distortion (High gain images produced high levels of false autofluorescence and false positive 
readings that could hamper interpretability of micrographs). Optimisation was undertaken for 
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each wavelength of excitation to account for natural wavelength inconsistencies (this further 
reduced the levels of autofluorescence). 
Regions of interest that were included were defined using guinea pig (Voitenko and Marlinsky, 
1993) and rat brain (Paxinos and Watson 2007) atlases to ensure similar anatomical positions 
along the rostro-caudal axis for coronal guinea pig sections and around the medial portion of 
the right hemisphere for sagittal rat sections. All whole brain region micrographs were taken 
using the 40x objective. The x- and y-planes were identified and outlined, whereby the whole 
regions were encapsulated using the tile parameters in the Leica software (LAS AF). The z-
plane of the sections were determined by measuring the z-plane extensity for all four corners 
on the x- and y-axes. High-powered images were taken using the 63x objective and the zoom 
function (range= a factor of 1.5-4) to best encapsulate individual regions of interest. Details 
more pertinent to each experiment are outlined in each Chapter. 
2.6 – Image analyses 
All micrographs were exported as individual monochrome images in the tagged image file 
format (TIFF), according to the specific wavelength it was taken. Image analysis for all 
micrographs was undertaken in the software FIJI ImageJ (Abràmoff et al., 2004). Images were 
initially stacked on the z-plane and then processed using the filters available in the software 
(specific features are explained in relevant results Chapters). Image stacks were then merged, 
depending on specific epitopes labelled and designated a colour. Individual slices were 
analysed, or a maximum intensity projection was rendered then analysed depending on the 
research question. 
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Chapter 3 – Iba1+ microglia interact with neuronal 
somata and synapses in the inferior colliculus 
3.1 – Introduction 
3.1.1 – The importance of inhibitory processing in the inferior colliculus 
Inhibition is an essential element of neural processing and a defining component of sensory 
systems. GABAergic inhibition is prevalent in the auditory system, particularly in the principal 
auditory midbrain nuclei, the IC. Around a quarter of neurons in the IC are GABAergic (Merchán 
et al., 2005), which may be one reason why the IC is the most metabolically active nucleus in 
the mammalian brain (Sokoloff et al., 1977a). Understanding how inhibitory cell types vary in 
different brain regions, to specialise for distinct functions, is a key area of neuroscientific study 
(Freund and Buzsaki, 1996, Tremblay et al., 2016). Most investigations into sub-types of 
inhibitory neurons naturally focus on the cells per se, including their morphology, 
electrophysiological firing characteristics, expression of cytoplasmic calcium binding proteins 
and peptides and RNA transcriptome. Another approach is to characterize and classify 
GABAergic neurons based on differences in the afferent axo-somatic inputs they receive (Ito 
et al., 2009, Beebe et al., 2016). 
3.1.2 – Each sub region of the IC has distinct functional roles 
The IC has a tonotopic topography that can be divided into sub-regions. The CNIC is 
dominated by neurons sharply tuned to simple auditory stimuli. The DCIC has much broader 
frequency tuning and receives extensive corticofugal input and is specialised for synaptic 
plasticity (Herbert et al., 1991, Winer et al., 1998, Bajo and Moore, 2005, Bajo et al., 2010). The 
other major sub-region is the LCIC which exhibits polysensory tuning (Aitkin et al., 1978). These 
sub-regions are analogous to the core, belt and para-belt sub-regions found throughout the 
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auditory pathway (Kaas and Hackett, 1999). Despite the essential role of the IC in hearing, little 
is known of how glial cells contribute to processing therein.  
3.1.3 – Microglia are involved in ongoing processing and synaptic functioning 
Microglia are an integral cell type present throughout the brain and are one of the most 
numerous cell types (van Rossum and Hanisch, 2004, Kettenmann et al., 2011, Nayak et al., 
2014). In addition to their neuroprotective and phagocytic functions, microglia contribute to 
ongoing synaptic function by removing unwanted structures in a process termed ‘synaptic 
stripping’ (Trapp et al., 2007). The morphology of microglia varies throughout the brain, 
suggesting adaptation to their surrounding milieu. Furthermore, microglia interact with 
neurons during ‘ongoing’ processing and can sense and respond to local chemical signalling 
(Pocock and Kettenmann, 2007, Wake et al., 2009, Schafer et al., 2012). Certainly, there is 
evidence for microglial influence on synaptic plasticity (Zhang et al., 2014, Riazi et al., 2015), 
but the nature of this role remains poorly understood.  
3.1.4 – Aims 
This Chapter aims to uncover anatomical contributions that glial cells make to auditory 
neuronal processing within the IC as a basis for future physiological experiments, by measuring 
the inter-relationships of Iba1+microglia, GFAP+ astrocytes, GAD67+ (putative GABAergic) 
neurons and homer1+ (putative excitatory) synapses in guinea pig. Multi-channel fluorescence 
immunohistochemistry and confocal microscopy have been implemented on adult guinea pig 
tissue in the DCIC, CNIC, LCIC and the ventral central nucleus (VCNIC) to investigate potential 
sub-regional differences. In addition, machine learning methods have been utilised to identify 
inter-relationships between microglia and GAD67+ neurons that could not be detected by 
traditional statistics. 
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3.2 – Methodology 
3.2.1 – Guinea pig tissue processing 
Results are described from four adult (one at four months old, three at six months old) outbred, 
tricolour guinea pigs (Cavia porcellus) of both sexes (three male, one female). Animals were 
culled at Newcastle University in accordance with Schedule 1 (table A section 4) of the Animals 
(Scientific Procedures) Act 1986. Sections (two per animal; 8 total) through the superior 
colliculus and the rostral-most third along the rostro-caudal axis through the IC were first used 
to optimise labelling. Data are presented from sections in the middle third of the IC along the 
rostro-caudal axis, which contained the CNIC, DCIC and LCIC. The location of each section 
through the rostro-caudal axis were referenced to an atlas of the guinea pig brainstem 
(Voitenko and Marlinsky, 1993).  
3.2.2 – Immunohistochemical labelling of tissue 
The immunohistochemistry labelling protocol used in this Chapter is outlined in Chapter 2.3.1 
All steps in the labelling protocol involved continuous gentle agitation of sections at room 
temperature (See Chapter 2.4.1 for antibody details). For double labelling of Iba1 and GAD67, 
goat anti-rabbit AlexaFluor 488 and goat anti-mouse AlexaFluor 568 were used. For double 
labelling of calbindin and GFAP, goat anti-rabbit AlexaFluor 488 and goat anti-mouse 
AlexaFluor 647 were used. For triple labelling of Iba1, GSL1 (pre-conjugated 568nm rhodamine 
fluorophore) and GFAP, goat anti-rabbit AlexaFluor 488 and goat anti-mouse AlexaFluor 647 
were used. For triple labelling of Iba1, homer1 and synaptophysin, goat anti-rabbit AlexaFluor 
405, goat anti-chicken AlexaFluor 568 and goat anti-mouse AlexaFluor 647 were used.  
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3.2.3 – Image acquisition 
Sequentially acquired micrographs were taken with a confocal microscope (Leica SP5) using a 
wide field stage and zoom function. Images (8 total; 1 per section) were acquired via a 40x 
objective (NA=1.25) for images of the entire cross-section of the IC, and a 63x objective 
(NA=1.4) for 5-row x 6-column (432x552µm) region of interest panoramas (see Figure 3.3). 
Whole IC images (8 total, 1 per section) were taken using 5µm equidistant slices in the Z-plane 
to produce maximum intensity tiled projections (pixel size; x & y=0.7583µm, z=50-60µm). For 
GAD67 and Iba1 region of interest panoramas, 5-row x 6-column (432x552µm) tiled images 
were taken using 1µm z-slices until the entirety of the labelling was imaged (pixel size; x & 
y=0.2406µm, z=40µm). High magnification images of Iba1 and synaptic marker labelling were 
imaged (1 per animal) using 0.05µm z-slices through the full cell (pixel size; x & y= 0.1396µm, 
z=25µm). 
3.2.4 – Image analyses 
All image analyses were performed using Fiji ImageJ (Abràmoff et al., 2004). For Iba1+ cell 
density estimates, tiled panorama images of the whole IC (8 images) were subject to manual 
cell counts. The peripheral borders of the IC were delineated, a contour drawn, and each image 
cropped to its respective contour. To make fair comparisons between cases, 450µm2 grids were 
placed across each IC panorama image and centred on the middle pixels of each micrograph 
in ImageJ (For example see Figure 3.1B). Only those grids which were filled entirely by labelled 
parenchymal tissue were subject to counts. Comparisons were then made between cases, such 
that only grids that were present in images from all four animals were included in calculation 
of group means and standard deviations per grid. 
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Two-dimensional maximum intensity projection region of interest 5-row x 6-column 
panoramas of Iba1 and GAD67 were analysed for i) cell counts and percentage field of view 
covered analyses. In addition, each individual 1µm slice was measured to allow three-
dimensional reconstruction and analysis of ii) GAD67+ cell counts, iii) individual Iba1+ cell 
Sholl (Example in Figure 3.5N) and iv) skeleton analyses (Example in Figure 3.5M). For Sholl 
and skeleton analyses a total of 256 cells were analysed (32 per section, 8 per subregion), as 
this was the maximum number of cells that could be consistently measured across the 
panoramas. All panorama micrographs were first processed by filtering monochrome images 
using a median pixel (1.5) filter and then thresholded to binary by implementing the IsoData 
algorithm. Cell counts, and percentage field of view covered analyses were then performed 
using the ‘Analyse Particles’ plugin. For volumetric Sholl analyses, individual Iba1+ microglia 
were cropped and a series of equidistant radiating 1µm concentric spheres were plotted from 
the centre of the cell body to the furthest radiating extent of ramification. Each intersection 
with a concentric ring was measured. The Skeletonize algorithm was used to display a one-
pixel thick framework of each Iba1+ microglial cell. The Analyse Skeleton plugin calculated 
number of branches and branch lengths for each cell. Additional measurements derived from 
the Sholl and skeleton analyses included, i)the total number of intersections with the plotted 
concentric circles as a measure of cell ramification from the centre of the soma, ii) the total 
number of branches defined by a turning point of the skeletonised framework, which indirectly 
related to the number of branches and iii) the longest path of each branch was measured and 
defined as the maximum branch length, which is indirectly a measure of the processes of the 
cell. Whole IC 40x objective images of synaptophysin were analysed for labelling (pixel 
intensity) density between sub-regions using the Measure function. 
57 | P a g e  
 
To measure Iba1+ putative-interactions with GAD67+ neurons, individual cells were cropped 
from panoramas, and were measured without filtering. The diameter of GAD67+ somata were 
quantified by measuring the extremes of each GAD67+ cell in the z-plane. Only cells that were 
entirely contained within the full z-range of the section were included (160 total, 20 per 
section). All other measures of putative interactions between Iba1+ and GAD67+ labelling 
were subject to extensive manual counts on a slice-by-slice basis through each z-stack. 
Initially, the levels of colocalisation of Iba1, synaptophysin and homer1 were determined using 
the colocalisation plugin in the LAS AF (Leica) software, which provided a measurement of 
pixel intensity colocalisation. For synaptic colocalisation measurements, z-slices through Iba1+ 
microglia were thresholded using the Itso algorithm to develop a mask of each slice of the cell 
and then converted into a stack. Synaptic marker labelling (synaptophysin and homer1) were 
thresholded using the Moments algorithm to create masks of each slice. To enable comparison 
of putative excitatory synapses, monochrome image slices of synaptophysin were merged with 
homer1+ labelling. These stacks were then respectively merged with the masks of the Iba1+ 
masked stack, enabling visualization of co-localisation between putative excitatory synapses 
and microglial processes. A three-dimensional Sholl analysis of volume was then conducted 
using concentric spheres of 0.025µm increments from the centre of each Iba1+ soma, which 
gave a quantitative measurement of co-localisation across the x, y, and z planes. Each point of 
colocalisation detected was visually inspected and verified before being included in the 
dataset. 
3.2.5 – Statistical analysis 
Data were collected in Excel spreadsheets. Statistical hypothesis testing was performed in 
Prism 7 (GraphPad). Factorial analyses were conducted using the non-parametric Kruskal-
58 | P a g e  
 
Wallis ANOVA with sub-region as the factor in all cases. Non-parametric testing was 
implemented due to the assumption of normality being violated. Where appropriate, post-hoc 
tests with Dunn’s method were conducted.  This post-hoc test was chosen as it is a more 
representative method for comparison of small samples of biological replicates. For post-hoc 
analyses the α was Šidák corrected for multiple comparisons. This correction method was used 
to control for false type 1 errors. Spearman’s rank correlations were used to investigate 
potential associations between dependent variables. A correlation matrix was implemented as 
a multivariate measure to identify associations between variables. To plot results from the 
correlation matrix and visualise the associations between variables, a principal component 
analysis was implemented. These variables defined the parameters for the principal 
component and two-step cluster analyses. Principal component and two-step cluster analyses 
were conducted in SPSS v25 (IBM). This method was used to identify trends that could not be 
uncovered by conventional statistics. The exploratory two-step cluster analysis employed 
Euclidean distance measures with Schwarz’s Bayesian clustering criterion. These methods were 
used to classify inter-relationships to potentially inform future physiological testing. ROC 
analysis was implemented to characterise the reliability of the results derived from the cluster 
analyses. All 160 cells were successfully classified by this analysis. Chi-squared analysis was 
implemented to compare the proportions of neurons across sub-regions classified by cluster 
analysis. The alpha level was set at P<0.05 for all statistical comparisons. Significance between 
factors from post-hoc analyses displayed in figures are referred to as stars (*= P≤0.05; **= 
P≤0.005; ***= P≤0.001; **** P≤0.0001). 
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3.3 – Results 
3.3.1 – GFAP+ astrocytes and Iba1+ microglia form the glia limitans externa and 
neurovascular unit in IC 
Initially, to identify glial distributions throughout the IC, immunohistochemical labelling of 
GFAP+ astrocytes and Iba1+ microglia was implemented in adult guinea pig. Coronal, 60µm 
sections showed pronounced GFAP+ and Iba1+ labelling of the glia limitans externa lining the 
dorsal and lateral borders of the IC (Figure 3.1A). Extensive labelling was also distributed 
medially, lining the cerebral aqueduct, with ramified GFAP+ astrocytic processes radiating into 
the periaqueductal grey, as well as the commissure of the IC. Interestingly, no GFAP+ 
astrocytes were present throughout the IC parenchyma, save for sparse labelling of cells in the 
outermost layers of the DCIC and LCIC. Conversely, ramified Iba1+ microglia tiled the 
parenchyma in non-overlapping domains with similar density throughout the IC, as quantified 
in Figure 3.1B.  
Combining Iba1 and GFAP labelling with the fluorescent-conjugated lectin GSL1 revealed 
extensive peri-vascular labelling along putative penetrating arteries and arterioles (Figure 
3.1C). Neurons expressing cytoplasmic calbindin or calretinin were distributed in the 
outermost regions of the cortices of the IC, matching previous reports (Zettel et al., 1997, Ouda 
et al., 2012) and in close proximity to vessels and GFAP+ processes (Figure 3.1D).  
These findings demonstrate that many aspects of IC glial organisation mirror those reported 
in other brain regions, with both GFAP+ astrocytes and Iba1+ microglia forming the glia 
limitans externa and lining adjacent to blood vessels. However, the observation that Iba1+ 
microglia but not GFAP+ astrocytes were found throughout the parenchyma, suggests a more 
fundamental role for Iba1+ microglia in glial-neuronal putative interactions in IC. 
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Figure 3.1. Microglia and astrocytes form the glia limitans externa and peri-vascular borders 
but only microglia tile the parenchyma. (A) Tiled maximum intensity projection confocal 
micrograph of GFAP+ astrocytes (magenta) and Iba1+ microglia (green) in IC. Scale bar 
400µm. Note that GFAP labelling is restricted to the peripheral borders and penetrating vessels 
while Iba1 is evenly distributed throughout. (B) Quantification of Iba1+ somata counts per 
450µm2 grid within the parenchyma across all four cases (see methodology for description). 
Numbers on top row refer to individual animals. (C) Confocal micrograph showing GFAP, Iba1 
and GSL1 (blue) labelling of a penetrating arteriole coursing into IC. Scale bar 50µm. (D) 
Confocal micrograph showing a calbindin (green) expressing neuron in the outer layers of the 
LCIC surrounded by GFAP+ axo-somatic processes. Scale bar 10µm. 
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3.3.2 – Distributions of Iba1+ microglia and GAD67+ somata vary between sub-
regions of IC  
To explore the role of parenchymal microglia in IC, tiled confocal micrographs of Iba1+ 
microglia (Figure 3.2A) and GAD67+ neurons (Figure 3.2B) across whole coronal IC sections 
were taken (Figure 3.2C). Dividing the IC into DCIC, LCIC, CNIC and VCNIC based on the criteria 
of Coote and Rees (2008) allowed definition of regions of interest for comparisons between 
sub-regions (Figure 3.2D). Specifically labelled colours represent DCIC (orange), CNIC (blue), 
LCIC (grey) VCNIC (green) for measurements and images throughout. 
Next, 5-row x 6-column (432x552µm) micrographs of each IC sub region were taken at higher 
power to enable representative measurements. Example micrographs can be seen in Figure 
3.3.  Labelling revealed putative GABAergic neurons throughout the sub regions of IC, with an 
appeared increased in GAD67+ cell density in high-frequency ventral regions, matching 
previous reports (Figure 3.3K&L) (Ito et al., 2009, Gleich et al., 2014, Beebe et al., 2016). Of note, 
Iba1+ labelling appeared higher in the DCIC compared to the other sub regions (Figure 
3.3A&C). These speculative increases in GAD67+ cells and Iba1+ labelling are quantified in 
along with cell counts, morphological characteristics and the interactions between Iba1+ 
microglia and GAD67+ somata are quantified in sections 3.3.3- 3.3.6 of this Chapter.
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Figure 3.2. GAD67+ neurons vary in density between sub-regions of IC. (A) Tiled confocal 
micrograph showing Iba1+ microglia tiling IC parenchyma. Scale bar 400µm. Same scale for 
panels (B) and (C). (B) GAD67+ neuropil can be seen to mark the medial and ventral borders 
of the IC. GAD67+ neurons are found throughout IC but vary in density. (C) Merge of (A) 
(green) and (B) (magenta). (D) Borders of IC sub-regions were delineated using those defined 
by Coote and Rees (2008). Regions of interest were located within distinct sub-regions of IC 
that could be clearly distinguished from one another. See figure 3.3 for high magnification 
panorama micrographs.
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Figure 3.3. Representative region of interest panoramas show differences between Iba1+ and 
GAD67+ cells in sub-regions of IC. Scale bar in (A) 50µm. Same scale for all panels. Maximum 
intensity projections of tiled confocal panoramas in all sub-regions show (left column; A,D,G,J) 
Iba1+ microglia tiling the parenchyma with similar density. Conversely, labelling of GAD67+ 
somata (middle column, B,E,H,K) reveals varied cell densities between sub-regions. Merging 
both labels (right column; C,F,I,L) reveals intercalating of Iba1+ processes with GAD67+ 
labelling.
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3.3.3 – The highest density of GAD67 is in VCNIC and Iba1 in DCIC  
Analysis of GAD67+ cell counts from 432x552µm regions of interest (Figure 3.4A) revealed that 
VCNIC had the highest density of cells with a median of 95 (range=66 to 117), followed by 50 
in CNIC (range=31 to 74), then 35 in LCIC (range=21 to 44) and 24 in DCIC (range=19 to 38). 
Post-hoc analysis confirmed a greater number of GAD67+ neurons in VCNIC (H(3)=24.42; 
p<0.001) than other sub-regions (post-hoc Dunn’s tests: VCNIC vs DCIC p<0.0001; VCNIC vs 
LCIC p=0.0023). CNIC also had a greater number of GAD67+ neurons than DCIC (p=0.026) and 
LCIC (p=0.395), albeit not significant.  
Additional analyses of regions of interest confirmed similar densities of Iba1+ microglia cell 
counts between sub-regions of IC, despite the varying density of GAD67+ cells (Figure 3.4B). 
The DCIC had slightly more densely packed Iba1+ microglia than other sub-regions, with a 
median of 88 cells (range=70 to 106) per 432x552µm region of interest. CNIC had a median 
of 83 (range=76 to 95), while LCIC had a median of 80 (range=63 to 104) and VCNIC had a 
median of 73 (range=57 to 92). However, a Kruskall-Wallis ANOVA with sub-region as the 
factor found no detectible difference between groups (H(3)=4.91, p=0.179). Contrastingly, the 
percentage field of view of Iba1+ labelling (see methodology) revealed greater differences in 
Iba1+ labelling between sub-regions (Figure 3.4C). The DCIC (median=14.8%; range=8.7 to 
22.5) demonstrated greater Iba1+ labelling than CNIC (9.5%; 7.1-13.9), LCIC (8.9% 4.9-12.4) 
and VCNIC (7.4%; 4.3-12.0). These differences between groups are a real effect (H(3)=12.67; 
p=0.0034; post-hoc Dunn’s test between DCIC and VCNIC p=0.002). The greater percentage 
field of view of Iba1+ labelling in DCIC, despite similar soma density between sub-regions, 
suggests differences in other aspects of Iba1+ microglia morphology.   
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Figure 3.4. (A) Box plot showing GAD67+ somata counts in each sub-region of interest, across 
cases. The VCNIC consistently had the highest number of GAD67+ somata while numbers in 
DCIC and LCIC were lower than CNIC. (B) Iba1+ cell counts across sub-regions of interest. DCIC 
has the highest number across cases, with the lowest in VCNIC contrary to the GAD67+ cell 
counts. (C) Percentage field of view analyses revealed a larger difference between DCIC and 
VCNIC and LCIC, which suggests further underlying sub-regional differences in morphology.
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3.3.4 – Iba1+ microglia in DCIC are more ramified than other sub-regions of IC 
Iba1+ microglia labelling was better characterised in DCIC by percentage field of view analyses 
than cell counts, which suggests this was primarily due to a greater number and extent of 
ramifications compared to other sub-regions of IC. To test this hypothesis, 3D volumetric Sholl 
analyses were implemented on a total of 64 cells per sub-region (N=256).  Individual 1µm 
slices were quantified for the entirety of each cell to produce a volumetric three-dimensional 
analysis. 
Cells were identified and selected based on whether the entirety of the cell was present across 
all x, y and z planes of the slices. The slices were projected as a two-dimensional maximum 
intensity projection to enable a contour to be drawn around the whole cell (Figure 3.5A). The 
cells were then split into individual slices to remove background/non-cellular labelling (Figure 
3.5B-I). Slices were then merged as three-dimensional projections (Figure 3.5J-L) and 
thresholded to generate binary images (Figure 3.5M). The number of intersections at every 
micrometre distance radiating volumetrically from the centre of the soma was calculated 
(Figure 3.5N). Binary thresholded cells were also skeletonized to derive information about the 
shape and structure of ramifications, including the number of branches and maximum branch 
length (Figure 3.5O).  
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Figure 3.5. Process for volumetric Sholl and skeleton analyses to quantify morphological characteristics of Iba1+ microglia. (A) Example of 
maximum intensity projection of region of interest tiled confocal micrograph showing Iba1+ microglia in IC. (A) 6-column x 5-row field of view 
tiled image was taken using 0.99µm z-slices. Individual cells were subject to Sholl and skeleton analyses (yellow box inset). Scale bar 50µm. (B-I) 
Examples from 8 extracted slices (of 24 total) from cell in (A) showing high resolution imaging of soma and processes surrounded by non-cellular 
labelling. Non-cellular labelling was cropped from each individual slice. Scale bar 20µm throughout. (J-L) Three-dimensional projection of the cell 
at different angles rotating around the x-axis. (M) Each slice was thresholded to binarize cellular processes. (N) Sholl analyses were performed at 
1µm resolution throughout x, y and z planes from binarized images. (F) Three-dimensional skeletonized cell framework from (M) to be analysed 
for number of branches and max branch length. Scale bar 20µm (J) through to (L).
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Iba1+ microglia were more ramified in DCIC than CNIC, LCIC or VCNIC at all distances away 
from the soma (Figure 3.6A). The total number of intersections of every ramification, across 
cells (independent of distance from the soma) had a median value of 438 in DCIC (IQR=385 to 
500). This was significantly greater than in CNIC (332; ±284-399), LCIC (363; ±326-422), or 
VCNIC (353; ±302-400) (Figure 3.6B). A Kruskal-Wallis one-way ANOVA on ranks, with sub-
region as the factor found the differences between sub-regions of IC (H(3)=54.36; p<0.0001). 
Post-hoc analyses via Dunn’s tests showed differences between DCIC and the other three sub-
regions was a real effect (all p<0.0001).   
Analyses of skeletonized Iba1+ microglia revealed those in DCIC also had a greater number of 
branches (Figure 3.6C), with a median of 269 (±222-312). This was greater than CNIC (183; 
±150-229), LCIC (193; ±165-224), and VCNIC (165; ±138-201). These greater number of 
branches in DCIC were also a real effect (H(3)=71.30, p<0.0001; Dunn’s tests DCIC vs other 
sub-regions all p<0.0001). 
Conversely, maximum branch length, defined as the longest distance covered by any 
ramification of skeletonized Iba1+ microglia without branching, followed the opposite trend. 
Longest distances were found in VCNIC (median=14.44µm; IQR=12.76-17.18) (Figure 3.6D). 
Shorter distances were found in LCIC (14.01; IQR±=11.92-16.16), CNIC (12.86; ±11.22-15.60) 
and DCIC (11.62; ±11.26-15.01). The difference between VCNIC and DCIC was a real effect 
(H(3) =12.18, P = 0.0068; post-hoc Dunn’s test p=0.0079). 
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Figure 3.6. Iba1+ microglia are more ramified in DCIC than other sub-regions of IC. (A) Sholl 
analyses (mean ±95% confidence intervals) showing Iba1+ microglia in DCIC have greater 
numbers of ramifications than other IC sub-regions at all distances from the soma. (B) Total 
number of ramification intersections independent of distance from soma are greater in DCIC. 
(C) Greater number of intersections in DCIC are due to a greater number of branching 
ramifications. (D) Maximum branch length, a measure of how long ramifications travel before 
branching, are longest in VCNIC and shortest in DCIC. Representative examples of Iba1+ 
microglia in (E) DCIC, (F) CNIC, (G) LCIC and (H) VCNIC. Scale bar in (E) 10µm. Same scale bar 
for panels (F-H). 
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3.3.5 – Iba1+ putative abutments reveal two new types of GAD67+ neurons in IC 
GAD67+ neurons have been found to receive a variety of presynaptic contacts (Ito et al., 2009, 
Beebe et al., 2016), but also of interest is whether they also receive different types of Iba1+ 
microglial abutments. To examine the nature of Iba1+ putative interactions with GAD67+ 
neurons, five dependent variables from each cell region of interest (n=40 per sub-region) were 
quantified: (i) GAD67+ soma maximum diameter; (ii) percentage of GAD67+ soma abutted by 
Iba1+ processes; (iii) number of Iba1+ microglia with processes abutting each GAD67+ soma; 
(iv) number of distinct Iba1+ processes abutting each GAD67+ soma; and (v) total length of 
Iba1+ processes abutting each GAD67+ soma (µm). The methods used to calculate these 
variables are shown in Figure 3.7. 
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Figure 3.7. GAD67+ cells were selected that were contained entirely within the x, y and z 
coordinates of the tissue section and region of interest. (A) Example of a 1µm slice of a region 
of interest panorama in VCNIC, labelled for GAD67 (magenta) and Iba1 (green). Example 
GAD67+ cell (white arrow) was selected for analysis. Scale bar 50µm. (B) Maximum intensity 
projection of Iba1+ cell through 13 z-planes in zoomed region around cell selected in (A), 
allowing visualization of microglial processes and soma. Scale bar 10µm. (C-O) Example 1µm 
slices though rostro-caudal axis in the z-plane. Soma perimeter length was measured in each 
slice. White arrows in (I&J) point to magnified region in (P-S). Scale bar 10µm. (P) Magnified 
region from (I) demonstrating an Iba1+ process abutting GAD67+ soma. Scale bar 1µm also 
applies to panels (Q-S). (Q) Thresholding using the Huang algorithm in ImageJ for each label 
reveals abutment of Iba1+ process onto GAD67+ soma, with no pixels separation, and a 1-2 
pixel thick plexus of double labelling (white), allowing quantification of the location and length 
of abutment. The distance of abutment was measured along the GAD67+ perimeter. Each 
distinct process abutting the GAD67+ cell was counted and the total number of Iba1+ cells 
abutting the GAD67+ cell were measured. (R) Magnified region from (J), showing Iba1+ 
process in close proximity to but not abutting GAD67+ soma. Thresholding each label reveals 
clear separation with unlabelled pixels between. This demonstrates that the measures taken 
facilitated positive and negative identification of abutments at 1µm intervals through the z-
plane of all cells analysed. 
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These features were calculated from micrographs such as the representative example in Figure 
3.8A, which shows a GAD67+ neuron being abutted by two Iba1+ microglia. A correlation 
matrix was undertaken by correlating each variable against other measured variables, and 
revealed weak associations between GAD67+ soma maximum diameter (i) and the other four 
dependent variables (ii-v) (Figure 3.8B). There were stronger correlations between the four Iba1 
related variables (ii-v). As these variables were only weakly correlated with GAD67+ neuron 
diameter. These results determined that GAD67+ soma maximum diameter was distinct from 
the other variables and that the other variables are interdependent. 
To try to understand the observed distributions, a multivariate analysis was implemented. 
Initially, a principal component analysis was undertaken for the five variables in all sub-regions 
of the IC. The data showed a clear dissociation between GAD67+ neuron diameter in one 
cluster and the other four variables, which clustered together (Figure 3.8C). Both clusters were 
categorized using a standard correlation coefficient of >0.5 as a cut-off value, which showed 
one cluster was explained by only the GAD67+ neuron diameter variable, while the other 
cluster had significant contributions from all four of the Iba1+ related variables. These trends 
were also true for all sub-region-specific analyses in IC (Figure 3.8Di-iv). Next, a two-step 
cluster analysis was conducted including all five variables. The parameters included Euclidean 
distance measures using the Schwarz’s Bayesian clustering criterion (Figure 3.8E). Contrasting 
iterations up to 15 clusters, the analysis found two clusters demonstrated the best explanatory 
power, displaying good (0.5) silhouette measures of cohesion and separation (Figure 3.8F).  
Overall, these variables defined the parameters of the clusters based on all the variables and 
enabled the visualisation of the contribution of each variable, which is not possible using 
conventional statistics.
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Figure 3.8. (A) Representative GAD67+ cell (magenta) receiving abutting somatic processes 
from two Iba1+ microglia (green). Scale bar 20µm. (B) Correlation matrix showing Spearman's 
rank correlation coefficient for each combination of measures derived from putative 
interactions between Iba1+ microglia and GAD67+ cells. Note lower values in first column. (C) 
Principal component analysis of the five variables in (B). GAD67+ soma diameter separated 
from the other four variables, which grouped together. (D) As (C) but for each sub-region in 
IC, showing similar findings in all sub-regions, suggesting robust clustering throughout IC. (E) 
The largest difference between Schwarz’s Bayesian criterion and the ratio of Euclidean distance 
measures is observed in cluster 2, demonstrating that two clusters display the best explanatory 
power. (F) Silhouette measures of cohesion and separation were compared from 2-15 clusters, 
with two clusters demonstrating the highest cluster quality. These data demonstrate that not 
only did two clusters exhibit the best available explanatory power, but also strong clustering 
quality, reflecting real underlying differences in Iba1+ abutments onto GAD67+ neurons 
between clusters. 
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All 160 cells were classified into one of the two clusters determined by the two-step analysis. 
Representative examples of each cluster found in each sub-region are shown in Figure 3.9. 
There were 23 cases in cluster 1, and 137 in cluster 2. To visualise the contribution of each of 
the four Iba1 related variables, each was plotted as a function of GAD67+ neuron diameter 
(Figure 3.10A-D). These scatterplots revealed a dissociation with little overlap between the two 
clusters using the percentage Iba1+ abutting GAD67+ somata (Figure 3.10A). There was 
almost perfect discrimination between the clusters of the normalized total µms of Iba1+ 
abutments onto GAD67+ neuron somata (Figure 3.10B). Conversely, the number of Iba1+ cells 
abutting each GAD67+ soma had a significant degree of overlap with little difference between 
clusters (Figure 3.10C). The number of Iba1+ processes abutting GAD67+ somata had little 
overlap between distributions (Figure 3.10D). To compare the ability of each of these variables 
to independently discriminate between the two clusters, ROC analyses were conducted (Figure 
3.10E). The high hit rate observed in the ROC analysis demonstrates the reliability of the tests 
undertaken, a high false alarm rate would indicate a high level of type 1 error rate. These data 
revealed that while each variable had an area under the curve >0.5, the three variables relating 
to the nature of Iba1+ processes abutting GAD67+ neurons had the best discriminatory power. 
Overall, these results demonstrate that two types of GAD67+ cell can be identified based on 
the interactions with Iba1+ microglia, which provides a strong basis exploratory physiological 
experiments looking at a microglial role in inhibitory processing. 
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Figure 3.9. Example GAD67+ cells taken from each sub-region of IC (maximum intensity projection of five 1µm slices through the centre of each 
cell in the rostro-caudal z-plane), with one example from each designated cluster from the two-step analysis. Scale bar 10µm applies to all images. 
Note the greater length of Iba1+ abutments surrounding GAD67+ somata in cluster 1 (top row), while adjacent Iba1+ processes in cluster 2 make 
few abutments onto the somata (bottom row).
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Figure 3.10. GAD67+ neurons in IC can be classified into two clusters based on the amount 
of somatic Iba1+ abutments they receive.  Scatterplots showing each GAD67+ cell from the 
cluster analysis, classified into either cluster 1 (magenta crosses; n=23) or cluster 2 (green open 
circles; n=137) for each Iba1+ related variable, plotted as a function of GAD67+ soma 
diameter: (A) Percentage Iba1+ labelling abutting GAD67+ somata; (B) normalized total length 
of Iba1+ labelling abutting  GAD67+ somata; (C) distinct number of Iba1+ cells abutting 
GAD67+ somata; (D) number of Iba1+ processes abutting GAD67+ somata. (E) ROC analyses 
showing classifier performance of each variable in discriminating GAD67+ cells into cluster 1 
or cluster 2. Normalized total µm Iba1+ abutting and number of processes of GAD67+ somata 
could almost perfectly discriminate between clusters. 
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3.3.6 – Iba1+ putative interactions with GAD67+ neurons show little difference between 
sub-regions of IC 
This section determined whether any of the variables or clusters identified had a relationship 
to the sub-region of IC in which the cells were located. Diameter of GAD67+ somata did not 
vary between sub-regions (Figure 3.11A) (H(3)=5.3; p=0.151). A small difference was found for 
the percentage of GAD67+ soma abutted by Iba1+ processes across all subregions (Figure 
3.11B) (H(3)=9.9; p=0.019) and a post-hoc Dunn’s tests revealed that the difference was 
between DCIC and VCNIC (p=0.012). The number of Iba1+ cells abutting each GAD67+ somata 
(Figure 3.11C) (H(3)=6.44; p=0.092), the number of Iba1+ abutments onto GAD67+ somata 
(Figure 3.11D) (H(3)=5.55; p=0.141), and the normalised total number of µm covered by Iba1+ 
abutments onto GAD67+ somata (Figure 3.11E) (H(3)=4.64; p=0.200) did not differ between 
sub-regions. However, the number of GAD67+ cells abutted by each Iba1+ cell was greater in 
VCNIC (Figure 3.11F) (H(3)=21.32; p=0.0006). Post-hoc Dunn’s tests revealed a difference 
between VCNIC and DCIC (p=0.005), which is likely due to the greater density of GAD67+ 
neurons in VCNIC. 
Both clusters had similar proportions of regions of interest from each of the four sub-regions 
of IC (cluster 1: 7 DCIC (30%), 8 CNIC (35%), 6 LCIC (26%), 2 VCNIC (9%); cluster 2: 33 DCIC 
(24%), 32 CNIC (23%), 34 LCIC (25%), 38 VCNIC (28%)) A Chi-squared test suggested that there 
was no difference in the relative proportion of each cluster, between sub-regions (χ2(3)=4.21 
p=0.24).
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Figure 3.11. No clear relationship between measured variables and IC sub-region. (A) GAD67+ 
soma diameter was similar across sub-regions of IC. (B) The percentage of Iba1+ abutting 
GAD67+ somata was lower in VCNIC than the other three sub-regions. (C)  The number of 
Iba1+ cells abutting GAD67+ somata, (D) the number of Iba1+ processes abutting GAD67+ 
somata, and (E) the normalized total µm of Iba1+ abutting of GAD67+ somata did not differ 
between sub-regions. (F) There were, on average, a greater number of GAD67+ somata 
abutted by each Iba1+ cell, owing to the greater density of GAD67+ cells in VCNIC. 
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3.3.7 – Iba1+ microglial processes colocalise at puncta with synaptophysin and homer1 
in greater numbers in DCIC 
To determine whether Iba1+ processes are present at synapses in IC, Iba1 was co-labelled with 
the pre-synaptic marker synaptophysin and a marker of glutamatergic post-synapses, homer1. 
Figure 3.12A shows a tiled confocal micrograph of synaptophysin (magenta) and Iba1 (green) 
labelling. A clear shift in synaptophysin density can be seen from DCIC to CNIC. Quantification 
from regions of interest in each sub-region confirmed synaptophysin was more densely 
distributed in DCIC than other sub-regions and mirrored the distributions of Iba1+ percentage 
field of view (Figure 3.12B). Note that these percentage field of view values are calculated from 
the same animals, but different sections than the analyses presented earlier. 
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Figure 3.12. Presynaptic marker synaptophysin has greater density of labelling in DCIC and correlates with Iba1 labelling. (A) Tiled confocal 
micrograph showing representative synaptophysin (magenta) and Iba1 (green) labelling. Note the greater density of synaptophysin labelling in 
DCIC. Scale bar 400µm (B). Quantification from regions of interest in sub-regions (See figure 3.2) showing greater synaptophysin puncta density 
in DCIC which correlates with Iba1 percentage field of view labelling. 
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To examine the cellular location of these puncta on Iba1+ microglia, three cells were imaged 
from each sub-region in very fine z-slice steps (0.05µm). A representative image of one z-plane 
through an Iba1+ microglial cell in VCNIC is shown in Figure 3.13A-D, showing a point of 
colocalisation between synaptophysin, Iba1, and homer1 (yellow arrowhead in D). Three-
dimensional reconstructions of Iba1+ microglia, including all ramifications (Figure 3.13E, 
green), and points of colocalisation with synaptophysin and homer1 (Figure 3.13H, magenta), 
allowed visualisation of the locations of these markers. A rectangular region of interest was 
drawn around colocalized pixels of approximately 0.5µm2. Plotting spectrographs of pixel 
intensity for pairwise combination of each of the three labels showed positive relationships 
(Figure 3.14A-C), with colocalisation rates ranging from 76.5% to 95.0% demonstrating on a 
slice basis that colocalisation of synaptic labels are in the same anatomical position on 
microglial processes, which is indicative of microglia interacting with putative excitatory 
synapses.  
Three-dimensional volumetric Sholl analyses (Figure 3.15A) revealed Iba1+ microglia in DCIC 
had a greater number of colocalised puncta. Fitting each sub-region with a LOWESS regression 
uncovered this trend occurred at all distances from the soma. Quantification of total number 
of colocalised Iba1+, synaptophysin+ and homer1+ punctum per cell in each sub-region 
showed that DCIC had a greater number than other sub-regions (Figure 3.15B). The location 
of each punctum with respect to the branching ramifications of each Iba1+ cell was also 
determined. Puncta were classified as being located on the soma, primary, secondary, tertiary 
or quaternary branches. Figure 3.15C shows that when normalised, the relative proportion of 
puncta locations on Iba1+ microglia were similar across sub-regions (Table 3.1; χ2=7.20; 
p=0.844).
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Figure 3.13. Colocalisation of synaptophysin and homer1 on 3D reconstructed Iba1+ 
microglia. Single plane confocal micrograph showing (A) synaptophysin, (B) Iba1, (C) homer1 
and (D) merged image. Arrowhead shows white pixels, indicating a point of colocalisation of 
all three labels. All z-planes were thresholded, binarized and pixels containing positive labelling 
for all three channels were quantified. Scale bars 10µm. (E) 3D reconstruction of Iba1+ 
microglial cell in VCNIC (green, as in (B)) showing two points of synaptophysin+ and homer1+ 
colocalisation (magenta; as in (A) and (C), respectively). Green signal to scale in (D) 10µm. 
Magenta points of colocalisation have been made 13-fold larger for clarity.  
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Figure 3.14. Region of interest analysis of point of colocalisation showing pixel intensity from 
images in Figure 13D&E. (A) synaptophysin and Iba1, (B) Iba1 and homer1 and (G) 
synaptophysin and homer1. All combinations showed high rates of colocalisation within region 
of interest. These results demonstrate the high levels of colocalisation across all three channels 
at points on an Iba1 process. Points and positions of colocalisation are quantified in Figure 15. 
These results clarify the strong level of colocalisation observed between the different markers 
and justify the representativeness of the results presented in figure 3.15.
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Figure 3.15. Iba1 colocalises at synaptophysin+ and homer1+ puncta in greater numbers in 
DCIC. (A) 3D volume Sholl analysis (plotted in 2D) showing colocalisation of synaptophysin+ 
and homer1+ puncta on Iba1+ microglia (n=3 per sub-region, colour-coded as in (B). LOWESS 
regressions highlight greater values in DCIC. (B) Number of colocalized puncta per microglia. 
The DCIC had a greater number of puncta per microglia. (E) Analyses of puncta location on 
Iba1+ branched ramifications show few puncta are located on somata and similar proportions 
are found on primary, secondary, tertiary and quaternary branches across sub-regions. 
 
 
 
 
Sub-region  Soma Primary Secondary Tertiary Quaternary 
DCIC 
 4 
(5.3) 
18 
(23.7) 
10 
  (13.2) 
19          
(25) 
25         
(32.9) 
CNIC 
 1 
(1.8) 
14 
(25.5) 
15             
(27.3) 
12              
(21.8) 
13         
(23.6) 
LCIC 
 1 
(2.2) 
12 
(26.7) 
9              
(20) 
9              
(20) 
14              
(31.1) 
VCNIC 
 1 
(3.2) 
5             
(16.1) 
7               
(22.6) 
8                
(25.8) 
10              
(32.2) 
 
Table 3.1. Absolute numbers (and % of the total for that sub-region) of colocalised puncta 
positive for synaptophysin, Iba1 and homer1, as shown in Figure 3.15C. Note similar 
proportions of puncta both within and between sub-regions. 
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3.4 – Discussion 
The results from this Chapter provide novel anatomical insight into the morphology of 
microglia and their interactions with GABAergic neurons and synapses. Subsequently, these 
results can be used as a foundation to inform future physiological investigations. Specifically, 
these findings reveal Iba1+ microglia express morphologies and putative synaptic interactions 
commensurate with a functional role in activity dependent neurotransmission and synaptic 
plasticity in the healthy, mature auditory system, which could provide fundamental insight into 
further understanding how auditory signals are processed. These data show that Iba1+ 
microglia ramifications, but not those of GFAP+ astrocytes, interact with homer1+ (putative 
glutamatergic) synapses in IC parenchyma, making the IC a prime model to understand the 
physiological role of microglia in neuronal processing that could be translated across the brain. 
Taking advantage of the specialised and functionally diverse sub-regions of IC, a greater 
number of such synapses in DCIC, an area known to receive a greater proportion of 
glutamatergic corticofugal contacts than other IC sub-regions were found, potentially 
suggesting that microglia are more involved in excitatory modulation. This chapter utilises a 
novel methodological approach to image analyses along with statistical cluster analyses as a 
way to classify numerous variables and their levels of correlations. This approach has enabled 
the identification of microglial-neuron interactions, that could not be uncovered by 
conventional approaches, and could be used as a framework for future researchers 
investigating other parts of the brain. The cluster analyses revealed two new types of GAD67+ 
neuron defined by the extent of Iba1+ microglial contacts onto their soma. These data 
contribute to the understanding of the role microglia play in ‘normal’ processing within 
sensory systems and propose hitherto unexplored avenues of investigation. Similar 
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approaches in other brain areas may produce novel understandings of how microglia 
contribute to fundamental brain organisation.  
3.4.1 – Significance of sub-regional differences 
Some aspects of central sensory processing can be interpreted through triad models of 
organisation. Such models are based on observations that central sub-regions of sensory 
pathways are dominated primarily by i) ascending innervation producing brisk responses at 
short latencies to simple stimuli. Located adjacent are at least two regions with longer response 
latencies - one of which typically receives ii) a diversity of polymodal inputs, while the other is 
iii) primarily driven by descending, top down afferents (Review Singer (1977)). In the 
somatosensory system, these have been respectively termed the lemniscal, para-lemniscal and 
extra-lemniscal pathways (Yu et al., 2006). 
In IC, there is longstanding evidence for a triad model of organisation using a diversity of 
methodologies. These include electrophysiology (Syka et al., 2000) , fMRI (Baumann et al., 
2011, De Martino et al., 2013), histology (Faye-Lund and Osen, 1985), immunohistochemistry  
(Coote and Rees, 2008) and tract tracing of projections (for review of afferent and efferent 
inputs see Malmierca and Hackett (2010) and Schofield (2010)). The present study provides 
evidence that Iba1+ microglial processes, despite superficially appearing similar throughout 
IC (Figure 3.1&3.3), also exhibit profound differences between sub-regions (Figure 3.5). 
Hafidi and Galifianakis (2003) demonstrated in the IC of gerbil, that GFAP+ astrocytes were 
present surrounding the borders, similar to Figure 3.1, but the marker S100 revealed astrocytes 
were indeed present throughout all sub regions of IC. This absence of GFAP+ labelling may 
not be indicative of absent astrocytes, but it does open the question to investigate differences 
in sub-regional astrocyte expression. Chapter 4 investigates differences in GFAP+ astrocyte 
89 | P a g e  
 
morphology in IC in contrast to other brain regions. The fact that Iba1+ microglia present 
different morphologies across sub-regions still provides insight into transitions in subsequent 
environments, which may influence auditory processing. The greater density of Iba1+ 
microglial processes at synaptophysin+ and homer1+ synapses in DCIC indicates that 
microglia contribute to synaptic processing in IC. Cortical regions of IC exhibit much stronger 
novelty detection and stimulus specific adaptation than CNIC (Ayala and Malmierca, 2013). 
This may partly relate to the primary afferent drive to DCIC being descending corticofugal 
fibres (Herbert et al., 1991, Winer et al., 1998, Bajo and Moore, 2005, Bajo et al., 2006). 
Projections to DCIC from auditory cortex originate from glutamatergic (Feliciano and 
Potashner, 1995) pyramidal cells in layer V (Games and Winer, 1988, Winer and Prieto, 2001). 
Corticofugal inputs to DCIC primarily target glutamatergic IC neurons (Nakamoto et al., 2013), 
while large GAD67+ neurons in DCIC are a source of tectothalamic inhibition with shorter 
response latencies than other cells in DCIC (Geis and Borst, 2013). How the greater proportion 
of Iba1+ synapses in DCIC influences auditory processing is unknown, but one might suggest 
on the basis of greater density of synaptophysin labelling in DCIC, that there are a greater 
number of synapses per se. Certainly the DCIC receives a greater diversity of inputs than CNIC, 
including from auditory cortex, the contralateral IC (Orton et al., 2016), and ascending 
projections from the brainstem. However, the highly plastic nature of synaptic processing in 
DCIC leads to the speculation that Iba1+ microglial processes may actively contribute to and 
shape synaptic processing and plasticity therein. Evidence for microglial involvement in such 
processing has been described in other models, including synaptic stripping and removal of 
existing synapses (Trapp et al., 2007), or sensing neuronal synaptic activity (Pocock and 
Kettenmann, 2007) in an activity dependent manner (Wake et al., 2009, Tremblay et al., 2010). 
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The latter may facilitate microglial influence over synaptic plasticity via modulation of 
glutamatergic  (Hayashi et al., 2006) or purinergic (Tsuda et al., 2010) neurotransmission. 
Corticofugal inputs to DCIC have been shown to play an essential role in auditory learning and 
plastic reweighting of cues (Bajo et al., 2010, Keating et al., 2013). These connections likely 
underlie elements of human adaptation in unilateral hearing loss (Kumpik and King, 2019), 
though molecular mechanisms for these observations are underexplored. Intriguingly, homer1 
has recently been shown to mediate behavioural plasticity in association with metabotropic 
glutamatergic synaptic plasticity in hippocampus (Wagner et al., 2014, Clifton et al., 2017, 
Gimse et al., 2018). The presence of Iba1+ processes at homer1+ synapses suggests a 
microglial role in modulating synaptic function and plasticity in DCIC, potentially in a similar 
manner to that shown in other brain regions. 
3.4.2 – Two novel clusters of GABAergic neurons 
As the auditory pathway contains a large proportion of inhibitory neurons, with around a 
quarter of neurons being GABAergic (Oliver et al., 1994, Merchán et al., 2005), understanding 
their structure, function, and organisation is a fundamental question. Previous approaches to 
classifying GAD67+ neurons in IC have focused on soma size (Roberts and Ribak, 1987a, 
Roberts and Ribak, 1987b, Ono et al., 2005) coupled with axo-somatic inputs (Ito et al., 2009), 
perineuronal nets (Beebe et al., 2016) or cytoplasmic calcium binding protein expression (Ouda 
and Syka, 2012, Engle et al., 2014). The present analyses show that while there is merit to these 
approaches, other features of GABAergic sub-types exist. Indeed, GAD67+ cells can be 
classified into two distinct clusters based on the total amount of Iba1+ contacts onto their 
soma (Figure 3.8). That GABAergic neurons in IC can be defined based on Iba1+ inputs 
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suggests that microglia are essential to the structure and function of IC processing in the 
mature, adult auditory system. 
Receiver operating characteristic analyses revealed that the two clusters could be 
distinguished by the three variables that quantified different aspects of Iba1+ processes but 
not by the number of Iba1+ microglial cells abutting each GAD67+ neuron. This may reflect 
the highly motile and dynamic nature of microglial processes, even under quiescent conditions 
(Wake et al., 2009). Other features of GABAergic neurons in IC, such as their discharge patterns 
and expression of associated ion channels also do not relate to soma size (Ono et al., 2005). 
Interestingly, the two newly identified clusters of GAD67+ neurons did not differ in their 
relative proportion between the four sub-regions in IC. Future work may investigate the 
differing afferent neural inputs to and efferent target of these cells, to identify likely 
physiological and connectional differences between clusters and their relationship to 
GABAergic signalling in auditory processing. 
3.4.3 – Technical Considerations 
The use of primary antibodies in less studied species such as guinea pig can be challenging 
due to potential differences in epitopes and when not adequately controlled for, this may lead 
to spurious observations (Schonbrunn, 2014). This is particularly important when using 
exploratory approaches such as in the present study, to ensure all analyses are predicated on 
specific and selective labelling (Voskuil, 2017). Extensive control experiments were therefore 
conducted, excluding primary antibody only, secondary antibody only and both antibodies, as 
well as changing mounting media and solutions throughout optimisation of labelling, to 
ensure that analyses were based on true labelling.  
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The lack of GFAP+ astrocytes in IC parenchyma was surprising and necessitated numerous 
confirmatory experiments. However, in all cases, a lack of GFAP+ astrocytes in the parenchyma 
was found alongside extensive labelling in peri-vascular regions and the glia limitans externa, 
demonstrating consistency within and between cases. The lack of GFAP+ astrocytes in IC 
parenchyma does not exclude the possibility that astrocytes reside throughout IC. Indeed, a 
recent report employing SR101 as a marker revealed a network of putative astrocytes 
throughout CNIC (Ghirardini et al., 2018). However, there is some labelling of oligodendrocytes 
with this marker, which hampers interpretability in studies trying to selectively label astrocytes 
(Hill and Grutzendler, 2014). Functional differences between astrocytes in CNIC and the outer 
layers of DCIC and LCIC have been suggested previously via 3-chloropropanediol-induced 
lesions, which selectively destroyed the former but not the latter (Willis et al., 2003, Willis et 
al., 2004). The present study leads to the speculation of fundamental gliochemical and 
physiological differences that may relate to the sub-region specific roles astrocytes and 
microglia play in their local milieu (Lawson et al., 1990, Olah et al., 2011). Sub-regional 
differences in GAD67+ neurons in the present study suggest that GABAergic and glycinergic 
signalling released from and received by glial cells may also exhibit such variations throughout 
IC and perhaps in other structures. 
With image analyses, there are inherent problems with using algorithms to threshold 
immunohistochemical labelling such as a potential loss of data. However, by thresholding the 
labelling to binary images allows the consistent comparison of the markers across all imaged 
sections, and also enables the removal of false positive labelling due to the imperfect nature 
of immunohistochemical labelling. Therefore, this approach is a more reliable and replicable 
method to comparing specific markers for analysis. 
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Colocalisation of synaptophysin with Iba1 and homer1 does not guarantee that this labelling 
is representative of neuron-neuron chemical synapses. Homer1 has been shown to localize 
with metabotropic glutamate receptors on astrocytes (Buscemi et al., 2017). Due to the 
absence of parenchymal GFAP labelling in the present study, one can exclude these astrocytes 
as potential loci of homer1+ labelling, but one cannot rule out non-GFAP expressing 
astrocytes. As astrocytes are known to interact at synapses, this would not exclude the 
possibility of functional neuron-neuron chemical synapses being identified using this 
approach. However, the strong weight of probability is that many of the observed loci of 
colocalisation between synaptophysin, Iba1, and homer1 are chemical synapses between 
neurons, closely abutted by microglial processes. To definitively confirm that Iba1+ microglia 
are interacting with neurons and synapses would need transmission electron microscopy, but 
the fact that they are located adjacent to the somata or in the same anatomical position, which 
cannot discredit that they share the same microenvironment.  
3.4.4 – Chapter conclusions 
There is a wealth of literature that has explored the electrophysiological nature of neurons in 
sensory systems, but our knowledge of glial cells lags far behind. Based on this research, future 
work could employ patch-clamp electrophysiology on isolated sections of IC to determine the 
cellular characteristics of microglia to identify physiological differences between sub types. 
This Chapter shows that Iba1+ microglia, but not GFAP+ astrocytes, colocalise at synapses 
throughout IC, with a greater number in DCIC, a sub-region specialised to mediate top-down 
plasticity. This finding highlights the role for microglia in mediating different aspects of 
fundamental auditory processes. Furthermore, two new clusters of GAD67+ neurons were 
discovered which can be distinguished based on the total amount of Iba1+ contacts they 
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receive. These data further highlight the fundamental role microglia play in the organisation 
and function of sensory systems and by future researchers implementing the novel 
methodology in this Chapter, they could identify more diverse roles for microglia elsewhere in 
the brain.  
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Chapter 4 – Increased labelling of astrocytic 
GFAP+ in the ageing TgF344-AD rat inferior 
colliculus is similar to CA3 in hippocampus 
4.1 – Introduction 
4.1.1–Importance of investigating Alzheimer’s disease 
Classic hallmarks associated with the progression of AD include cerebral amyloid angiopathy, 
the development of parenchymal amyloid plaques, hyperphosphorylated tau protein 
associated neurofibrillary tangle formation, an upregulated chronic inflammatory mediated 
glial response, synaptic and neuronal loss and ultimately cognitive disturbances (Serrano-Pozo 
et al., 2011). In a clinical diagnosis, symptoms are thought to appear after a long prodromal 
stage (Amieva et al., 2008), highlighting the importance of understanding the early 
mechanisms leading to AD. A symptom commonly associated with AD is the loss of episodic 
memory, which is predominantly associated with processing in the hippocampus (Tulving and 
Markowitsch, 1998). Consequently, the hippocampus is the most common locus in AD studies 
and has been characterised to undergo ‘classic’ neuropathological hallmarks of AD, including 
neuronal loss and gliosis (Amenta et al., 1998, Padurariu et al., 2012, Navarro et al., 2018). 
Magnetic resonance imaging of AD patient brains has revealed that the hippocampus 
demonstrates a large reduction in grey matter volume (Kesslak et al., 1991). Histological 
analysis has also uncovered in CA1 and CA3 regions of hippocampus, a reduction in neuronal 
density in AD patients compared to healthy controls (Padurariu et al., 2012). In addition, 
numerous studies have characterised age-dependent astrocyte and microglial responses in 
the hippocampus of transgenic mouse models of AD (Irizarry et al., 1997, Girard et al., 2014) 
as well as human post-mortem tissue (Griffin et al., 1989, Simpson et al., 2010). 
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4.1.2 – Hearing loss is associated with early-onset dementia 
In humans, increasing levels of hearing loss have been correlated with an increased 
susceptibility to developing all-cause dementia (Lin et al., 2011b). The manifestation of 
dementia has multiple components, both non-modifiable such as genetic predispositions 
(including the expression of mutant human familial genes), and modifiable risk factors that 
contribute to the development. Numerous studies have uncovered that certain modifiable 
factors including obesity (Kivipelto et al., 2005), smoking (Zhong et al., 2015), alcohol 
consumption (Sabia et al., 2018) and a lack of exercise (Laurin et al., 2001) all contribute to 
increased risk in the early development of dementia. Interestingly, research investigating the 
aforementioned modifiable risk factors, Livingston et al. (2017) has revealed that the risk factor 
that accounts for more of the variance than any other single, modifiable mid-life risk factor to 
increased predisposition of dementia, is hearing loss. This link between hearing loss and 
dementia has highlighted the importance of exploring potential mechanisms in the auditory 
pathway that are involved/contribute to the development of dementia. 
Case-control studies have revealed that age-related hearing loss is associated with a 
premature development of cognitive dysfunction (Uchida et al., 2019). Cognitive behavioural 
tests have uncovered a link between hearing loss and cognitive dysfunction in the C57BL/6 
mouse model (Park et al., 2016). In addition, anatomical links have correlated that a loss of hair 
cells precedes a consequent loss of auditory nerve fibres (Hequembourg and Liberman, 2001) 
and as a result, the central auditory system has been found to compensate by increasing the 
gain of ascending signals (Salvi et al., 2017). The C57BL/6 mouse model demonstrates early-
onset hair cell loss correlating with a decrease in principal neurons in the CNIC and a 
substantial decrease in synaptic density (Kazee et al., 1995).  
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Atrophy of grey matter volume is prominent within basal temporal lobe, prefrontal cortex and 
the hippocampus (Salat et al., 2011). This link with hearing loss however, has uncovered a need 
for understanding age-related changes within the central auditory pathway that may link 
central auditory dysfunction to increased dementia risk. The IC is an integral nucleus in the 
central auditory pathway, that demonstrates mechanistic deterioration associated with age-
related hearing loss (Willott, 1986, Kazee et al., 1995, Palmer and Berger, 2018), and also, is the 
most metabolically active region in the brain (Sokoloff et al., 1977b). 
4.1.3 – Neuronal loss and gliosis are critical components in Alzheimer’s disease 
Gliosis and neuronal loss are fundamental hallmarks in the development of human AD. 
Microglia and astrocytes are the two main cell types that constitute the glial response. 
Microglia are resident immune cells present throughout the brain and constitute 
approximately 10% of all cells (van Rossum and Hanisch, 2004, Kettenmann et al., 2011, Nayak 
et al., 2014). Depending on the brain region, microglia demonstrate varying functions and are 
essential in developing neural circuits and related plasticity (Salter and Stevens, 2017). Chronic 
activation of microglia is considered to exacerbate the symptoms of AD (Solito and Sastre, 
2012), but the nature of this activation is unclear. Astrocytes are the most abundant cell type 
in the brain and are involved in a large repertoire of roles, including regulating 
neuroinflammation and active inter-cellular signalling (Sofroniew and Vinters, 2010). As a result 
of their range of functions, the particular role of astrocytes in AD is debated. Neuronal loss is 
a recognised outcome of AD, following deposition of Aβ peptides and subsequent Aβ plaques 
(Hardy and Higgins, 1992), yet the exact mechanical pathophysiology preluding this loss is 
currently unclear (De Strooper and Karran, 2016).  
98 | P a g e  
 
The measurement of anatomical age-dependent cellular changes throughout the 
development of AD in humans would be insightful in understanding the region of brain and 
specific mechanisms that cause morbidity. However, there are no techniques that enable age-
dependent observations of cell densities in living humans. Using rodents to better understand 
age-dependent AD progression is an achievable alternative. Animals such as rats are 
appropriate alternatives, due to the similar conserved phylogeny seen in the genetics that code 
for almost all cellular processes, which are conserved between species (Gibbs et al., 2004) 
An integral aspect of familial AD in humans is the progressive increase in insoluble Aβ, caused 
by a mutation in amyloid precursor proteins (O'Brien and Wong, 2011). In addition, a mutation 
of the PSEN1 gene causes the abnormal production of presenilin 1 proteins, which results in 
an inability to cleave amyloid precursor proteins into soluble derivatives (De Strooper, 2007). 
The Tg rat model has been developed to analyse changes in AD, via expression of the human 
amyloid precursor protein Swedish mutation and presenilin 1 genes mutations (Cohen et al., 
2013) each of which independently lead to familial AD in humans.   
Another interesting feature of the Fischer 344 rat model is the early development of 
presbycusis, which is appears at 12-months of age (Bielefeld et al., 2008), making this a 
potentially useful model to investigate age-related hearing loss. The TgF344-AD rat therefore 
affords the opportunity to investigate potential interactions between age-related hearing loss 
with activity of mutant human genes that lead to the development of AD. The Tg rat model 
has been shown to follow similar age-dependent AD development to humans, by 
demonstrating an active glial response, formation of insoluble Aβ fibrils that comprise 
extracellular plaques, further development of aggregated tau proteins, subsequent neuronal 
loss and cognitive disturbances (Cohen et al., 2013). Collectively, the parameters of this model 
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suit the investigation into cellular changes caused by the human familial AD genes and the 
effects of presbycusis. 
4.1.4 – Aims of this Chapter  
This Chapter aims to uncover if sub regions of IC (CNIC, DCIC, and LCIC) undergo age-
dependent glial adaptations and neuronal loss in the Tg model of AD, and how this compared 
to other regions of the brain. The time points included in this Chapter were 6-month (~18 
years old human), 12-month (~30 years old human) and 18-month (~45 years old human) rats 
(Andreollo et al., 2012). These time points are important because humans with either familial 
AD gene mutation would have developed AD by this point (Noguchi et al 1993). Therefore 
these time points were used to measure age-dependent pathological mechanisms in line with 
the progression of human AD (Langa and Levine, 2014), to identify if certain regions of the 
brain demonstrate more pronounced age-dependent glial responses under the pressure of 
the mutant human familial AD genes. The CA3 region of hippocampus was targeted in addition 
to the IC as this region has been identified to undergo neuronal loss in AD patients (Padurariu 
et al., 2012) and profound GFAP labelling in 3- and 6-month TgCRND8 mice (Ugolini et al., 
2018). Furthermore, the striatum has been investigated due to it demonstrating substantially 
different astrocyte anatomical and physiological properties to hippocampus (Chai et al., 2017). 
Finally, white matter tract regions including the corpus callosum and fimbria were used, as 
white matter varies substantially from grey matter in anatomy and physiology and microglia 
have been observed commensurate with Aβ deposits in AD (Uchihara et al., 1995).  
To identify if these regions underwent age-dependent neuronal loss, the marker NeuN was 
implemented as a neuronal specific nuclear antigen that marks neuronal cell bodies in 
comparison to other regions of the brain. The label CD11b was used in this Chapter as a marker 
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of activated microglia, to identify if there was heterogenous expression across the brain 
regions as a result of age-dependent changes in the Tg model. In addition to Chapter 3, this 
Chapter utilised the marker GFAP to identify if GFAP+ astrocytes became present in the IC of 
the Tg model and if they are morphologically different in contrast to other regions of the brain. 
4.2 – Methodology 
4.2.1 – Tissue processing and immunohistochemical labelling 
Animals were culled at the University of Manchester in accordance with Schedule 1 (table A 
section 4) of the Animals (Scientific Procedures) Act 1986. Animal tissue was processed using 
the methods outlined in Chapter 2. Parasagittal sections were immunohistochemically labelled 
to report CD11b+ activated microglia, GFAP+ reactive astrocytes and NeuN+ neurons (See 
Chapter 2.4.2 for antibody details) in CA3, striatum, corpus callosum, fimbria, CNIC, DCIC and 
LCIC. Sections were cut sequentially at 10µm using a cryostat (Leica CM3050s).  Sections were 
taken from littermate wild type and Tg rats aged 6- (wild type n=4, Tg n=5), 12- (wild type 
n=10, Tg n=9) and 18-month-old (wild type n=10, Tg n=10). Sections were labelled for CD11b 
(a marker indicative of activated microglia), GFAP (intermediate filament protein of reactive 
astrocytes) and NeuN (nuclei of post mitotic mature neurons). Fluorescent labelling of CD11b, 
GFAP and NeuN (all 1:500 in PBS) were implemented using the methods outlined in Chapter 
2.3.2. The Alexa Fluor 488 fluorescent goat anti-rabbit secondary antibody was used to bind 
to the GFAP antibody (1:250). The Alexa Fluor 555 goat anti mouse was used to bind to the 
CD11b and NeuN antibodies (both 1:250) on separate sections. CD11b and GFAP were double 
labelled while NeuN was single labelled.  
For chromogenic neuronal labelling, the sections were obtained using the methods outlined 
in Chapter 2.3. Sections were initially washed 3x5 minutes with PBS. The Sections were then 
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incubated in a citrate 6.0pH antigen retrieval buffer for 20 minutes at 80ºC. The sections were 
then washed 3x3 minutes in PBS and blocked and permeabilised in 5% normal goat serum and 
0.05% Triton X-100 in PBS for one hour at room temperature. After blocking, goat anti-mouse 
NeuN was added to blocking solution and incubated overnight at 4°C in a humidified chamber. 
The next day, sections were washed 3x5mins in PBS and then immersed in anti-mouse IgG 
(1:1000) for 1 hour at room temperature, then agitated with an Avidin-Biotin solution (Vector 
Labs ABC kit) for 30 minutes at room temperature to amplify labelling. Finally, the sections 
were developed using a Vector DAB peroxidase substrate kit for 10 minutes at room 
temperature. 
4.2.2 – Image acquisition 
Fluorescent confocal micrographs were taken using a Leica SP5 confocal microscope. Images 
were taken from around the lateral ventricle (CA3, striatum, fimbria and corpus callosum) and 
the IC (CNIC, DCIC and LCIC). The lasers were set up to detect the secondary antibody specific 
fluorophores and the optimisation procedure and methodology outlined in Chapter 2.5 was 
implemented to detect signals from secondary antibodies bound to CD11b, GFAP and NeuN 
respectively. Images from the microscope were taken using the wide-stage function that 
enabled imaging of the whole IC and desired sub regions around the lateral ventricle in x, y & 
z dimensions. All images that were quantified were taken using the 40x objective (NA=1.25) 
and the pixel sizes are x & y=0.7583µm and z=3.8µm across slices. These parameters were 
optimised to sample a wide enough region to cover all sub-regions. Acquisition parameters 
were kept the same for all sections, to enable fair between-groups comparisons. 
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4.2.3 – Image analyses 
Methods for acquisition of exported images is outlined in Chapter 2.6. Images were stacked 
and presented as 2D maximum intensity projections to represent independent brain regions. 
Each label was acquired as individual monochrome images and a 303x455x10µm region of 
interest was outlined within each brain region. Regions of interest were utilised to compare 
labelling density as an indirect representation of cell number, in opposition to measuring 
whole area counts. This approach was used to consistently compare labelling across numerous 
sub-regions and develop an understanding of how the various factors influence cell type 
anatomy. Measurements taken from CA3 incorporated cells external to the principal cell layer. 
This specific size was used to cover a large enough, but comparable size across each brain 
region. 303x455x10µm regions of interest were pre-processed prior to analysis: i) contrast was 
enhanced by 0.005% (note that no specific pixel intensity density analyses were conducted, 
making this an appropriate method), ii) thresholding using the IsoData algorithm converted 
the labelling into binary images, iii) parameters in the analyse particles plugin were set to 
exclude labelling below 30µm2 with no circularity parameters set. These methods produced 
cell counts and the percentage field of views for each positively labelled marker. 
2D rendered maximum intensity projections of GFAP+ labelling from regions of interest in 
CA3, striatum and CNIC were used to analyse and compare astrocyte morphologies. These 
regions were selected due to the consistent level of GFAP+ cell bodies present that could be 
quantified. Five cells from each region of interest were selected and 2D Sholl analyses 
conducted, as this provided a representative sample of cell morphology for each brain region. 
Parameters of the Sholl analysis were set to measure intersections with process ramifications 
at 0.76µm equidistantly radiating concentric circles until the furthest intersection was met. This 
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specific distance covered representative measurements of cell process branch points and 
junctions across brain regions. Sholl quantification in this Chapter included, i) the total number 
of intersections, ii) longest process span and iii) ramification density, as measurements of cell 
morphology.  
Imaging of chromogenic NeuN labelled sections were taken using a 3D Histech Pannoramic 
250 slide scanner. Chromogenic NeuN analysis was conducted using the 3dhistech CaseViewer 
software. To consistently and representatively count NeuN+ neurons and disregard false 
positives from cellular debris, manual cell counts were conducted for each NeuN+ cell in 
303x455x10µm regions of interest in CA3, striatum, CNIC, LCIC and DCIC. 
4.2.4 – Statistical analyses 
Results from these analyses were recorded in Microsoft Excel and were plotted using Prism 
(GraphPad) and statistically analysed using SPSS (v24, IBM). For cell counts and percentage 
field of view, sample size (n) in the text represents individual animals and in the Sholl analyses 
represents individual cells. Significance was set to p<0.05 and determined using 3-factorial 
between groups ANOVA to measure the effects of brain region, age and genotype. Post-hoc 
Tukey HSD tests were undertaken where appropriate and effect sizes were determined by eta 
squared and partial eta squared analyses as appropriate. Effect sizes were employed to 
determine the validity of the significance found between completely different brain regions 
been contrasted. The effect sizes were used to quantify the strength of the relationship 
between factors, small effect sizes refer to a weak relationship (<0.01), medium that there is a 
good relationship (<0.09) and large indicates a strong relationship (>0.25). Weak relationships 
between factors infer that the probabilities derived from the tests have reduced validity. 
Significance between factors from post-hoc analyses displayed in figures are referred to as 
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stars (*= P≤0.05; **= P≤0.005; ***= P≤0.001; **** P≤0.0001). The alpha level was set at P<0.05 
for all statistical comparisons. 
4.3 – Results  
4.3.1 – No observed age-dependent neuronal loss in TgF344-AD model 
Region of interest analysis was implemented over whole area counts as a more representative 
way to compare brain regions and understand the distributions of cells. Brains from all groups 
(wild type and Tg) were analysed in terms of cell counts and percentage field of view analyses. 
NeuN+ cell counts revealed no trend towards varying cell counts across all categories within 
brain regions (Figure 4.1). Cell counts demonstrated that 6-month-old wild type striatum had 
the highest number of NeuN+ cells, reaching 171±30 per 0.138mm². Fimbria had the lowest 
number of cells, with 1 cell per 0.138mm² in the 12-month-old Tg category, indicative of 
negligible NeuN+ labelling. 
Percentage field of view analyses demonstrated similar trends across categories to cell counts 
(Figure 4.2), however, the CA3 region demonstrated much higher levels of NeuN+ labelling 
reaching 21.42% per 0.138mm² in the 6-month-old wild type category. As a result of the 
densely packed neurons found in CA3, percentage field of view was a better measurement to 
quantify fluorescent NeuN+ labelling. NeuN labelling in fimbria covered 0.08% per 0.138mm², 
which was the lowest across the 12-month-old wild type groups.  
Closer inspection of fluorescent NeuN+ labelling revealed noticeable increases in NeuN+ 
labelling between 12 and 18 months Tg groups that did not resemble neuronal morphology 
(Figure 4.3). Labelling in Figure 4.3E resembled NeuN+ neuronal cell bodies (Panzanelli et al., 
2007), compared to labelling in Figure 4.3F, which looks like damaged neurons with 
105 | P a g e  
 
surrounding cellular debris as observed by Streit and Kreutzberg (1988). By implementing 
fluorescent labelling made it impossible to disentangle neurons from cellular debris. Therefore, 
to better represent the number of neurons chromogenic NeuN labelling was implemented and 
subjected to manual cell counts.
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Figure 4.1. Boxplots displaying NeuN+ cell counts from 303x455x10µm regions of interest. Striatum had consistently the highest density of 
NeuN+ cells. The 6-month Tg group has the highest number of neurons in CA3 hippocampus. The white matter tract region fimbria had low 
levels of labelling throughout. All regions of IC demonstrated similar trends in neuronal numbers across groups. There was no observed NeuN+ 
neuronal loss up to 18-months of age in the Tg model using this approach – however, this could be as a result of non-specific labelling of cellular 
debris.
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Figure 4.2. Boxplots displaying the percentage field of view covered by NeuN+ cells across 303x455x10µm regions of interest. CA3 had the overall 
highest neuronal labelling. Similar to cell counts, fimbria demonstrated negligible labelling across all groups, with the most labelling in the 6-
month Tg group reaching 1%. All IC regions displayed similar trends across all categories. There was no observed significant change in NeuN+ 
labelling up to 18-months of age in the Tg model. 
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Figure 4.3. Example micrographs of NeuN+ labelling from CNIC. (A), 12-month wild type. (B) 
18-month Tg.  (C&D), median filtered monochrome examples of (A)&(B). (E&F), masks of cells 
counted after (B)&(D) were thresholded using the IsoData algorithm. Of note, differences in 
neuronal morphology between wild-type (E) and Tg (F) was evident. Labelling in (F) resembles 
damaged neurons and the surrounding labelling is similar to the cellular debris described by 
Streit and Kreutzberg (1988) (magenta arrows). To compensate for this, parameters in the 
analyse particles plugin were set to exclude labelling under 30µm2. This did not compensate 
for the increases observed at the 18-month time point, so chromogenic labelling was 
implemented to enable differentiation of neurons from debris (Figure 4.4).
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A drawback to fluorescent labelling is that it merged debris with cell bodies and resulted in 
unrepresentative images. To combat this, chromogenic immunohistochemical labelling of 
NeuN was implemented and this enabled the differentiation of debris from cell bodies. To best 
encapsulate the number of neurons present, the positive cells were subjected to manual cell 
counts. 303x455x10µm regions of interest from CA3, striatum, CNIC, LCIC and DCIC (excluding 
fimbria due to negligible labelling) at 6- (wild type n=3, Tg n=8), 12- (wild type n=9, Tg n=12) 
and 18-month-old (wild type n=12, Tg n=11) rats were analysed. Figure 4.4 displays an 
example micrograph taken from around the lateral ventricle and demonstrates the 
demarcation of bounding regions of interest in CA3 and striatum. The same process was used 
to isolate sub regions of IC for cell counts. 
Cell counts revealed that the highest density of NeuN+ cells were in the CNIC and striatum 
across all categories with the maximum in the 12-month CNIC Tg group, which contained a 
mean of 215 neurons per 0.138mm² (Figure 4.5). The CA3 had consistently lower counts than 
the other regions reaching a maximum of 79 neurons per 0.138mm² in the 6-month wild type 
group, although this was due to the inherent different anatomical distribution of neurons in 
CA3.   
Similar to fluorescent NeuN+ cell counts and percentage field of view, chromogenic cell counts 
revealed that age and genotype did not affect cell density. These results confirm that up to 
18-months in the Tg model, that there is no NeuN+ cell loss observed across the CA3, striatum, 
CNIC, DCIC and LCIC between 6- and 18-months of age.
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Figure 4.4. (A) Representative micrograph taken of chromogenic NeuN+ labelling from around the lateral ventricle. 5x magnification. Scale bar 
200µm in (A) same in (B). Rostral (left), caudal (right), same orientation across all images. (B) 303x455x10µm regions of interest demarked by blue 
rectangles as examples of bounding boxes. Neurons within the blue boxes, CA3 hippocampus (left) and striatum (right), were subjected to manual 
cell counts. (C) Higher magnification (14x) example of CA3 hippocampus. Notice the difference to fluorescent NeuN+ labelling in Figure 4.3C. 
Scale bar 100µm in (C) same in (D). (D) example of striatum. By implementing chromogenic labelling and manual cell counts enabled the 
discrimination of neurons from debris.
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Figure 4.5. Boxplots displaying chromogenic NeuN+ cell counts from 303x455x10µm regions of interest. The highest number of neurons were 
found in the striatum. 6-month wild type had the highest number of cells in CA3 hippocampus. Similar to fluorescent labelling, all regions of IC 
demonstrated similar trends in neuronal counts. There was no neuronal loss observed up to 18-months old in the Tg model.
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4.3.2 – CD11b+ and GFAP+ labelling is elevated at 12- and 18-months in the 
TgF344-AD model 
The level of CD11b+ and GFAP+ labelling was investigated comparing age-related changes in 
wild type and Tg rats. Example regions of interest are demarked in Figure 4.6. Labelling from 
these regions of interest were used throughout the whole Chapter. Micrographs were taken 
around the lateral ventricle adjacent to the hippocampus and striatum labelled with CD11b 
and GFAP antibodies (Figure 4.7). All sections showed a high density of GFAP+ labelling of the 
glia-limitans externa border surrounding the ventricle, which demonstrated increased density 
of labelling adjacent to the striatum in Tg 12- and 18-month sections (Figure 4.7D&F 
respectively). Myelinated white matter fibre tracts adjacent to the somatosensory cortex 
(dorsal to ventricle) and CA3 demonstrated elevated numbers of CD11b+ labelled cells in 
contrast to the grey matter regions in the 12- and 18-months-old Tg sections. Striatum was 
devoid of CD11b+ cells across all sections. In contrast, CA3 CD11b+ labelled cells became 
apparent in the 18-month wild-type and 12-month and 18-month Tg groups. GFAP+ labelled 
cells were visible in CA3 and striatum throughout all sections. Fimbria and corpus callosum 
demonstrated sparse GFAP+ labelling throughout. The most densely labelled GFAP+ regions 
were observed in the 12-month and 18-month Tg CA3 and striatum (Figure 4.7D&F 
respectively). CD11b+ and GFAP+ labelled cells increased in density in the aged Tg groups.  
Micrographs were also taken of the IC (Figure 4.8). A similar GFAP+ glial response detected 
around the lateral ventricle was observed encompassing the glia-limitans externa surrounding 
the dorsal border of the IC in Tg sections. CD11b+ labelled cells were minimal in the IC of the 
6-month wild type group (Figure 4.8A) in contrast to all other groups, which demonstrated a 
higher density of CD11b+ labelling, with increased cell numbers in Tg groups. GFAP+ labelling 
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was present throughout all sections. The Tg groups demonstrated a higher density of GFAP+ 
labelling in the neuropil than wild type, with a markedly higher number of cells in the centre 
of the 12- and 18-month groups (Figure 4.8D&F). Interestingly, glial labelling in IC, to some 
extent mirrored that observed in the CA3. To quantify glial responses in the IC, regions of 
interest outlining the CNIC, LCIC and DCIC were contrasted to the regions around the lateral 
ventricle outlined in Figure 4.6. 
 
 
Figure 4.6. Example bounding 303x455x10µm regions of interest from each brain region that 
were used throughout the whole Chapter. Boxes in (A) represent regions from around the 
lateral ventricle, Green (corpus callosum), yellow (striatum), magenta (CA3 hippocampus), cyan 
(fimbria). Boxes in (B) represent regions from within the IC, white (DCIC), pink (CNIC and grey 
(LCIC). Scale bar 200µm in (A) and (B). White arrowhead in (A) points to putative artefact. 
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Figure 4.7. Representative micrgraphs taken from around the lateral ventricle to quantify 
CD11b+ (magenta) and GFAP+ (green) labelling. 303x455x10µm GFAP+ and CD11b+ labelling 
in (A&C&E) wild type sections is noticably lower than in (B&D&F) Tg sections. Particularly 
notice the denser labelling in Tg 12- and 18-month groups. White arrowhead highlights an 
artifact in (A). Scale bar and axis in (A) 200µm; dorsal (up), ventral (down), rostral (right), caudal 
(left), applies to all panels. Specific regions were quantified across groups using the regions of 
interest demarked in Figure 4.6A.
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Figure 4.8. Representative micrographs taken from the IC, summarising CD11b+ (magenta) 
and GFAP+ (green) labelling. Similar to the observed labelling in Figure 4.7, labelling in 
(A&C&E) wild type sections is noticeably lower than in (B&D&F) Tg sections. Particularly notice 
the denser labelling in the Tg groups. White arrowheads indicate putative artifacts. Scale bar 
in (A) 400µm scale bar applies to all panels and axis dorsal (up), ventral (down) rostral (left), 
caudal (right). Specific regions were quantified across groups using the regions of interest 
demarked in Figure 4.6A.
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There was a higher level of CD11b+ and GFAP+ labelling in the Tg model, particularly from 6- 
to 12-months. Figure 4.9 demonstrates the increase in labelling observed from 6- to 12-
months in the Tg groups CA3, fimbria, CNIC and DCIC. CD11b+ labelling substantially 
increased from 6- to 12-months in fimbria (Figure 4.9B&E respectively). There was also an 
increase in labelling in CA3, albeit less pronounced (Figure 4.9C&F). Oppositely, GFAP+ 
labelling in fimbria increased from 6- to 12-months (Figure 4.9B&E), but not as substantially 
as CA3 (Figure 4.9C&F). Notice, the increased size of GFAP+ cell ramifications from 6- to 12-
months, this is quantified by Sholl analysis in section 4.4.5. 
GFAP+ cell processes were larger and more ramified in CA3 than in fimbria, where they were 
less ramified, and had long axes, which is consistent with previous studies (Wolburg et al., 
2009). GFAP+ cells also increased in ramification density and soma size at 12-months. In the 
parenchyma of both CNIC and CA3 starting at 12-months, pockets of GFAP+ labelling 
increased in density with CD11b+ labelling (Figure 4.10) and resembled reactive gliosis 
surrounding putative amyloid plaques, similar to observations in studies of human post-
morten tissue and other transgenic models (Orre et al., 2013, Perez-Nievas and Serrano-Pozo, 
2018, Sakakibara et al., 2019). Labelling of both glial markers in IC demonstrated a similar 
increase in density from 6-months to 12-months. GFAP+ labelling also increased in density 
from 6- to 12-months and changed in morphology.  
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Figure 4.9. Micrographs contrasting CD11b+ activated microglia and GFAP+ reactive 
astrocytes in 6- and 12-month-old Tg sections. (A) 6-month-old Tg section around the lateral 
ventricle labelling the fimbria (B) and CA3 (C). (D) 12-month-old Tg section around the lateral 
ventricle labelling the fimbria (E) and CA3 (F). Scale bar 50µm. (G) 6-month-old Tg IC section, 
labelling CNIC (H) and DCIC (I). Scale bar 200µm. (L) 12-month-old Tg IC section, labelling 
CNIC (K) and DCIC (L). Both markers increase in density in the 12-month sections. Notice the 
localised pockets of increased CD11b+ and GFAP+ labelling resembling reactive gliosis 
(Kamphuis et al., 2012, Rodriguez et al., 2014).  Scale bar in (A) 200µm applies to D, scale bar 
in G 200µm applies to J and scale bar in B 50µm applies to C, E, F, H, I, K and L. 
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Figure 4.10 Maximum intensity projection of a confocal micrograph displaying reactive gliosis 
in CNIC.  CD11b+ activated microglia (magenta) and GFAP+ reactive astrocyte (green) in a 12-
month-old Tg IC section. Scale bar 20µm. This response appears at different points across the 
parenchyma from 12-months in the Tg rat model CNIC similar to hippocampus. The labelling 
appears to have similar anatomical charcteristics to reactive gliosis observed responding to 
amyloidosis seen in hippocampus (Sakakibara et al., 2019). 
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4.3.3 – CD11b+ microglial cell counts and percentage field of view increased in 
CA3 hippocampus 
To investigate sub-region-specific differences in CD11b+ labelling, regions of interest were 
outlined, processed and analysed as in Figure 4.11. Figure 4.12 shows boxplots for every region 
of interest. The highest average number of CD11b+ cells were found in the 18-month-old Tg 
fimbria (mean=103, standard deviation±61 per 0.138mm²) and corpus callosum (118±69). The 
lowest numbers were found in the 6-month Tg striatum (2±1). Cell counts in CA3 were highest 
in the 18-month Tg group (59±24) and lowest in 6-month Tg (6±7) and CNIC, LCIC and DCIC 
demonstrated similar numbers to each other.  
A 3-factorial ANOVA of cell counts with brain region, age and genotype as factors identified 
no interactions (F(12,265) = 0.380, p = 0.970). A 2-factor ANOVA measuring age and genotype 
revealed that CA3 was the only region to demonstrate a two-way interaction (F(2,42) = 3.798, 
p=0.030). Partial eta squared uncovered a large effect size (ηp2>0.25) and post-hoc analysis 
revealed age differences between all categories (all p<0.001). However, 1-factor ANOVA of 
brain region (F(6,265) = 33.631, P = <0.001), age (F(2,265) = 5.651, P = 0.004) and genotype 
(F(1,265) = 9.634, P = 0.002) revealed independent effects on cell count and an eta squared 
demonstrated that the effect sizes were large (all ηp2>0.25). Post-hoc analyses via Tukey HSD 
tests showed fimbria and corpus callosum were different from all other regions (all p<0.001). 
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Figure 4.11. Micrographs demonstrating the methodology to process CD11b+ (magenta) and GFAP+ (green) labelling prior to cell count and 
percentage field of view analyses from a 6-month Tg section. (A) 6-month old Tg section from IC, yellow box outlines an example 303x455x10µm 
region of interest from the CNIC. (B&C) CD11b+ and GFAP+ labelling were isolated by splitting CD11b+ (B) and GFAP+ (C) into individual 
monochrome images. (D&E) Output from implementing a median filter to remove non-specific labelling. (F&G) Images threholded using the 
IsoData algorithm to binarise positive labelling. (H&I) Consequent masks of markers after setting parameters to exclude sizes under 30µm for the 
measurements.
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Figure 4.12. Boxplots displaying CD11b+ cell counts across 303x455x10µm regions of interest. CA3 hippocampus demonstrated age-dependent 
increases in the 12-month Tg, 18-month wild type and 18-month Tg groups, which were significantly higher than the other groups. Fimbria and 
corpus callosum showed the highest CD11b+ cell counts across all regions. CNIC flowed a similar trend to CA3, with the largest differences 
between 6- and 18-months, but these did not reach the criterion for significance. Striatum has the lowest CD11b+ labelling across all brain regions.
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In addition to cell counts, percentage field of view analyses were used to measure CD11b+ 
labelling. Figure 4.13 illustrates boxplots for every region of interest.  The highest percentage 
fields of view were found in the 18-month-old Tg fimbria (3.29%±2.65) and corpus callosum 
(3.55%±2.23) and the lowest in the 12-month wild type striatum (0.09%±0.07). CA3 and CNIC 
displayed similar trends in increased percentage field of view with age and genotype. LCIC and 
DCIC demonstrated similar percentage field of views across factors. 
A 3-factorial ANOVA of percentage field of view contrasting brain region, age and genotype 
identified no interactions between factors (F(12,265) = 0.483, p = 0.924). Unlike cell counts, a 
2-factor ANOVA of individual brain regions measuring age and genotype revealed that CA3 
did not demonstrate a two-way interaction (F (2,42) = 2.067, p=0.139). Partial eta squared 
uncovered a large effect size (ηp2>0.25). However, a post-hoc analysis did reveal age 
differences between all categories (all p<0.001). However, similar to cell counts, 1-factor 
ANOVA of brain region (F(6,265) = 22.212, p = <0.001), age (F(2,265) = 6.230, p = 0.002) and 
genotype (F(1,265) = 13.650, p = <0.001) revealed independent effects on percentage field of 
view and a partial eta squared demonstrated that the effect sizes were large (all ηp2>0.25). 
Post-hoc analyses via Tukey HSD tests showed differences from fimbria and corpus callosum.
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Figure 4.13. Boxplots displaying CD11b+ percentage field of view measurements across 303x455x10µm regions of interest. Similar to cell counts 
(Figure 4.12), CA3 hippocampus demonstrates age-dependent increases in the 12-month Tg, 18-month wild type and 18-month Tg groups. 
Fimbria and corpus callosum do not display age-dependent changes, but consistently have the highest level of CD11b+ labelling across groups. 
CNIC follows a similar trend to CA3, with a large increase in labelling in the 12-month Tg group. CD11b+ labelling in striatum is negligible. These 
results highlight the similarity in CD11b density between CA3 and CNIC and that the white matter tracts have a higher level of activated microglia 
independent of experimental factors.
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4.3.4 – Hippocampus and central nucleus inferior colliculus display pronounced 
age dependent GFAP+ labelling, increasing at 12- and 18-months in the TgF344-
AD model 
To investigate sub-region-specific differences in GFAP+ labelling, regions of interest were 
outlined, processed and analysed by the same methods used in (Figure 4.11). Figure 4.14 
shows boxplots for every region of interest. The highest number of GFAP+ cells were found in 
the 18-month-old Tg CA3 (219±61 per 0.138mm²) and the lowest numbers were found in the 
6-month wild type fimbria (18±10 per 0.138mm²). Striatum demonstrated similar trends to 
CA3, with the highest numbers in the 18-month Tg group (203±82 per 0.138mm²). All other 
regions showed little difference across the categories.  
A 3-factorial ANOVA of cell counts contrasting brain region, age and genotype identified no 
interactions between factors (F(12,265) =0.395, p = 0.965). 2-factor ANOVA revealed that brain 
region and age influenced cell count (F(12,265) = 2.769, p = 0.001) and a partial eta squared 
demonstrated that the effect size was medium (ηp2 = 0.012). Post-hoc analyses showed that 
CA3 and striatum were similar in number (p=0.838), but different to all other regions (all 
p=<0.001) and CNIC was similar to fimbria and corpus callosum (p= 0.764 and 0.993 
respectively). 
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Figure 4.14. Boxplots displaying GFAP+ cell counts across 303x455x10µm regions of interest. CA3 region hippocampus demonstrated the most 
profound increases in GFAP+ cells between the 18-month Tg group and the 6-month wild type and Tg groups. Striatum counts followed a similar 
trend to CA3, with the highest numbers found in the 18-month Tg group and the lowest in the 6-month wild type. CNIC demonstrated a near 
doubling in cell number from 6-month groups to 12- and 18-month Tg groups, which is similar to CA3 and striatum, albeit less cells.
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In addition to cell counts, percentage field of view analyses were used to measure GFAP+ 
labelling. Figure 4.15 depicts boxplots for every region of interest. The highest percentage 
fields of view were found in the 12-month-old Tg CNIC (8.27%±4.72 per 0.138mm²) and DCIC 
(9.35%±8.47 per 0.138mm²) and the lowest in the 6-month wild type fimbria (0.41%±0.22 per 
0.138mm²). CA3, striatum and CNIC displayed similar trends in increasing percentage field of 
views with age and genotype. 
A 3-factorial ANOVA of percentage field of view contrasting brain region, age and genotype 
identified no interactions between factors (F(12,265) = 0.983, p = 0.466). Post-hoc analyses 
showed differences between 6 and 18 months (p=0.001) and similarities between CNIC, CA3, 
striatum and LCIC. 1-factor ANOVA of individual brain regions revealed that the CNIC was the 
only region to demonstrate effects, both age (F(2,33) = 6.447, p=0.004) and genotype (F(1,33) 
= 5.515, p=0.025) independently influenced the percentage field of view.  Eta squared analysis 
showed that the effect size was large (ηp2>0.25), demonstrating the validity of the results. 
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Figure 4.15. Boxplots displaying GFAP+ percentage field of view measurements across 303x455x10µm regions of interest. CNIC demonstrated 
the largest increase in levels of GFAP+ labelling between the 6-month Tg and the 12-month Tg groups. CA3 and striatum follow a similar trend 
to CNIC, albeit less pronounced. DCIC demonstrated high variability with the highest levels of labelling in the 6-month Tg group. The high 
variability is as a result of the dense layer of labelling adjacent to the ventricle, likely indicative of the protective nature to the circulating 
cerebrospinal fluid. These measurements with the results shown in Figure 4.13, highlight the similarity in GFAP+ labelling increases in the Tg 
model between CA3 and CNIC from 12-months. Differences in results between cell counts and percentage field of view, suggests astrocytes differ 
in morphology between regions.
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4.3.5 –Sholl analyses reveals GFAP+ astrocytes in CA3 undergo age-dependent 
changes in the Tg model 
Utilising the marker GFAP+ enabled the labelling of ramified astrocytes. Different brain regions 
were observed to display various astrocyte morphologies. Figure 4.16 demonstrates observed 
anatomical differences in GFAP+ labelled cells across CA3, striatum and CNIC. To quantify 
these observations, a Sholl analysis was undertaken as a measurement of astrocyte 
morphology. The CA3, striatum and CNIC were included in this analysis due to their 
contrastable level of cell bodies with ramified morphologies. Figure 4.17 illustrates the process 
undertaken to isolate and quantify the astrocytes. The analysis was implemented on a total of 
545 astrocytes from CA3, striatum and CNIC at 6- (CA3 and striatum wild type n=20, Tg n=20 
and CNIC n=10, n=25), 12- (CA3 and striatum wild type n=30, Tg n=35 and CNIC n=40, n=30) 
and 18-months old (CA3 and striatum wild type n=40, Tg n=35 and CNIC n=45, n=35) (Figure 
4.18). This allowed the quantification of the total number of intersections, the farthest-ramified 
processes and the most ramified cells (Figure 4.19, 4.20&4.21 respectively). 
Comparing the groups highlighted GFAP+ cells in striatum and CNIC were similar throughout, 
and the CA3 had consistently larger cells from 12-months with the largest separation apparent 
in 18-month Tg group, which reached a total number of 11 intersections. The smallest cells 
were found in the 6-month striatum Tg group were the cells reached 7 intersections. These 
changes uncover that the CA3 region demonstrates age-dependent increases in the number 
of intersections, particularly in the 18-month Tg group.
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Figure 4.16. Representative example micrographs taken from 18-month-old wild type 303x45x10µm regions of interest to visualise GFAP+ 
labelled cellular morphologies across the CA3 hippocampus, striatum and CNIC. Notice the vast differences in GFAP+ morphologies across the 
categories. Cells in CA3 appear highly ramified in contrast to the other regions. Scale bar 50µm.  Axis represents dorsal (up), ventral (down), caudal 
(right), rostral (left).
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Figure 4.17. Cell isolation and Sholl analysis process. (A) Monochrome 303x455x10µm region of interest image outlining an individual GFAP+ 
cell in CA3 hippocampus. Scale bar 50µm (B) cropped cell. Scale bar 10µm same as in (C). (C) Centre of the soma marked, with radiating equidistant 
0.76µm concentric circles from the point of origin. Each intersection with the binary representation of the cell is counted as an intersection. Notice 
the cell processes are not fully connected, due to the thinness of the sections (10µm), thicker sections (≥45µm) would provide a complete 
representation of the cell, however, this was beyond the scope of this study.
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Figure 4.18 Line graphs contratsing the mean values of the age-dependent results from Sholl analysis in CA3, striatum and CNIC of wild type and 
Tg rats. The CA3 displays the highest number of intersections across categories. The striatum and CNIC display similar numbers, with the CNIC 
being marginally higher. The highest number and largest separation of intersections between groups is found between CA3 and other regions in 
the 18-month Tg category. CA3 is the only region to display an age-dependent and genotype influence on increasing the number of intersections 
in the Tg model. 
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To explore aspects of astrocyte morphology, the total number of intersections were quantified 
(Figure 4.19). Every intersection of GFAP+ labelling intersecting with the radiating concentric 
circles from the Sholl analysis were collated. The total number of intersections were then 
contrasted across the categories (Figure 4.19). Total intersection analysis revealed that the CA3 
rangeD from a mean of 201±68 intersections per cell in the 6-month wild type group, to 
415±170 intersections per cell in the 18-month Tg. Striatum ranged from 141±61 intersections 
per cell in the 6-month wild type group, to 214±92 intersections per cell in the 18-month Tg 
group. CNIC ranged from 187±80 intersections per cell in the 6-month Tg group to 247±90 
intersections per cell in the 6-month wild type group. 
A 3-factorial ANOVA revealed that age, genotype and brain region interacted and collectively 
influenced the total number of intersections (F(4,527) = 2.505, P=0.041). Post hoc analysis 
revealed the age-dependent increase in total number of intersections is between 6-months to 
12- and 6- to 18-months (both P=<0.001) and that all brain regions were independent from 
each other (all P=<0.001). Interestingly, 1-factor ANOVA revealed that the CA3 was the only 
region to show an age-dependent increases with age (F(2,174) = 9.937, P=<0.001) and 
genotype (F(1,174) = 4.111, P=0.044) independently. The striatum demonstrated an age-
dependent increase in total number of intersections with age (F(2,174) = 3.361, P=0.037), but 
not genotype and the CNIC displayed no influences across factors. 
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Figure 4.19. Boxplots displaying the total number of intersections recorded from Sholl 
analysis. CA3 had the highest total number of intersections in all groups. There were 
consistently higher numbers of intersections in the Tg groups compared to the wild type in 
CA3. Striatum 18-months Tg had a higher number of intersections than 6-month wild type and 
12-month Tg. CNIC had marginally more intersections than the striatum, with no clear 
genotype or age-dependent influences. This figure displays that astrocytes demonstrate 
regional specific morphologies depending on brain region and genotype.
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To address another aspect of astrocyte morphology, the furthest radiating processes were 
measured from the soma of each cell as a measure of astrocyte span, to determine whether 
astrocyte processes extended further across factors (Figure 4.20). In the CA3, the largest span 
was in the 12-months Tg, 18-months Tg and 12-months wild type, all with the same distance 
of 42.6µm in contrast to the 6-months wild type spanning 32.7µm. In striatum, the farthest 
span distance was much lower than in CA3, with the largest span reaching 31.2µm in the 18-
months Tg groups, and the lowest in 6-months wild type at 23.6µm. The distances in CNIC 
were inbetween CA3 and striatum, with the highest span reaching 36.5µm in the 18-months 
Tg group and the lowest in 6-months Tg at 29.6µm. 
A 3-factor ANOVA revealed that age, genotype and brain region interacted and influenced 
astrocyte branch length (F(4,527) = 2.642, P=0.033). Post-hoc analysis uncovered an age-
dependent increase in branch length between 6- to 12- and 18-months across all groups 
(P=0.004 and P=<0.001 respectively) and that all regions were distinctly different in span from 
each other (all P=<0.001). Although astrocytes in the striatum displayed shorter branch lengths 
than in CA3, a 2-factor ANOVA highlighted that age and genotype interacted and influenced 
striatum astrocyte process span (F(2,174) = 3.824, P=0.024). Post-hoc analysis revealed age-
dependent changes between 6- and 18-months (P=0.005) and 12- and 18-months (P=0.029). 
1-factor ANOVA showed that only age influenced the CA3 astrocyte span (F(2,174) = 7.419, 
P=0.001) and post-hoc analysis revealed the difference is between 6- to 12- and 18-months 
(P=0.003 and P=<0.001 respectively). Interestingly, no factors influenced astrocyte process 
span in the CNIC. 
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Figure 4.20 Boxplots displaying the maximum branch length recorded from the Sholl analysis. 
Results from GFAP+ cells in the CA3 demonstrated an age-dependent increase in wild type 
and Tg groups from 6- to 12- and 18-months, with the largest difference between 18-month 
TG and 6-month wild type. Striatum displayed significant increases in GFAP+ branch span from 
the 6-months wild type and Tg groups to the 18-month Tg group. CNIC decreased in process 
span from 6-month wild type to the 6-month Tg group, but overall does not reveal age-
dependent or genotypic influences. CA3 underwent age-dependent and genotypic branch 
alterations, striatum also does at 18-months and CNIC span remains unaffected.
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Another anatomical feature measured was the maximum number of intersections at any 
distance from the centre of the soma, which was an indirect measure of astrocyte ramification 
density (Figure 4.21). The most ramified astrocytes were found in the 18-months old Tg CA3 
group, with a mean of 15±4 intersections per cell and the least in the 12-months old Tg 
striatum group with a mean of 10±4 intersections per cell. Unlike in CA3, the maximum 
intersections are comparatively similar in striatum and CNIC, both with a similar mean 
astrocyte ramification density of 11 intersections in 18-months transgenic and 6-months wild 
type respectively. Overall, the CA3 had a larger maximum number of intersections than the 
other regions across all factors.  
In contrast to astrocyte total number of intersections and process span, a 3-factorial ANOVA 
demonstrated that age, genotype and brain region did not interact and affect ramification 
density (F(4,527) = 1.378, P=0.240). However, post-hoc analysis revealed that ramification 
density across CA3, striatum and CNIC were independent, with the strongest effect between 
CA3 and the other regions (both P=0.001), differences between striatum and CNIC was a 
smaller effect (P=0.039). 1-factor ANOVA revealed that only age influenced astrocyte 
ramification density in CA3 (F(2,174) = 7.145, P=0.001) and post-hoc analysis showed that the 
differences were between 6- to 12- and 18-months (P=0.004 and P=0.002 respectively). 
Astrocyte ramification density in both striatum and CNIC was not influenced by any 
experimental factors. 
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Figure 4.21. Boxplots displaying the maximum ramification of GFAP+ cells recorded from the 
Sholl analysis. Ramification density across the groups displayed similar numbers. Cells in CA3 
hippocampus demonstrated in the 18-month Tg group significantly more ramified cells than 
in the 6-month Tg group. CNIC and striatum remained unaffected by age and genotype.
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4.4 – Discussion 
The main findings of this Chapter demonstrate in the Tg model that there is no evidence for 
neuronal loss across CA3, striatum, CNIC, LCIC and DCIC up to 18-months-old. Secondly, there 
is a similar trend in upregulated CD11b+ activated microglia and GFAP+ astrocyte labelling 
from 12-months-old in the CNIC and CA3. Finally, GFAP+ astrocytes display different 
morphologies across CNIC, striatum and CA3 and the astrocyte processes undergo age-
dependent and genotype morphological adaptations in the CA3. 
4.4.1 –Lack of neuronal loss in the Tg model up to 18-months-old 
A critical component in the progression of AD is the atrophy of grey matter within the brain 
(Migliaccio et al., 2015, Blanc et al., 2016, Thompson et al., 2003). This includes the widespread 
loss of neurons resulting in a reduction in brain volume and ultimately, cognitive disturbances 
(Kelley and Petersen, 2007). These symptoms only occur after a long prodromal stage of prior 
symptoms and surround the later stages of the condition (Wilson et al., 2011). This highlights 
the importance of uncovering key elements of AD prior to neuronal loss that could prevent 
progression to this stage. Neuron loss in AD development is considered particularly to be 
induced by apoptosis under circumstances such as excessive Aβ, oxidative damage, and low 
energy metabolism (Cotman and Su, 1996). However, neuronal loss is not considered to 
surround the earlier stages of human AD patient development (Yang et al., 2003). The exact 
stages of AD when neuronal loss becomes prominent in humans is currently unknown, which 
makes finding an animal model that can emulate the human stages of AD development crucial. 
Many transgenic mouse models have been developed over the years to try and recapitulate 
neuronal loss, but many have proven to be unsuccessful, including the APPSw (Irizarry et al., 
1997) and PDAPP (Ohno et al., 2007) mouse models. Cohen et al. (2013), demonstrated 
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profound neuronal loss at 16-months, which plateaus at 24-months in hippocampus and 
cingulate cortex in the Tg model. However, this Chapter demonstrates in hippocampus, 
striatum and all sub regions of IC of the Tg model up to 18-months of age, there is no observed 
loss of NeuN+ neurons. The results from Cohen et al. (2013) and this Chapter both utilised an 
approach sampling a large sample of neurons to estimate the population of neuronal loss. 
Considering these conflicting views, more sensitive approaches could be implemented in the 
future including investigating morphological changes of neurones or employing electron 
microscopy. These experiments would provide a clearer representation of what is happening 
to the neurons and a more firm conclusion could then be made about the model. 
4.4.2 – Increased glial response in the Tg model  
In 1992, the classification of the amyloid cascade was postulated, which hypothesised that AD 
was defined by the accumulation of Aβ followed by subsequent neurofibrillary tangles, 
neuronal loss and cognitive disturbances (Hardy and Higgins, 1992). Almost three decades 
later, there is extensive literature that has contributed to identifying the mechanisms that are 
involved in AD development surrounding the formation of Aβ deposits. Two of these 
mechanisms include microgliosis and astrogliosis, which are critical in development of amyloid 
plaque formation (Sakakibara et al., 2019). Astrocytes and microglia become activated as a 
neuroinflammatory response to Aβ and it is uncertain whether this response is positive or 
negative (Pekny and Pekna, 2016, Burda and Sofroniew, 2014). Activated microglia have been 
found to phagocytose Aβ in the early stages of AD and if the microglia become chronically 
activated, can lead to neuronal damage (Solito and Sastre, 2012). The role of reactive astrocytes 
is mainly thought to be neuroprotective, yet, astrocytes have been observed releasing 
neurotoxic chemokines and pro-inflammatory cytokines that are detrimental to neurons (Choi 
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et al., 2014). The fact that microglia and astrocytes have both been found to display 
heterogeneous morphologies depending on brain region (Lawson et al., 1990, Salter and 
Stevens, 2017, Oberheim et al., 2012), throughout aging and pathology (Dossi et al., 2018, 
Koellhoffer et al., 2017) infers that brain regions will be affected differently throughout AD 
development. Results from this Chapter show a clear upregulation of glial responses in the 
CA3 region and CNIC demonstrates a similar increase in GFAP+ labelling to the CA3 from 12-
months in the Tg model, which is more profound than other regions of the brain. Yuan et al. 
(2016) found that triggering receptor expressed on myeloid cells 2 mutations in mice and 
humans disrupted the neuroprotective effects of microglia, hence the formation of less refined 
amyloid plaques, which highlights the contribution of microglia in preventing plaque 
formation. The research of Yuan et al. (2016) into the role of microglia in synaptic regulation 
in a transgenic mouse model of AD shows that if microglia are chronically activated, this can 
result in synapse loss. The results in Figures 4.12&13 show that there is an increased level of 
activated microglia in CA3, which could render the hippocampus more susceptible to synaptic 
loss. 
Astrocytes have been found to play a crucial role in regulating neuronal activity through the 
formation of tripartite synapse, which is constituted by the bidirectional communication 
between neurons and astrocytes (Perea et al 2009; Fields et al 2014). Therefore, if astrocytes 
exhibit dysfunction, one would suggest that this connection would be affected. Hence, Forman 
et al. (2005) utilised a transgenic mouse model expressing human tau protein driven by the 
GFAP promoter, which enabled the measurement of astrocytic tau expression. They found that 
dysfunction of astrocytes contributes to the degeneration of neurons. Astrocytes have also 
been found to increase the levels of Aβ in the presence of inflammatory cytokines such as IFN 
144 | P a g e  
 
in combination with TNFα or IL-1β (Blasko et al., 2000), which are important inflammatory 
components in AD progression (Zheng et al., 2016). Figures 4.14&15 show that in the Tg model 
that astrocyte labelling undergoes age-dependent increases in CA3 and CNIC, which could 
render these regions more susceptible to the pressure of the Tg model and could explain why 
these were two of the regions to exhibit plaque like structures (Figure 4.10) from 12-months. 
4.4.3 – Hippocampal CA3 astrocytes undergo age-dependent adaptations in 
morphology in the Tg model 
The emerging evidence supporting that hearing loss contributes to the early development of 
dementia (Lin et al., 2011a, Livingston et al., 2017) emphasises the need to identify a 
mechanistic link in a region of central auditory processing. This Chapter provides evidence, in 
IC, that glial labelling prior to neuronal loss follows a similar trend to that of the CA3, albeit to 
a reduced extent. Pyapali and Turner (1996) measured age-dependent neuronal dendritic 
alterations in Fischer344 rat CA1 hippocampus and found that that they became more 
ramified. This most likely transfers to the age-dependent increase in astrocyte ramifications 
observed in CA3 in this Chapter (Figure 4.18) as a mechanism to accommodate for denervation 
because of reduced afferent input and the fact that this response was exemplified in the Tg 
model, suggests that this denervation is accelerated in AD. Due to the highly dynamic plastic 
nature and rapid memory storage capability of the CA3 region (Rebola et al., 2017) it is not 
surprising that there is an increased glial response. The main findings of this Chapter 
demonstrate that astrocyte morphologies undergo age-dependent modifications in the CA3 
of the Tg model (Figure 4.18) prior to neuronal loss (Figure 4.5). Contrastingly, CNIC and 
striatum do not undergo any adaptations in astrocyte morphology (Figures 4.18 & 19 & 20 & 
21), even though there was a significant increase in labelling similar to CA3 (Figures 4.13&14). 
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Therefore, why do astrocytes in hippocampus adapt their morphology with ageing and to a 
greater extent in the Tg model, but not in striatum or CNIC? Matias et al. (2019) suggest that 
the functions of astrocytes include modulating neuronal activity, maintaining pH, homeostasis 
of synapses, provide nutrients to neurons, blood brain barrier formation and function, 
glymphatic system regulation and homeostasis of ions and water. Research by Wilhelmsson et 
al. (2006) suggest that GFAP+ astrocytes under stress in hippocampus do not increase in 
number, but increase in size and number of processes, which is commensurate with the 
findings in Figure 4.18-20. However, the fact that astrocyte morphology was unchanged in 
CNIC and striatum, suggests differences in the underlying neuroprotective roles of astrocytes 
across the brain that requires further investigation. Taking these factors into account, it is more 
than likely that astrocytes in IC are different morphologically due to their differences in 
function, which is likely a result of the inherent auditory anatomy and physiology. Hippocampal 
astrocytes are larger and have more ramified processes, which is more likely to be due to their 
high number of neuronal and synaptic interactions, perhaps reflecting the distinct 
cytoarchitecture of these subcortical structures. Therefore, one could suggest that the changes 
in hippocampus are as a result of age- and genotype-dependent stress on the resident 
astrocytes and perhaps in the Tg model are primed to respond in a more active manner, 
causing cells to remodel. In contrast, the increase in GFAP+ labelling observed in the aged Tg 
model of the IC could represent a different mechanism in response to the stress causing not 
an adaptation of resident cells, but an increase in number. The methodology employed in this 
Chapter opens up a new avenue of investigation into understanding AD and could be used as 
a basis for physiological experiments investigating changes in astrocyte functionality across 
the brain. 
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4.4.4 – Limitations 
When quantifying neuronal and glial numbers, region of interest analysis was an appropriate 
measurement to provide insight into the differences of labelling across brain regions. This 
method was implemented to provide a large representative sample size across many regions 
of the brain, that would have been impossible in the same time frame implementing 
stereology. It also provided consistent easy to replicate measurements with less margin of 
error that may arise in other approaches. However, this method of analysis did not produce 
the total representation across all three dimensions of the total density of cells throughout the 
whole brain region and contrasting the differences in distinct brain regions such as the primary 
cell layer in hippocampus, to the evenly distributed cells in striatum hampers the 
interpretability. Future work could utilise the stereological approach as a more rigorous 
measurement of whole brain regions, which may uncover a more representative quantification 
of neurons, but may not produce the same sample size. In addition, more specific markers of 
sub types of neuronal markers could be implemented as a more sensitive method of labelling, 
but as a starting point, this would not have provided a good basis for future work as the above 
methods. 
Also, GFAP+ astrocytes in rodents differ substantially to the astrocytes found in humans (Vasile 
et al., 2017), which hampers the interpretability of changes in astrocyte morphologies to 
human studies. However, one could argue that transferability to measuring age-dependent 
AD development in humans, may lead to more substantial morphological astrocytic changes. 
Fundamentally, rodent models are never going to recapitulate AD, but finding the closest 
possible option is paramount. By using rats opposed to mice has underlying issues such as the 
time it takes to mimic human aging is much slower, but rats have more similar synteny blocks 
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to humans than mice (Bourque et al., 2004), which demonstrates they are more evolutionarily 
like humans.  This means that the underlying physiology of rats is more comparable to humans 
than mice. The Tg model has been characterised to undergo amyloidosis, tauopathy, gliosis, 
neuronal loss and cognitive disturbances (Cohen et al., 2013), which is unattainable in most 
transgenic mouse models.  
In addition, the thickness of the sections were 10µms, which is much smaller than the extensity 
of astrocytic process length (~40µm). Therefore, using thicker sections would have better 
represented astrocyte morphology across the x, y and z planes. However, as the sections were 
cut on the sagittal plane, it is difficult obtain a high number of sections to quantify, therefore 
it was beyond the scope of this study to implement this. 
4.4.5 – Chapter conclusions 
This Chapter provides anatomical evidence in the TgF344-AD rat model of AD of an age-
dependent upregulated, activated CD11b+ microglial response in the CA3 hippocampus. An 
age-dependent upregulation of GFAP+ astrocyte labelling in the CA3 and CNIC in the TgF344-
AD model. Astrocytes undergo age-dependent morphological adaptations in the CA3 of the 
TgF344-AD model, but do not demonstrate changes in CNIC. In addition, there was no 
observed neuronal loss up to 18-month of age in the TgF344-AD rat model. These results 
demonstrate differences in glial responses across different regions of the brain, with a 
particular response in CA3 hippocampus and to a lesser extent the CNIC. Together the results 
from this Chapter highlight that these glial responses are upregulated heavily but vary in 
morphology from 15-months in the Tg rats (~30 years humans), and the cells responses differ 
across the regions of the brain as a result of Alzheimer’s disease.  Therefore, this Chapter 
provides evidence for age-related gliosis that could be used as a basis for better understanding 
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the progression of Alzheimer’s disease in humans. Chapter 5 further investigates the age-
dependent effects of the TgF344-AD model by measuring synaptic mitochondrial dysfunction. 
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Chapter 5 – Age-dependent synaptic dysfunction 
in the inferior colliculus and hippocampus of Tg-
F344AD rats 
5.1 – Introduction 
This Chapter focuses on physiological and molecular approaches to identify putative 
mechanisms of synaptic mitochondrial dysfunction in the Tg rat model. Fundamental hallmarks 
in the progression of AD are synaptic dysfunction and an overall reduction in metabolic rates 
(Jack and Holtzman, 2013). Synaptic loss and a reduction in metabolism are products of 
amyloidosis and tauopathy (Gouras, 2019). Amyloid beta (Aβ) regulates synaptic function by 
evoking the release of soluble Aβ, making synapses a key target in understanding subsequent 
dysfunction (Parihar and Brewer, 2010). The initiation of synaptic loss precedes cognitive 
impairment and is a critical component in the progression of AD (Kashyap et al., 2019). The Tg 
model used in this study has been characterised to undergo amyloidosis and tauopathy 
(Cohen et al., 2013), making it a potential platform to better understand synaptic dysfunction. 
This Chapter investigates presynaptic terminals where mitochondria are present, using ex vivo 
synaptosomes as an approach (see Whittaker (1993)) across different regions of the brain. 
5.1.1 –Metabolic studies of brain function 
Numerous techniques enable quantification of metabolic function within the brain. (Sokoloff 
et al., 1977b) utilised the [14C]deoxyglucose autoradiography method which allowed the 
measurement of local cerebral glucose consumption across different sub-regions of the brain, 
ex vivo. Another approach involves injecting a subject with a radioactive tracer, most 
commonly fludeoxyglucose (FDG), and implementing Positron Emission Tomography (PET) to 
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identify regional glucose uptake. This method is used in assessing gross synaptic loss in AD 
(e.g. (Mosconi et al., 2010)).  
Post-mortem analysis of markers associated with metabolism, include histochemical labelling 
of mitochondrial enzymes. Cant and Benson (2005) described strong labelling of the 
mitochondrial enzyme cytochrome oxidase in gerbil IC compared to other regions of the brain. 
Measuring cytochrome oxidase has been found to correlate with functional measures of 
metabolic activity (Wong-Riley, 1989). Another approach to identify mechanisms of metabolic 
functioning, include measuring the enzyme citrate synthase, which is an indirect measurement 
mitochondrial density. The primary focus of this Chapter measures oxygen consumption rate 
(OCR) and subsequent mitochondrial function/dysfunction by implementing mitochondrial 
stress analysis using a Seahorse XFP flux analyser (Seahorse) across IC, hippocampus, auditory 
cortex, frontal cortex, superior colliculus and cerebellum 
5.1.2 – Parameters used in Seahorse analysis 
Mitochondrial dysfunction is a fundamental hallmark in many diseases and mitochondrial 
respiration is consequently an indicator of mitochondrial health. Methods commonly used to 
quantify mitochondrial dysfunction in vivo include magnetic resonance imaging. However, 
magnetic resonance imaging does not provide precise measurements of individual isolated 
mitochondria. Therefore, using Seahorse analysis allows for the precise control and 
comparison of individual factors, which is unattainable using other methods.  
Seahorse analysis manipulates the electron transport chain of mitochondria by introducing 
different compounds that interfere with electron flow. The first compound introduced is the 
antibiotic Oligomycin, which targets complex V on the mitochondrial electron transport chain 
and inhibits ATP synthase and prevents oxidative phosphorylation. This however, does not 
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block all electron transport due to the passive transport of protons across the mitochondrial 
membrane (proton leak), which can be viewed as a measure of mitochondrial membrane 
dysfunction. The second compound introduced is the uncoupling agent FCCP that causes 
uninhibited electron flow through the mitochondrial electron transport chain and results in 
maximal oxidative respiration. By subtracting basal respiration from maximal respiration 
generates the measurement spare respiratory capacity. Varying levels of spare respiratory 
capacity are measures of reserve that mitochondria can utilise under stress. Finally, a 
combination of the pesticide Rotenone and the antibiotic Antimycin A are added to the 
sample, which together block the mitochondrial electron chain and prevent oxidative 
respiration per se. Any readings still present following this stage are as a result of non-
mitochondrial oxygen consumption (Figure 5.15). The methods and animal model were chosen 
over other techniques due to the reliable and invasive measurement of metabolic function, 
which provides a direct metabolic measurement of synaptic populations that would be 
otherwise impossible to determine in human AD development. 
5.1.3 – Chapter aims 
After discovering that there was no observed loss of neurons in the Tg model up to 18-months 
in Chapter 4. This Chapter aimed to identify if synapses were affected prior to neuronal loss. 
Therefore, the time-points of the animals chosen in this Chapter were at 7- and 15-months to 
recapitulate key early time points of AD development. Using the IC as a model, due to it being 
the most metabolically active nucleus in the brain, makes it a prime candidate for targeting 
synaptic metabolic dysfunction. This Chapter is the first to utilise the physiological Seahorse 
mitochondrial stress analysis to analyse potential synaptosome dysfunction in the Tg rat 
model. In addition to physiological analysis, scanning electron microscopy (SEM) has been 
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employed to validate the presence of synaptic structures in synaptosome samples and 
undertake subsequent morphological analyses of these. Further experiments included 
quantitative real-time PCR, investigating expression of genes in synaptosomes, hypothesised 
to be modified in the Tg model with ageing. These include the inhibitory presynaptic target 
GAD65, Synaptic vesicle glycoprotein 2A (SV2A), which is involved in neurotransmitter release, 
and the ubiquitous presynaptic gene synaptophysin. Finally, the gene Iba1 was targeted to 
understand changes in this marker of microglial expression. This Chapter provides novel 
insight into age-dependent mitochondrial dysfunction in presynaptic terminals and the 
adaptations undergone in the Tg model of AD. 
5.2 – Methodology 
5.2.1 – Seahorse XFP Flux Mitochondrial Stress Analysis of Synaptosomes 
Results are described from 7-month old Fischer344 wild type (n=7), 15-month old wild type 
Fischer344 (n=7), 7-month old Tg (n=7) and 15-month old Tg (n=7) rats (N=28). The night 
before each experiment, to calibrate the Seahorse XFp Extracellular Flux Cartridge, each well 
of the culture plate underneath the cartridge was filled with 200µl seahorse calibrant (Agilent 
#100840-000), surrounding wells with 400µls and incubated at 37°C until use. On the morning 
of each respective experiment, the Seahorse XFp Extracellular Flux Analzer (Seahorse; Agilent) 
was turned on and allowed to initialise.  
Animals were culled at the University of Manchester in accordance with Schedule 1 (table A 
section 4) of the Animals (Scientific Procedures) Act 1986. Trial experiments comparing 
removing the brain pre- and post-transportation were undertaken to verify the most viable 
procedure. Methodology including taking the whole animal on ice and transporting to 
Manchester Metropolitan University (ca. 15 minutes) demonstrated the greatest sample 
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viability. After transportation, the skull was removed with rongeurs (Micro Friedman, 0.8mm 
jaws, WPI) and a cut was made sagittally through the brain. The right hemisphere was placed 
in optimal cutting temperature (OCT) compound, snap-frozen using liquid nitrogen and placed 
in a -80°C freezer for molecular biology. The left hemisphere was analysed using Seahorse. 
From the left hemisphere, cerebellum, frontal cortex, auditory cortex, IC, superior colliculus 
and hippocampus were dissected and placed in 500µl of sucrose solution (320mM sucrose 
and 10mM Tris-HCl in deionised water). Samples were kept on ice throughout the dissection. 
Samples were then homogenised using an Ultra-Turrux T8 homogeniser (IKA) until all tissue 
was liquified. All steps of centrifugation to isolate synaptosomes were undertaken using the 
Refrigerated SIGMA 3-16KL centrifuge and kept at 4°C throughout. Each brain region was then 
centrifuged at 1,617G for 1 minute, to isolate cellular fractions, the supernatant was removed 
and the sediment resuspended in 500µls of sucrose solution and centrifuged again for 1 
minute at 1,617G and further resuspended. Samples were then centrifuged at 15,973G for 4 
minutes to separate synaptosomes from cellular fractions, cellular supernatants were collected 
and frozen at -80°C (process adopted from Gray and Whittaker (1962)). The synaptosome 
sediments were then resuspended in 500µls of sucrose solution and centrifuged again a 
further 4 minutes at 15,973G and resuspended in sucrose solution. The supernatant was then 
discarded and 5µl of synaptosome sample from each brain region was diluted with 45µl of 
sucrose solution. A Pierce bicinchoninic acid assay (BCA) protein assay kit (ThermoFisher) was 
used, according to the manufacturer’s instructions, to determine the protein concentration 
from each brain region by measuring absorbance using a plate reader (Synergy HT microplate 
reader BioTek). Absorbances from unknown synaptosome samples were plotted against 
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known standards at 562nm and the readings were calculated using linear regression (See 
example in Figure 5.1).  
 
Figure 5.1. Absorbances of standards from BCA assay were plotted for each brain region in 
each experiment, producing a linear increase in absorbance. Linear regression analysis was 
used to produce the resultant formula, and by rearranging the equation, the volume of 
solution required to include 5µg of protein was determined for each sample.  The correct 
amount of liquid corresponding with 5µg of protein for each brain region was pipetted into a 
seahorse culture miniplate (Figure 5.2A).
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Figure 5.2. Example photographs taken of a Seahorse culture miniplate (A) and sensor 
cartridge (B). (A) Wells A and H were left blank for background measurements of culture 
solution. 5µg of protein from IC, superior colliculus, auditory cortex, frontal cortex, 
hippocampus and cerebellum were pipetted into wells B to G respectively. (B) 20µl of 
Oligomycin was pipetted into every sub-well A, FCCP into B and Rotenone and Antimycin A 
into C, all sub-wells D were left blank. 
 
After protein concentrations were determined, 5µg of synaptosome sample from each brain 
region was pipetted into individual wells B to F of a seahorse culture miniplate (See Figure 
5.2A), wells A and H were left blank to measure background levels. The miniplate was 
centrifuged at 2,129G for 40 minutes for samples to stick to the bottom of the plate using a 
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Sigma 3K10 centrifuge. The rest of the synaptosome samples were frozen for subsequent 
citrate synthase activity measurements. After centrifugation, 10ml of culture solution was made 
up (180µl glucose, 100µl sodium pyruvate and 100µl L-glutamine in 10ml of Seahorse XF RPMI 
medium pH 7.4) and 180µls was pipetted into every well, ensuring the synaptosome samples 
were not disrupted on the bottom of the miniplate. The plate was then incubated at 37°C for 
45 minutes. In this period the compounds from the Seahorse XF Cell Mito Stress Test Kit 
(Agilent), which included eppendorfs of Oligomycin, FCCP and Rotenone and Antimycin A. 
Stock solutions of Oligomycin were made up with 252µl of culture solution, FCCP with 288µl 
and Rotenone and Antimycin A with 216µl. Oligomycin was then further diluted by introducing 
60µl of stock solution to 240µl culture solution, FCCP 120µl to 180µl and Rotenone and 
Antimycin A 60µl to 240µl. Final stock solutions were then pipetted into a sensor cartridge (See 
Figure 5.2B). 20µl of final Oligomycin stock solution was pipetted into each sub-well labelled 
A, 22µl of FCCP into sub-wells labelled B and 25µl of Rotenone and Antimycin A into sub-wells 
C. The sensor cartridge was then calibrated in the Seahorse for 15 minutes. After calibration, 
incubated synaptosomes were entered into the Seahorse to initiate the measurement of OCRs 
of mitochondria per sample. The Seahorse initialised for 5 minutes, and then readings were 
taken every 7 minutes for 84 minutes. The first three 7-minute time points were measurements 
of basal respiration prior to compound injections. The first substrate introduced was 
Oligomycin, readings were taken at 7-miunte intervals for 21 minutes, then FCCP was 
introduced and measured three times over 21 minutes and finally, Rotenone and Antimycin A 
were injected onto the samples and measured at 7-minute intervals over 21 minutes (See 
figure 5.6 for an overview).  
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5.2.2 – Citrate Synthase Relative Quantity Analysis 
Protein estimations were implemented to account for inconsistencies in protein concentrations 
across brain regions, however, this did not account for the varying levels of mitochondria in 
each sample. The measurement of citrate synthase an enzyme present in all mitochondria and 
is involved in catalysing initial reaction in the Krebs cycle, was used to provide estimates of 
mitochondrial abundance. These measurements were then used to normalise relative 
mitochondrial levels to account for heterogeneity across samples. Citrate synthase activity 
levels were calculated taking advantage of the formula 𝐴𝑐𝑒𝑡𝑦𝑙 𝐶𝑜𝐴 +  𝑂𝑥𝑎𝑙𝑜𝑎𝑐𝑒𝑡𝑎𝑡𝑒 + 𝐻20 →
𝐶𝑖𝑡𝑟𝑎𝑡𝑒 +  𝐶𝑜𝐴 − 𝑆𝐻 along with 𝐶𝑜𝐴 − 𝑆𝐻 +  𝐷𝑇𝑁𝐵 →  𝑇𝑁𝐵 +  𝐶𝑜𝐴 − 𝑆 − 𝑆 − 𝑇𝑁𝐵 to 
identify maximum absorbance at 412nm wavelength, which was identified by Srere (1969). 
Reagents used were purchased from Sigma-Aldrich (cat# CS0720). Initially, 15µg (5.1-15.3µl) 
of synaptosome samples were pipetted into individual wells of a 96-well plate, then 2µl of 30 
mM Acetyl-CoA (cat#A2181) and 10 mM 5’, 5’-Dithiobis 2-nitrobenzoic acid (DTNB) (cat# 
D8130) and the difference was rounded up to 200µl with Assay Buffer for Citrate Synthase 1 
(diluted from Assay Buffer for Citrate Synthase 5 cat# B6935). The plate was then placed into 
a plate reader (Synergy HT microplate reader). The protocol was set up to warm the samples 
to 25°C, then shake for 10 seconds to mix reagents and to read samples at 10 second intervals 
for 90 seconds at 412nm (subsequent level of baseline absorbance from reaction of DTNB with 
CoA-SH). Next, 10µl of oxaloacetate (cat# O4126) was introduced to each well to initiate the 
experiment to form 6-carbon citrate from two-carbon acetyl CoA with four-carbon 
oxaloacetate. The plate reader underwent the same protocol as above, which produced a linear 
plot of increasing absorbance for each sample (See figure 5.8 for examples). By subtracting the 
change in activity at baseline from the change in activity from the experiment, produced citrate 
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synthase activity (CSA) levels. The formula enabled determination of citrate 
synthase/mitochondrial density in each sample: 
𝐶𝑆𝐴/𝑚𝑖𝑛×𝑣𝑜𝑙𝑢𝑚𝑒×𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝐸𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡(13.6)×𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑝𝑎𝑡ℎ𝑙𝑒𝑛𝑔𝑡ℎ(0.552)×𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑒𝑛𝑧𝑦𝑚𝑒 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
× 𝑡𝑜𝑡𝑎𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 
By doing this for every brain region from each experiment produced results that enabled the 
calculation of relative quantities and normalisation of synaptosomal mitochondrial densities 
across regions. 
5.2.3 – Scanning Electron Microscopy of Synaptosomes 
To validate the presence of synaptosomes isolated from the procedure outlined in section 
5.2.1, SEM was implemented using a Zeiss Supra 40VP microscope. Images were taken of 
samples from IC and hippocampus from each animal (n=7; N=28). Samples were prepared by 
pipetting 1µl of synaptosome sample onto a 20mm circular coverslip (ThermoScientific) and 
distributed evenly by using another coverslip and gently pressing down until the whole 
coverslip was evenly covered in solution. The coverslip was then dried using a bench slide dryer 
(Elctrothermal) for 20 seconds at setting 6/10. To preserve the samples the coverslips were 
immersed in 150µls of 0.2% glutaraldehyde in 1M PBS and left at 4°C overnight to fix. The next 
day the coverslips were washed with 1M PBS twice for 2 minutes. Coverslips were immersed 
in 150µls of increasing concentrations of industrial methylated spirit in deionised water at 20, 
40, 60 and 80% each for 30 minutes and twice at 100% for 30 minutes to dehydrate the 
samples. The samples were then left to dry in a closed case to minimise particle build-up. Once 
samples were dry, coverslips were placed, attached to 20mm aluminium pin stubs using a silver 
coating. The stubs were then coated with a thin layer of gold using gold splutter coating. This 
was improved by employing the silver-enhancement method, which involved enlarging the 
small diameter gold particles to optimise visualisation of the samples on the microscope (see 
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Scopsi et al. (1986)). The stubs were then placed into the Zeiss Supra 40VP. Initial images were 
taken at 1,000x along three 5mm increments across the diameter of the coverslip to develop 
an understanding of synaptosome density for each sample (Figure 5.3A-C). 10,000x images 
were then taken from each increment for region of interest analysis (Figure 5.3D-F). Image 
analyses were undertaken in FIJI (ImageJ) software (Abràmoff et al., 2004). Three synaptosomes 
per image were subject to manual outlining using the contour tool in ImageJ for area, 
perimeter and circularity analyses using the measure plugin. Circularity measurements were 
calculated by using the formula: Circularity = 4π ∗ area/perimiter² (example 4π* 
0.27µm2/0.1932 = 0.91) with 1 being a perfect circle. A total of 236 synaptosomes in 
hippocampus (7- and 15-month wild type = 62 and 48 respectively, and Tg = 63 and 63 
respectively) and 223 in IC (7- and 15-month wild type = 63 and 54 respectively and Tg = 52 
and 54 respectively) were quantified. 
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Figure 5.3.  Example scanning electron micrographs from one brain region, validating synaptosome presence in samples. (A-C) 1,000x 
magnification images were taken of synaptosome densities at 5mm, equidistant distances from the centre to edge of the 20mm coverslip to 
estimate the quantity of synaptosomes presence within each sample. Scale bar in (A)_10µm, same in (B) and (C). (D-F – from A-C) 10,000x 
magnification images were then taken from regions of interest within each 1,000x image, to be used in individual synaptosome measurements of 
area, perimeter and circularity analyses. Scale bar in (D) 2µm, same in (E) and (F).
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5.2.4 – Quantitative real time PCR analysis of GAD65, SV2a, synaptophysin and 
Iba1 
Primers designed for quantitative real-time PCR (QRT-PCR) included four targets GAD65, Iba1, 
SV2a and synaptophysin and three housekeepers, Cyc1, EIF4A2 and GAPDH (see Table 5.1 for 
design). Three animals per group (7- and 15-month wild type and Tg) were used in the 
experiments. Samples for molecular biology were obtained from the snap frozen right 
hemisphere obtained in section 5.2.1. The right hemisphere was taken out the -80°C freezer 
and placed in a cryostat (Leica CM3050 S) at a chamber temperature of -16°C and operating 
temperature of -18°C. The right hemisphere was frozen in the coronal plane, facing rostrally 
onto a specimen disc using OCT. Sections were then taken at 20µm intervals for 
immunohistochemistry (data not shown in this thesis), until the brain regions of interest were 
present. For brain region dissection for molecular biology, 200µm thick sections were taken 
on the cryostat and trimmed using a scalpel to dissect the regions of interest. To identify the 
regions of interest, initially the Paxinos and Watson rat atlas (2007) was used to identify (in 
order of first appearance in the rostro-caudal direction of sectioning) frontal cortex, 
hippocampus, auditory cortex, SC, IC and cerebellum. Photos were taken before each region 
of interest was cut to use as references for the remainder of experiments (Figure 5.4). All 
reagents used in the preparation of samples for QRT-PCR were from a Norgen Total RNA 
Purification Kit (Cat# 48400). Dissected brain regions were lysed in 2-mercaptoethanol in RL 
buffer (10:600) and homogenised by pipetting up and down until liquified, the samples were 
then stored at -80°C until RNA quantification. All steps undertaken for isolating RNA were 
followed using the protocol in the Norgen kit. The purity of RNA was quantified using a 
Nanodrop (Thermoscientific Nanodrop Onec). Equal amounts of RNA (5µg) from each brain 
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region was then reverse transcribed (Quantinova SYBR green PCR kit cat# 208052) following 
the manufacturer’s instructions. cDNA generated was then diluted 1:10 and specific primers 
were added to each brain region along with a no template control, then the experiment was 
initialised using a thermocycler (Bio-Rad CFX Connect Real Time System). After QRT-PCR, the 
samples were analysed using the Bio-Rad CFX Maestro software and quantified using double 
delta ct to identify the number of cycles needed to reach a fixed signal.
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Gene Accession number Forward primer Reverse primer 
Synaptophysin NM_012664.3 TCCCTCCACACTCCCGTTTG GCAGAGGGTACAGGATCGGG 
Glutamate decarboxylase 2 
(GAD65) NM_012563.1 CCAGGCTCATCGCATTCACG TCTGTTCCGATCCCCAAGGC 
Eukaryotic translation initiation 
factor 4A2 (EIF4A2) NM_001008335.1 CCGCGGATTACAACAGAGAACAT CTCTCTGCTGAATAGCTGAAGGC 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) NM_017008.4 CAGTGCCAGCCTCGTCTCATA CAAGAGAAGGCAGCCCTGGT 
Cytochrome c-1 (Cyc1) NM_001277194.1 GCCCCGGCATCTTCCATTAC ACAGCATCACCTTTCGGCCT 
Allograft inflammatory factor 1 
(Iba1) NM_017196.3 CTAAGGCCACCAGCGTCTGA CCTGTTGGGCTTTCAGCAGT 
Synaptic vesicle glycoprotein 2a 
(SV2a) NM_057210.2 GAGTACCGGCGCATCACTCT TCGGGCTGCATAGTCCACAG 
Table 5.1. List of primers used for QRT-PCR analysis. Accession number correlates t exact gene from rattus norvegicus. Exact forward and reverse 
base sequences designed using NCBI nucleotide database https://www.ncbi.nlm.nih.gov/nucleotide/.
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Figure 5.4. Reference images and respective contours outlining the specific regions dissected from (A) frontal cortex (green), (B&C) hippocampus 
(yellow)and auditory cortex (red), (D) superior colliculus (cyan), (E) IC (blue) and (F) cerebellum (magenta).
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5.2.5 – Statistical analyses 
Results from these analyses were recorded in Microsoft Excel and plotted using Prism 
(GraphPad) and statistically analysed using SPSS (v24, IBM). All line graph measurements are 
averaged, and the error presented as standard error of the mean and all box and whisker and 
violin plots are presented as median and standard deviation. For physiological Seahorse and 
molecular biology analyses, group sample size (n) in the text represents individual animals and 
in the anatomical SEM analyses represents individual synaptosomes. Significance was set to 
p<0.05 and determined using 3-, 2- and 1-factorial between groups ANOVA to measure the 
potential effects of brain region, age and genotype, as appropriate. Post-hoc Tukey HSD tests 
were undertaken where appropriate and effect sizes were determined by partial eta squared 
for 3- and 2- factor ANOVA and eta squared analyses for 1-factor ANOVA. Effect sizes were 
determined due to the nature of physiological analysis being more variable, to determine the 
validity of the significance found between results. The effect sizes were used to quantify the 
strength of the relationship between factors, small effect sizes refer to a weak relationship 
(<0.01), medium that there is a good relationship (<0.09) and large indicates a strong 
relationship (>0.25). Weak relationships between factors infer that the probabilities derived 
from the tests have reduced validity.  Significance between factors from post-hoc analyses are 
either written in text above the figures or are displayed in figures as stars (*= P≤0.05; **= 
P≤0.005; ***= P≤0.001; **** P≤0.0001). 
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5.3 – Results 
5.3.1 – Physiological Analysis of TgF344-AD Model 
5.3.1.1 – Oxygen consumption rates are elevated in the TgF344-AD model 
compared to wild type controls 
To understand age-dependent changes in synaptic metabolism across different regions of the 
brain in the Tg model, synaptosomal OCRs were manipulated and quantified by the addition 
of numerous substrates, which collectively enabled the measurement of different aspects of 
mitochondrial functioning (see Figure 5.5 for overview).  
Overall, OCRs were consistently higher across all time points in the Tg 15-month-old groups 
(Figure 5.6). Oligomycin had the opposite effect to results observed in Figure 5.5 in the Tg 15-
month old groups, whereby there was an increase in OCR, which correlates to a decrease in 
ATP production. Hippocampus, frontal cortex and IC followed similar trends across factors. 
OCRs were highest overall in the auditory cortex and frontal cortex and there were no 
differences between groups in the cerebellum. 
Basal respiration was highest in the 15-month Tg auditory cortex, reaching 177.7±63.4 
pmol/min, followed by the 15-month Tg superior colliculus with 157.7±70.8 pmol/min. All 
brain regions demonstrated a decrease in ATP production at the 15-month old time point, this 
was most prominent in hippocampus (21.6±29.8 pmol/min). Non-mitochondrial respiration 
was highest in the 15-month-old superior colliculus and auditory cortex (131.5±144.6 
pmol/min and 124.5±85.5 pmol/min respectively). Maximal respiration displayed the largest 
OCR increase in the Tg 7-month old group frontal cortex, whereby the OCR more than doubled 
as a result (134±35 pmol/min).
167 | P a g e  
 
 
 
Figure 5.5. Model trace of OCRs taken from the Agilent Report Generator User Guide as an 
example to visualise how the different parameters of synaptosome mitochondrial functioning 
were measured. Basal respiration (cyan) is determined by averaging the initial three time points 
of OCRs. ATP production (magenta) is determined by the addition of the antibiotic Oligomycin, 
which inhibits ATP synthase resulting in the inability to convert ADP to ATP. The reduction in 
ATP production gives a measure of production.  Next, adding the protonophore FCCP causes 
uncoupling of oxidative mitochondrial phosphorylation, by transporting protons across the 
mitochondrial membrane, resulting in the generation of the maximal oxygen consumption 
capacity (green). Finally, by together adding the pesticide Rotenone and the antibiotic 
antimycin A to the samples, both result in the inhibition of protons to cross the mitochondrial 
electron chain. Any OCRs still present must be as a result of non-mitochondrial oxygen 
consumption (red). In addition, by finding the difference between ATP production and non-
mitochondrial oxygen consumption gives a measure of the protons leaking through the 
mitochondrial chain as a quantification of mitochondrial inefficiency (proton leak (blue)). Also, 
by subtracting basal respiration from maximal respiration gives a measure of spare respiratory 
capacity (dark green). 
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Figure 5.6. Seahorse mean OCR traces taken from 5µg synaptosomal fractions derived from each brain region. Notice that all traces do not 
demonstrate a profound decrease in OCR after the addition of Oligomycin, this trend is consistent with previous work investigating synaptosomal 
fractions (Flynn et al., 2011); (Scott and Nicholls 1980). Across IC, hippocampus, auditory cortex and superior colliculus the Tg 15M group 
consistently has higher OCRs than the other groups, with the lowest readings in the wild type groups. Superior colliculus demonstrates a profound 
increase in OCR in the 15M Tg group compared to the other groups. IC, hippocampus and frontal cortex all share similar trends in OCR across all 
groups, with Tg groups being consistently higher than wild type. Cerebellum has the lowest OCRs across all brain regions and demonstrates 
similar responses across groups. Results presented as See figure 5.5 for reference on how to interpret mitochondrial function.
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5.3.1.2 – Citrate synthase activity is highest in inferior colliculus, auditory cortex 
and cerebellum 
When collecting different brain regions, there is substantial variability in tissue composition. A 
protein estimation was undertaken for each synaptosome sample to ensure that the level of 
protein was consistent, but this did not account for the underlying heterogenous synaptic 
densities found across brain regions. Therefore, citrate synthase activity experiments were 
undertaken on each sample to determine the level of mitochondria present (Figure 5.7&8). 
Initially changes in baseline absorbance readings were taken from a cocktail of synaptosomes 
mixed with 1MTris-Cl (pH 7.4) and acetyl coenzyme-A to subtract from changes obtained from 
the catalytic reaction of the tricarboxylic acid cycle (Figure 5.7 baseline). The addition of 
oxaloacetic acid caused the catalytic reaction to occur resulting in a time dependent increase 
in absorbance (Figure 5.7 experiment). From the subtraction of baseline activity from the 
resultant absorbance of the catalytic reaction, measurements of citrate synthase activity were 
calculated (Figure 5.8). Citrate synthase activities were consistently highest in the IC, auditory 
cortex and cerebellum, with the highest levels reaching 57±55.4 nmols/min/µg in the 15-
month Tg auditory cortex. Across groups, superior colliculus had the lowest citrate synthase 
activity, with the lowest level of 15.9± 7.9 nmols/min/µg found in the 15-month Tg group.  The 
higher levels of citrate synthase activity observed in the 15-month Tg IC, auditory cortex and 
frontal cortex could be indicative of mitochondrial adaptation  with age in the Tg model, but 
further investigation would need to be implemented to conclude this.
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Figure 5.7. Process of measuring citrate synthase activity levels in synaptosome samples as a measure of mitochondrial density (n=7 each 
group). There was no statistical significance found between any groups. Each synaptosome sample was measured at baseline absorbance and 
then the experiment was initiated by the addition of oxaloacetic acid. To determine citrate synthase activity (CSA), the rate of change at baseline 
was subtracted from the rate of change of the experiment. To determine the amount of citrate synthase in the sample, the formula below was 
used. Across groups, IC, auditory cortex and cerebellum have highest levels of citrate synthase activity:  
𝐶𝑆𝐴/𝑚𝑖𝑛 × 𝑣𝑜𝑙𝑢𝑚𝑒 × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝐸𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡(13.6) × 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑝𝑎𝑡ℎ𝑙𝑒𝑛𝑔𝑡ℎ(0.552) × 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑒𝑛𝑧𝑦𝑚𝑒 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
× 𝑡𝑜𝑡𝑎𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
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Figure 5.8. Calculated citrate synthase levels of protein across brain regions using the formula in Figure 5.7.  Citrate synthase activity was highest 
in the 15-month Tg auditory cortex and lowest in 15-month Tg superior colliculus. Three-, two- and one-factor ANOVA uncovered no significant 
interactions or differences across groups. The calculated levels of citrate synthase activity from each brain region, from each experiment, were 
used to normalise the traces in Figure 5.6 accordingly to account for mitochondrial density variances between groups. 
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5.3.1.3 – Hippocampus demonstrated age-dependent increases in oxygen 
consumption rates in the TgF344-AD model 
To account for possible differences in mitochondrial densities across brain regions, the raw 
OCRs were normalised by applying citrate synthase levels to produce rates relative to 
mitochondrial density, for each respective sample (Figure 5.9). These results show the 
normalised overall OCRs in the 15-month Tg groups are consistently highest in the 
hippocampus, auditory cortex and superior colliculus. The highest rates are found in the 15-
month auditory cortex reaching 611.7±566.3 pmol/min. Hippocampus demonstrated an 
increase in OCR in response to the Oligomycin at 15-months in the Tg group. Area under the 
curve revealed that the total OCRs across the experiment were highest in the 15-month Tg 
group auditory cortex reaching 33,615±8182 pmol, followed by 15-month Tg superior 
colliculus with 32,006±3341 pmol. 
Two-factor ANOVAs of OCRs across all brain regions revealed that together, genotype and 
age (F(1,264)=7.557, P=0.006), genotype and brain region (F(5,264)=3.962, P=0.002) and age 
and brain region (F(5,264)=4.768, P=<0.001) influenced OCRs. Partial eta squared analysis 
uncovered that the effect sizes were pη2=0.028, pη2=0.070 and pη2=0.083 respectively, 
indicating that the effect sizes were modest. Post-hoc analysis revealed that hippocampus and 
IC were similar (P=1.000) and auditory cortex and frontal cortex were similar (P=0.972) and 
superior colliculus was different from all other regions (all P=<0.001). The most striking finding 
was found by an additional two-factor ANOVA hippocampus, which revealed an interaction 
between age and genotype influenced OCR (F(1,44)=14.768, P=<0.001) and a partial eta 
squared showed that the effect size was large (pη2=0.251). 
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Figure 5.9. Traces of OCRs normalised to mitochondrial density from citrate synthase assays (Figure 5.7&8). Across hippocampus, auditory cortex 
and superior colliculus, the Tg-15-month groups have the highest OCRs. Superior colliculus has the highest OCRs across all brain regions in the 
Tg 15-month group. Both Tg groups are higher than the wild type in hippocampus and superior colliculus. Hippocampus demonstrates clear age-
dependent differences in oxygen consumption. The wild type 15-month groups have the lowest OCRs in the IC, hippocampus, frontal cortex and 
cerebellum. In contrast to all other regions the 7-month wild type group is highest in cerebellum. See figure 5.5 for information on how to interpret 
mitochondrial function.
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5.3.1.4 – Hippocampus undergoes compensatory age-dependent increases in 
basal respiration in the TgF344-AD model 
In addition to the synaptosomal oxygen consumption readings, individual measures of 
mitochondrial function were calculated from the addition of different substrates and how they 
affected oxygen consumption (See figure 5.5 for an overview). The first readings across brain 
regions included quantifying and contrasting the oxygen consumption levels needed to 
maintain basal functioning before addition of any substrates that induced stress, this was the 
measure of basal respiration (Figure 5.10). Hippocampus and IC follow similar trends across all 
groups. In both superior and inferior colliculi and hippocampus, the highest levels of basal 
respiration were found Tg 15-month groups, which suggests increased demand to undertake 
basal functioning. This was in contrast to the cortical regions, where the 7-month wild type 
groups had the highest levels. Cerebellum rates remained consistent across cases. Superior 
colliculus had the highest overall basal respiration measurement of 270.1±219.4pmol/min OCR 
in the 15-month Tg group and had the lowest with 65.4±62.9pmol/min in the 7-month Tg 
group. 
A two-factor ANOVA demonstrated age and genotype influenced basal respiration 
(F(1,103)=4.993, P=0.028) and a partial eta squared shows a medium effect size (η2=0.046). 
Additional two-factor ANOVA of individual brain regions revealed an interaction between age 
and genotype influenced basal respiration in hippocampus (F(1,18)=5.844, P=0.027) and the 
effect size was large (pη2=0.256). One-way ANOVA of individual regions, uncovered that 
frontal cortex was the only region to display an age-dependent decrease in basal respiration 
(F(1,18)=4.527, P=0.047) and an eta squared showed that the effect size was large (η2=0.201), 
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Figure 5.10. Basal respiration measurements derived from quantifying OCRs prior to addition of substrates as a measure of energy demand for 
basal activities. IC and hippocampus follow similar trends in basal respiration with the highest levels in Tg 15-month groups and the lowest in 15-
month wild type. Superior colliculus has the highest overall basal rates in the 15-month Tg group and the lowest overall in the 7-month wild type. 
Auditory cortex and frontal cortex display similar trends across groups, both with the highest basal levels in the 7-month wild type.  Cerebellum 
was unaffected by factors and remains consistent across all groups. 
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5.3.1.5 – Hippocampus undergoes an age-dependent increase in proton leak in 
the Tg model 
Another measurement derived from the Seahorse mitochondrial stress analysis, includes the 
proton leak, which is a measurement of the inefficiency of the mitochondrial membrane to 
transport proteins across the matrix and the ‘leaking’ of protons outside the mitochondrial 
membrane (Figure 5.11). 
 The largest trends of increased proton leak are found in the IC, hippocampus, auditory cortex 
and superior colliculus, with the largest level of proton leak in the auditory cortex reaching 
188.4±267.9 pmol/min. Proton leak in cerebellum was unaffected across factors. The lowest 
level of proton leak was found in the IC 15-month wild type group with an OCR of 38.1±32.8 
pmol/min. 
Statistical analysis of all brain regions demonstrated a two-factor interaction between age and 
genotype influencing proton leak (F(1,103)=9.113, P=0.003) and a partial eta squared showed 
that the effect size was small (pη2=0.081). Two-factor ANOVA of individual brain regions 
revealed age-dependent increases in the Tg model hippocampus (F(1,17)=11.563, P=0.003) 
and the effect size was large (pη2=0.405).  
These results show that proton leak in the hippocampus of the Tg model is affected by age-
dependent changes indicative of mitochondrial dysfunction.
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Figure 5.11. By subtracting the non-mitochondrial oxygen consumption from the basal respiration of synaptosomes, provides a measure of 
mitochondrial intactness. Any reading is as a result of protons leaking outside the mitochondrial membrane and mitochondrial membrane 
inefficiency. Proton leak is elevated in the 15-month Tg groups of IC, hippocampus, auditory cortex, superior colliculus and cerebellum. IC, 
hippocampus and auditory cortex share similar trends in proton leak, with hippocampus having the most profound increase in proton leak at 15-
months in the Tg model. These results suggest that there are age-dependent decreases in mitochondrial membrane intactness of the IC, 
hippocampus and auditory cortex indicative of mitochondrial dysfunction within synaptosomes.
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5.3.1.6 – ATP production is substantially reduced from 7-months wild type to 15-
month Tg rats in auditory cortex and frontal cortex 
To identify what constituted ATP production from the normalised OCR traces, the response of 
blocking ATP synthesis by the addition of the antibiotic Oligomycin was measured (Figure 
5.12). In the IC, hippocampus, auditory cortex, frontal cortex and cerebellum, the 7-month wild 
type groups all had the highest levels of ATP production. Frontal cortex has the highest ATP 
production across all regions in the 7-month wild type group, producing 72.5±60.4 pmol/min 
oxygen. In contrast, across all groups the Tg 15-month groups had the lowest levels of ATP 
production, with diminished production found in the Tg-15-month cerebellum with 0±0 
pmol/min production. These diminished readings more than likely do not emulate a real 
physiological response, however, they are indicative of mitochondrial dysfunction. 
A two-factor ANOVA showed that genotype and brain region influenced ATP production 
(F(5,106)=3.943, P=0.003) and a partial eta squared demonstrated that the effect size was 
medium (pη2=0.161).  In auditory cortex and frontal cortex, one-factor ANOVAs revealed that 
genotype independently influenced ATP production (F(1,17)=6.630, P=0.022 and 
F(1,18)=8.089, P=0.011 respectively) and eta squared analysis demonstrated that the effect 
sizes were large (η2=0.272 and 0.310 respectively).
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Figure 5.12. ATP production of synaptosomes derived from the inhibition of ADP conversion into ATP by the antibiotic Oligomycin. 7-month wild 
type groups across IC, hippocampus, auditory cortex, frontal cortex and cerebellum have the highest level of ATP production, in contrast to the 
15-month TG groups. Frontal cortex has the highest level of ATP production in the 7-month wild type group. All groups, excluding superior 
colliculus demonstrate similar trends in ATP production across all groups. ATP production in superior colliculus follows the opposite trend to all 
other regions, which could provide insight into the much higher overall OCRs. 
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5.3.1.7 – The efficiency of synaptosomal mitochondria to couple oxidation to 
phosphorylation, decreased in the 15-month Tg group of all regions 
To determine the ability of synaptosomes to couple oxidation to phosphorylation, the ATP 
production rate was divided by the basal rate of respiration, which was a measure of coupling 
efficiency (Figure 5.13). Interestingly, across all brain regions there was no heterogeneity in 
coupling efficiency, all regions displayed the lowest readings in the Tg 15-month and the 
highest efficiency in the 7-month wild type groups. Frontal cortex showed the highest coupling 
efficiency across all brain regions with 31.6±16.2% in the 7-month wild type group and 
cerebellum demonstrated diminished efficiency. These diminished readings more than likely 
do not emulate a real physiological response, however, they are indicative of mitochondrial 
dysfunction. 
Two-factor ANOVA revealed an interaction between genotype and brain region that 
influenced coupling efficiency (F(1,106)=3.943, P=0003) and a partial eta squared showed that 
the effect size was medium (pη2=0.161). In addition, a one-factor ANOVA of individual brain 
regions uncovered that auditory cortex and frontal cortex were the only regions to 
demonstrate a genotypic influence on coupling efficiency (F(1,17)=6.371, P=0.022 and 
F(1,18)=8.087, P=0.011 respectively) and an eta squared showed the effect sizes were medium 
and large (η2=0.122 and η=0.310 respectively).
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Figure 5.13. Dividing the rate of ATP production by the basal respiration rates provides an estimation of mitochondrial coupling oxidation to 
phosphorylation as a measure of synaptosomal coupling efficiency. The coupling efficiency of all measured regions of the brain was ubiquitously 
distributed across groups. 7-month wild type had the most efficient mitochondrial, which diminished in the 15-month Tg groups. The most 
efficient mitochondria were found in the 7-month wild type superior colliculi and in the 15-month Tg cerebellum group the efficiency was 
negligible. These results demonstrate that the efficiency of mitochondria in synaptosome is similarly affected across the brain. These results should 
be treated with caution as the equation that produces coupling efficiency responses does not incorporate negative values, however, these results 
do demonstrate that there is significant dysfunction of synaptosome mitochondria in the 15-month Tg group.
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5.3.1.8 – Inferior colliculus and hippocampus demonstrate similar age-dependent 
increases in maximal respiration in the Tg model 
Adding the ionophore FCCP to the synaptosome samples as a phosphorylation uncoupler, 
caused the uncoupling of ATP synthesis and resulted in hydrogen ions to traverse through the 
mitochondrial membrane. This caused the synaptosomes to respire at maximal oxidative 
capacity, enabling the measurement of maximal respiration (Figure 5.14).  
Hippocampus and IC follow similar trends in maximal respiration across groups. Maximal 
respiration in IC and hippocampus was highest in the 15-month Tg groups. The highest overall 
respiration was found in the 7-month wild type auditory cortex reaching 450±156.5 pmol/min.  
In contrast, the lowest rate was found in the 15-month wild type auditory cortex, with 123±36.2 
pmolmin. 
ANOVA of all brain regions revealed a two-factor interaction of age and genotype that 
influenced maximal respiration (F(1,106)=5.125, P=0.025) and a partial eta squared showed 
that the effect was medium sized (pη2=0.046). Two-factor ANOVA of individual brain regions 
uncovered that IC and hippocampus independently demonstrated age-dependent increases 
in maximal respiration in the Tg model (F(1,17)=5.088, P=0.038 and F(1,17)=5.864, P=0.027 
respectively) and the effect sizes were large (pη2=0.230 and 0.256 respectively). These results 
demonstrate that the mitochondria in IC and hippocampus undergo similar increases in the 
maximal oxidative capacity in the Tg model with age.
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Figure 5.14. Boxplots displaying the culmination of adding FCCP to uncouple oxidative phosphorylation of the mitochondrial membrane of 
synaptosomes resulting in maximal oxidative respiration. Maximal respiration was highest and lowest in the auditory cortex 7-month wild type 
and 15-month wild type respectively. IC and hippocampus demonstrated similar trends in increasing maximal respiration at 15-months in the Tg 
groups. Interestingly, auditory cortex demonstrated the largest overall OCRs in the 15-month Tg model (see figure 5.5), however maximal 
respiration is an interdependent value and due to the high levels of non-mitochondrial respiration (see figure) hippocampus demonstrates the 
highest maximal respiration in the 15-month Tg group. These results suggest there is an increased mitochondrial maximal oxidative respiration 
present in the 15-month Tg rat model in IC and hippocampus.
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5.3.1.9 – Non-mitochondrial respiration was unaffected by increasing age in the 
Tg model 
From the traces of normalised OCRs (Figure 5.6) it can be noted that there are differences in 
trends across factors. By adding the pesticide rotenone and antibiotic antimycin A to 
mitochondrial samples, causes inhibition of mitochondria to respire, which results in any OCRs 
present are due to non-mitochondrial respiration. This approach enabled the identification of 
the influence of non-mitochondria to the overall results (Figure 5.15).  
Surprisingly, non-mitochondrial rates were not significantly influenced by the different factors. 
The highest level of non-mitochondrial respiration reached 209.8±147 pmol/min OCR in the 
15-month Tg superior colliculus. The cerebellum had the lowest levels of non-mitochondria 
across all regions and had the lowest overall consumption in the 15-month wild type group 
with 37.8±20.4 pmol/min OCR. 
A one factor analysis across all brain regions revealed that brain region was the only factor to 
influence non-mitochondrial respiration (F(5,105)=3.647, P=0.004) and an eta squared analysis 
showed that the effect was medium sized (η2=0.148). Post-hoc analysis contrasting the brain 
regions uncovered that the difference observed was between superior colliculus with 
hippocampus (P= 0.050) and cerebellum (P=0.020). This lack of influence that age and 
genotype have on non-mitochondrial levels across samples, suggests that effects of genotype 
and age are as a result of mitochondrial dysfunction, thus providing validity to all measures 
and claims of metabolic dysfunction.
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Figure 5.15. To measure the level of non-mitochondrial oxygen consumption of synaptosomes, the pesticide rotenone and antibiotic antimycin 
A were added, which together block mitochondrial oxygen production. Non-mitochondrial respiration was highest in the 15-month old Tg 
superior colliculus compared to the lowest in 15-month wild type cerebellum. Non-mitochondrial respiration did not vary substantially across all 
brain regions.
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5.3.1.10 – Spare respiratory capacity differed across sub regions, but remained 
unaffected by age in the Tg model 
To identify if the synaptosomal mitochondrial capacity changed across factors, analysis of 
spare respiratory capacity was implemented. The spare respiratory capacity is derived from 
subtracting the basal respiration rate from the maximal respiration (See figure 5.5). Spare 
respiratory capacities of groups varied across brain regions (Figure 5.16). The highest 
capacities were found in the 7-month wild type auditory cortex with 279.7±107.3 pmol/min 
followed by 257±159 pmol/min in the 7-month Tg frontal cortex. The smallest respiratory 
capacities were found in the 15-month wild type cerebellum with 61.6±32.1 pmol/min and 15-
month wild type hippocampus reaching 65.3±53.5 pmol/min. 
One-factor ANOVA across all brain regions revealed that brain region influenced spare 
respiratory capacity (F(5,103)=3.936, P=0.003) and an eta squared analysis showed that the 
effect size was small (η2=0.160). Post-hoc analysis uncovered that the differences in brain 
region were attributed to superior colliculus differing from cerebellum (P=0.047) and IC 
(P=0.014). There are no statistical age or genotype influences on individual brain regions. 
These results suggest, unlike the other mitochondrial analyses, that there are no age-
dependent or genotype influences on spare respiratory capacity, which suggests that this 
measurement is maintained across brain regions in this model.
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Figure 5.16. Subtracting basal respiration from maximal respiration provided a measure of the respiratory capacity of mitochondrial in 
synaptosomes. Spare respiratory capacity was highest in the 7-month wild type auditory cortex and lowest in the 15-month wild type cerebellum. 
There was increased capacity in the IC, hippocampus and superior colliculus, albeit not substantial. Respiratory capacity remained largely 
unaffected by age and genotype, which suggests that synaptosome mitochondrial dysfunction, is not attributed to an increased spare respiratory 
capacity.
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5.3.2 – Anatomical Analysis of TgF344-AD Model 
5.3.2.1 – Synaptosome area and perimeter substantially decreased with age in 
the Tg model inferior colliculus 
There is currently a paucity of anatomical investigations into synaptosome structure in the 
literature, which is as a result of the difficulty of isolating synaptosomal fractions. This Chapter 
provides thorough anatomical quantification of individual synaptosomes through using SEM. 
Initially, SEM was used to visualise whether synaptosomes were present in the samples (Figure 
5.17A). After identifying that synaptosomes were present, they were also identified to be 
heterogenous in morphology. To quantify these differences, region of interest analysis was 
undertaken on synaptosome samples from 7- and 15-month wild type and Tg IC and 
hippocampus. Analyses were taken using the measure function in ImageJ to produce area, 
perimeter and circularity measurements. Synaptosomes in micrographs were first isolated 
(Figure 5.17B) and cropped. Using pixel inspector in ImageJ produced a table of pixel 
intensities (Red box in Figure 5.17B), the borders of the synaptosomes were determined by 
using the formula in Figure 5.17C and then the perimeter was manually outlined using the 
contour tool (Figure 5.17D). 
Interestingly, areas differed across groups and brain regions (Figure 5.18A&B), with the largest 
synaptosomes present in the 7-month Tg IC, reaching 0.400±0.204µm2 opposed to the lowest 
with 0.216±0.124µm2 in the 15-month Tg group. A three-factor ANOVA revealed that age, 
genotype and brain region interacted and influenced synaptosome area (F(1,453)=11.069, 
P=0.001) and a partial eta squared showed that the effect size was small (pη2=0.024). A further 
two-factor ANOVA including both brain regions demonstrated an interaction between age 
and genotype influenced synaptosome area (F(1,453)=4.593, P=0.033) and a partial eta 
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squared showed the effect size was below small (pη2=0.002). Statistical analysis of IC 
uncovered a two-factor interaction between genotype and age on synaptosome area 
(F(1,220)=12.835, P=<0.001) with a medium effect size (pη2=0.055). A two-factor ANOVA did 
not reveal a two-way influence on area in hippocampus, but a single-factor ANOVA 
demonstrated that genotype did (F(1,233)=10.665, P=0.001) and the effect size was medium 
(η2=0.044).  
When measuring circularity, readings range from 0 to 1, with a reading of 1 being a perfect 
circle and 0 a straight line. A lower value indirectly correlates to more appendages, which could 
be axonal input or from other cell types. Therefore, more circular synaptosomes corresponds 
with reduced input/weaker connections. The most circular synaptosomes were found in 7-
month Tg hippocampus with a circularity reading of 0.901±0.068, opposed to the least circular 
synaptosomes in 7-month wild type IC with a reading of 0.853±0.076 (Figure 5.18C&D). A 
three-factor ANOVA uncovered age, genotype and brain region interacted and influenced 
circularity (F(1,453)=4.130, P=0.043) and a partial eta squared shows the effect size was less 
than small (pη2=0.009) -circular results informed further analysing perimeter quantifications to 
identify if the measurements differed from area measurements (Figure 5.18E&F). Synaptosome 
perimeters were largest in the 7-month Tg IC, reaching 2.333±0.619µm around, in contrast to 
1.694±0.463µm in 15-month Tg IC. Like area measurements, a three-factor ANOVA revealed 
age, genotype and brain region interacted and had a substantial influence on perimeter 
(F(1,453)=9.723, P=0.002) and a partial eta squared showed a medium effect (pη2=0.021).  
Two-factor analysis of age and genotype demonstrated that the effects were mainly attributed 
to IC (F(1,220)=13.949, P=<0.001) and effect size was large (pη2=0.60).
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Figure 5.17. Process of isolating synaptosomes for area, perimeter and circularity analysis. (A) 
region of interest taken using a scanning electron microscope. Scale bar 50µm. (B) yellow box 
outlines the cropping region of a synaptosome. (C) Cropped region of interest from yellow 
box in (B), red box outlines an example region of interest from the pixel inspector tool used in 
ImageJ. Scale bar in (B) same in (D) 0.2µm. (D) Output of pixel intensities from pixel inspector 
plugin from red region in (C), the formula: 𝑀𝑎𝑥 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 (250) − 𝑆𝑇𝐷𝐸𝑉 ∗ 2 and any readings 
under were not included in the analysis. Definition of the borders of synaptosomes were 
determined by pixel intensities (in this example >132) and using these parameters, contours 
were manually drawn around synaptosomes. Regions of interest were quantified using the 
measure function in ImageJ to produce area, perimeter and circularity measurements.
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Figure 5.18. Outputs from synaptosome measurements were taken using the process in Figure 
5.17 to determine area, perimeter and circularity. Area and perimeter measurements were 
implemented to understand synaptosome sizes. n=individual synaptosomes. (A) 
Synaptosomes in hippocampus had the largest area in the 7-month wild type group and were 
significantly larger than both transgenic groups. The smallest synaptosomes in hippocampus 
were found in the 15-month Tg group. Synaptosome sizes were reduced in the Tg model. (B) 
Largest synaptosome areas were found in the 7-month Tg group, and the smallest were in the 
Tg-15-month group. Synaptosomes were significantly smaller in the 15-month Tg group 
compared to all other groups. (C) Hippocampus demonstrated significant levels of reduced 
circularity between the 15-month wild type with all other groups. (D) IC increased in circularity 
from 7-months wild type to the 15-month Tg group. (E&F) Perimeter measurements followed 
similar trends to area measurements. (G&H) Example high-power scanning electron 
micrographs demonstrating significance from parameter measurements of synaptosomes 
form 7-month wild type (G) and 15-month Tg (H) IC. Notice the smaller sized and more 
uniformed circular synaptosome in Tg IC. Scale bars 0.2µm in (G&H). 
 
5.3.3 – Molecular Analysis of TgF344-AD model 
5.3.3.1 – Inferior colliculus demonstrates an age-dependent reduction in GAD65 
mRNA abundance 
To further understand age-dependent changes in the Tg model, QRT-PCR was conducted to 
identify whether strain affected specific mRNA abundance.  Primers were optimised by 
determining the ideal melt temperature and in the experiment, only results that had similar 
cycles and melt curves were included (Figure 5.19). Housekeeping genes were referenced 
against each other (Cyc1, GAPDH and EIF4A2) to identify the most appropriate reference genes 
(Figure 5.20). This process identified that EIF4A2 did not produce consistent mRNA abundance 
across cases, so was not included as a housekeeper. All target genes were contrasted across 
brain regions and normalised to the housekeeping genes Cyc1, GAPDH. The first gene targeted 
was GAD65 as a marker of GABAergic synapses (Figure 5.21). mRNA abundance was highest 
in 7-month age groups across all brain regions, with the highest in 7-month wild type superior 
colliculus with more than double the levels of the housekeepers. There was a lower level of 
GAD65 mRNA abundance expression across all groups in auditory cortex, frontal cortex and 
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cerebellum in contrast to the colliculi, which suggests less inhibitory synapse activity. The 
lowest mRNA abundance was found in the 15-month Tg auditory cortex with a relative 
decrease to 0.6±0.08 normalised levels. 
One-factor ANOVAs uncovered that age independently influenced GAD65 mRNA abundance 
(F(1,48)=9.035, P=0.004) and an eta squared showed that this was a medium effect size 
(η2=0.158). Additionally, mRNA abundance also was influenced differently depending on brain 
region (F(5,48)=15.474, P=<0.001) and the effect size was large (η2=0.617). Post-hoc analysis 
revealed that superior colliculus was independent in GAD65 mRNA abundance from all other 
groups (all P<0.005) and IC was much higher than in auditory cortex and cerebellum (P=0.015 
and 0.036 respectively). One factor ANOVA of individual brain regions demonstrated that the 
only region that underwent an age-dependent decrease in GAD65 mRNA abundance, was the 
IC (F(1,8)=8.336, P=0.020) and an eta squared showed that the effect size was large (η2=0.510).
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Figure 5.19. Example traces from one experiment including all genes across all brain regions. 
QRT-PCR experiment taken using the Bio-Rad CFX Maestro software, demonstrating the 
optimisation of primers to undergo consistent amplification and melting temperatures. (A) 
Cycles per relative fluorescent units. (B) Changes in relative fluorescent units with temperature. 
(C) Peak temperature for primer to reach maximum cycles of mRNA abundance. If results 
underwent abnormal cycles or melting temperatures, they were excluded from analyses.
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Figure 5.20.  (A) Referenced housekeeping genes Cyc1and EIF4A2 to GAPDH across the brain 
regions. Note the variability in EIF4A2. (B)  Referenced housekeeping genes EIF4A2 and GAPDH 
to Cyc1, notice again the high variability in EIF4A2. (C) Cyc1 and GAPDH were referenced to 
EIF4A2. Not the variability across both. The housekeeper EIF4A2 was excluded from 
normalising the mRNA abundance of target genes, due to high variability.
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Figure 5.21. GAD65 mRNA abundance was highest in the 7-month wild type IC, hippocampus, auditory cortex and superior colliculus, with the 
highest levels in superior colliculus. The lowest expression was found in the 15-month Tg cerebellum. Age influenced mRNA abundance in IC 
resulting in a reduction. Most markedly, there is a decrease between 7-month wild type and 15-month Tg IC and hippocampus, suggestive of 
selective pressure on GABAergic synapses. 
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5.3.3.2 – Iba1 expression decreases with age across all brain regions 
Next, Iba1 was measured as a marker of microglia, to determine whether mRNA abundance 
increased across brain regions (Figure 5.22). mRNA abundance was lowest in the 15-month Tg 
group of all brain regions, except hippocampus where 15-month wild type was lowest. The 
highest levels of Iba1 mRNA abundance were found in the 7-month wild type superior 
colliculus, with a 2±1 fold difference above housekeepers in expression. Cerebellum had the 
lowest levels of Iba1 mRNA abundance across all groups, with the lowest overall of 0.5±0.1-
fold change in the 15-month Tg group. 
One-factor ANOVA of all brain regions shows an age-dependent influence on Iba1 mRNA 
abundance (F(1,48)=4.126, P=0.048) and eta squared demonstrates that the effect size was 
medium  (η2=0.079). Moreover, ANOVA revealed that brain region influenced the levels of Iba1 
mRNA abundance (F(5,48)=6.429, P=<0.001), which had a large effect size (η2=0.401). Post-
hoc analysis revealed that the cerebellum was largely different from auditory cortex (P=0.011), 
hippocampus, IC and superior colliculus (all P=<0.001). All other regions displayed similar 
levels of mRNA abundance.  Analysis of individual brain regions measuring different factors 
uncovered no significant influences. These results show that across all brain regions Iba1 
decreases with age but is not attributed to individual regions. Levels of Iba1 mRNA abundance 
were substantially lower in cerebellum than other regions.
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Figure 5.22. Iba1 expression underwent age-dependent decreases across all brain regions, except for cerebellum. Highest expression was found 
in the 7-month wild type superior colliculus, followed by 7-month Tg hippocampus. Lowest readings were found in the 15-month Tg cerebellum. 
The most striking differences were found between 7-month wild type and 15-month Tg IC and superior colliculus. Similar to GAD65 expression 
(Figure 5.22), there was a decrease between 7-month wild type and 15-month Tg, indicative of the deteriorative effects of the Tg model with age. 
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5.3.3.3 – SV2a expression across the brain undergoes age-dependent decreases 
In addition to inhibitory GAD65 synapses, excitatory synapses were targeted by implementing 
the marker SV2a (Figure 5.23). SV2a expression was marginally higher in the 7-month groups 
across all brain regions, except cerebellum, which remained unaffected. IC demonstrated the 
largest difference in SV2a mRNA abundance was between 1.5±0.3 fold above housekeepers 
in the 7-month wild type group, to 0.9±0.2 in the Tg 15-month group. Expression in cerebellum 
was consistently lower in all groups in contrast to other regions, with 0.7±0.3 in the 15-month 
wild type group. 
One-factor ANOVA of all brain regions demonstrated an age-dependent decrease in SV2a 
expression (F(1,48)=5.045, P=0.029) and an eta squared showed a medium effect size 
(η2=0.095). Additionally, brain region also influenced the levels of mRNA abundance 
(F(5,48)=15.065, P=<0.001) and the effect size was large (η2=0.611). Post-hoc analysis that the 
IC and superior colliculus were similar in expression (P=>0.999) but were distinct from all other 
regions (all P=<0.002). Analysis of individual brain region revealed no significant influences. 
These results show that across all brains regions, there is age-dependent decrease in SV2a 
expression. 
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Figure 5.23. Like Iba1 expression (Figure 5.23), there was an age dependent decrease in SV2a expression across all brain regions. The highest 
levels of expression were in 7-month wild type and Tg IC and superior colliculus. Lowest levels were found in the 15-month Tg group of IC, 
hippocampus, auditory cortex and frontal cortex, with similar numbers across regions. Cerebellum remained unaffected across groups. The largest 
effect was in IC between 7-month wild type and 15-month Tg groups. IC demonstrates an age-dependent decrease in SV2a expression in the Tg 
model.
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5.3.3.4 – Across brain regions synaptophysin expression demonstrates an age-
dependent decrease in the Tg model 
To contrast with GAD65 and SV2a, synaptophysin was measured as a marker of presynapses 
(Figure 5.24). Synaptophysin mRNA abundance was notably highest in the 7-month Tg group 
of the hippocampus, auditory cortex and frontal cortex, with the highest relative levels 
reaching 2.3±1.9 in frontal cortex. Consistent with SV2a results, synaptophysin expression in 
IC and superior colliculus followed similar trends across groups. The lowest overall relative 
synaptophysin mRNA abundance was found at 0.6±0.1 in the 15-month Tg IC group. 
A two-factor ANOVA across all brain regions revealed age and genotype influenced 
synaptophysin mRNA abundance (F(1,48)=5.908, P=0.019) and a partial eta squared revealed 
a medium effect size (pη2=0.110). Post-hoc analysis uncovered that the differences in brain 
region were attributed to between cerebellum with auditory cortex (P=0.033), frontal cortex 
(P=0.037) and hippocampus (P=0.024). A single-factor ANOVA of individual brain regions 
demonstrated that genotype influenced mRNA abundance in cerebellum (F(1,8)=7.491, 
P=0.026) and the effect size was small (pη2=0.026). 
These results demonstrate that across brain regions, synaptophysin expression is affected 
collectively by age and genotype. Also, expression in cerebellum is lower in the Tg model 
independent of age.
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Figure 5.24. Across synaptic measurements of mRNA abundance, synaptophysin elicited the most profound effect, uncovering a two-factor 
interaction between age and genotype influencing expression across brain regions. Highest readings were found in 7-month Tg frontal cortex 
and hippocampus, although frontal cortex could be due to one outlier. The lowest expression was found in cerebellum but remained consistent 
across groups. The largest between-groups differences were found in IC, hippocampus, auditory cortex and frontal cortex. 
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5.4 – Discussion  
The results from this chapter are the first to contrast age-dependent mitochondrial 
dysfunction in the Tg model, along with in-depth anatomical quantification of individual 
synaptosomes and molecular analysis. The main findings from this Chapter include i) age-
dependent increases in proton leak found in hippocampus (Figure 5.1), ii) increases in basal 
respiration in hippocampus of the 15-month Tg model (Figure 5.10) and iii) age-dependent 
increases in maximal respiration of IC and hippocampus in the Tg groups (Figure 5.14). Similar 
levels of non-mitochondrial oxygen consumption (Figure 5.15) corroborate that changes in 
mitochondrial functioning are attributed to mitochondrial dysfunction and are not due to non-
mitochondrial respiration. Additionally, consistent levels of spare respiratory capacity (Figure 
5.16) suggest that the above parameters are dependent measures of mitochondrial 
dysfunction and not as a result of ancillary metabolic pathways. The other measures included 
are decreases in ATP-production (Figure 5.12) and coupling efficiency (Figure 5.13) in the 15-
month Tg groups, but these results incorporated negative responses after the addition of 
Oligomycin, which led to negative readings and in turn hampers the interpretability of the 
findings. However, these negative responses do indirectly uncover possible aspects of 
mitochondrial dysfunction commensurate with the other parameters meriting further 
investigation.  
Overall changes in OCRs across brain regions demonstrate that synaptosomes are 
physiologically dependent on where they are situated. The opposite response observed after 
the injection of Oligomycin (review Figure 5.9) onto the synaptosomes of the 15-month Tg 
groups, suggest age-dependent adaptations in mitochondrial physiology in the Tg model 
indicative of mitochondrial dysfunction. The process of measuring the mitochondrial 
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parameters basal respiration, proton leak, maximal respiration, non-mitochondrial oxygen 
consumption, spare respiratory capacity, ATP-production and coupling efficiency using the 
Seahorse instrument is a well characterised model (Divakaruni et al., 2014). By identifying 
specific changes in these inter-dependent parameters, highlight independent measures of 
mitochondrial function attributed to synaptosomal dysfunction.  
5.4.1 – Identifying mechanisms behind synaptic dysfunction is in Alzheimer’s 
disease is critical to understanding the condition  
It is well established that synaptic dysfunction is a major contributor to AD (Marcello et al., 
2012, Davies et al., 1987, Dekosky and Scheff, 1990, Selkoe, 2002). Jackson et al. (2019) focus 
on the early pathology of AD and suggest that synaptic neuroplasticity is a targetable 
mechanism that could restore cognitive function. They suggest that the brain adapts in 
response to damage and the synapse morphology changes accordingly. Hebb (1952) 
postulated the mechanism whereby synaptic plasticity is defined by the pre-synapses’ 
repeated stimulation of the post-synapse, which suggests that dysfunction of pre-synapses 
would result in altered synaptic plasticity. This Chapter targeted the energy production that 
drives synaptic transmission by measuring aspects of synaptic mitochondrial functioning to 
identify changes in physiological synaptosome plasticity in the Tg model that could translate 
to potential targets in early onset AD. 
5.4.2 – The efficiency of the mitochondrial membrane decreased in the 15-month 
Tg hippocampus 
Proton leak is defined by protons that re-enter the mitochondrial matrix by other means than 
via complex V of the mitochondrial chain (Jastroch et al., 2010). The direct mechanisms 
contributing to proton leak involve movement across the phospholipid bilayer, transport 
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across integral membrane proteins or other protein-based sites located on the mitochondrial 
membrane.  
Dysfunction of mitochondria and increased membrane inefficiency leading to proton leak, 
cause the production of reactive oxygen species furthering the damage to mitochondria. 
Generation of reactive oxygen species is more than likely generated at complex III of the 
mitochondrial chain during the oxidation of complex I substrates (Chen et al., 2003). In 
contrast, the excess of reactive oxygen species accumulation can also promote damage to the 
mitochondrial membrane, causing proton leak (Cheng et al., 2018). This makes interpreting 
what initiates proton leak difficult, but highlights the importance of the measurement in that 
dysfunction could result in a dialectic feedback loop that promotes progressive deterioration 
of the mitochondrial membrane. Therefore, if AD induces mitochondrial membrane 
inefficiency, could contribute to a progressive reduction in metabolism 
When interpreting changes in proton leak, it is unclear which specific mechanisms are 
associated, but increased levels induced by the Tg model can be attributed to mitochondrial 
membrane dysfunction and the production of reactive oxygen species. This Chapter uncovered 
a selective increase in age-dependent proton leak in hippocampus of the Tg model (Figure 
5.11), which suggests a high level of induced mitochondrial membrane injury impairing the 
efficiency of the mitochondrial chain. These regional-specific responses highlight the increased 
susceptibility of hippocampus to synaptic mitochondrial dysfunction in this model of AD. 
5.4.3 – Age-dependent increases in basal metabolism within hippocampus of the 
Tg model is suggestive of increased pressure to maintain synaptic functioning 
The minimal rate of rate of metabolism required to undertake basic functions, is basal 
respiration. Measuring OCRs of synaptosomes and contrasting across cases in a consistently 
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metabolising environment, allows the detection of adaptations that mitochondria undergo to 
maintain basal synaptic functioning. Changes in basal respiration are indicative of 
synaptosome adaptations to the surrounding milieu. These are the first results to demonstrate 
an increase in age-dependent basal synaptic metabolism in the Tg model. The results show 
elevated pressure on synaptosomes in hippocampus, in contrast to other regions of the brain, 
to undergo increases in basal energy demand (Figure 5.10). Increases are found at 15-months 
in the Tg model, demonstrating the adaptations that the hippocampus experiences due to its 
environment. Rylett et al. (1983) demonstrated in synaptosomal fractions from hippocampus 
and frontal cortex from AD patients, sodium-dependent and hemicholinium-sensitive choline 
uptake into hippocampal fractions were twice as great as in frontal cortex fractions. These 
results are commensurate with the findings in Figure 5.10, that basal metabolism in 
hippocampal synaptosomes undergo a doubling in OCR. Similarly, Rylett et al. (1983) identified 
that choline transport into synaptosomes was reduced more markedly in frontal cortex than 
in hippocampus of AD patients compared to healthy controls. Contrastingly, their results 
suggest that although hippocampus choline uptake increases, frontal cortex has a reduced 
capacity to uptake choline. This could explain why basal and maximal respiration OCRs were 
substantially higher in young cortical regions, but lower in sub-cortical regions such as 
hippocampus and IC, and the Tg model causes an opposite compensatory effect, which could 
provide insight into how synapses are affected across the different regions of the brain. This 
increase in energy needed to maintain basal functioning in the Tg model could be a source of 
accelerated synaptic dysfunction that promotes early changes in plasticity in hippocampus. 
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5.4.4 – Elevated maximal respiration in 15-month Tg model in inferior colliculus 
similar to hippocampus 
Yao et al. (2009) demonstrated a decrease in basal and maximal respiration in triple transgenic 
AD mice 14-day old embryo hippocampal neurons compared to age-matched non-transgenic 
controls. Contrastingly, in synaptosomes, the results from this Chapter show an increase in 
maximal respiration (Figure 5.14) of 15-month old Tg rat IC and hippocampus. Synaptosomal 
studies of AD patient post-mortem tissue identified a reduction in cortical acetylcholine 
(Nordberg and Winblad, 1986), which correlates with the age-dependent decreases in basal 
and maximal respiration observed in the Tg model of both cortical regions in this Chapter 
(Figure 5.10&14). Hardy et al. (1987) show in synaptosomes taken from AD patients and 
healthy controls, that there is approximately a 70% reduction of GABAergic terminals in 
hippocampus and cortices in the AD patients. They also suggest that although there may not 
be neuronal loss (Chapter 4), GABAergic terminals are substantially affected. This large effect 
on GABAergic terminals in AD, therefore, will more than likely have a substantial effect on the 
highly GABAergic IC (Merchán et al., 2005), which is probably why the results in IC mirrored 
those of the hippocampus. Dekosky and Scheff (1990) correlated that a loss of synapses in 
human AD patients is associated with a reduction in mental ability, which more than likely 
translates the synaptosomal dysfunction observed in this Chapter to potential dysfunction in 
humans. 
Spare respiratory capacity (Figure 5.16) remained similar across groups, which suggests that 
the increased levels of maximal respiration are interdependent with increases in basal 
respiration (Figure 5.10) and proton leak (Figure 5.11). An elevated maximal respiration 
corresponds with the maximal level of substrate utilisation and oxidation capacity of 
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mitochondria (Divakaruni et al., 2014). Therefore, the increases in maximal respiration of 
synaptosomes are more than likely a compensatory response to accommodate for the 
increasing stress of aging in the Tg model.  
5.4.5 – Decreases in ATP production and coupling efficiency are indirectly 
suggestive of synaptic dysfunction in the aging Tg model 
The production of ATP is determined by the addition of Oligomycin, by selectively blocking 
the synthesis of ATP, and coupling efficiency is calculated by dividing ATP production by basal 
respiration and multiplying by one-hundred. Figure 5.5 outlines the typical responses in OCR 
to added compounds. Across all cases, Oligomycin had little effect on synaptosome fractions, 
but interestingly at 15-months in the Tg groups there was an increase in OCR. The other 
substrates added to the synaptosomes elicited somewhat expected results, suggesting that 
the response to Oligomycin is a real effect. Scott and Nicholls (1980) found that Oligomycin 
had a similar response in guinea pig synaptosomes, where there was a slight increase in OCRs 
and Flynn et al. (2011) demonstrated in SOD2 null mice very minor changes in OCR similar to 
the results seen in 7-month wild type groups in Figure 5.9. Although the decreases in ATP 
production and coupling efficiency cannot be interpreted as real effects, the nature of the 
results are real physiological responses to Oligomycin. It appears that the uptake of 
Oligomycin does not have a profound effect on blocking ATP synthesis, which could suggest 
a more glycolytic role, but could also be as a result of a lack of blocking due to a insufficient 
concentration of Oligomycin introduced. However, measurements between groups 
demonstrated different responses, which highlights that here were effects. Therefore, the 
nature of increasing OCRs in the 15-month Tg group is more than likely suggestive of synaptic 
dysfunction which merits further investigation. 
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5.4.6 – Synaptosome size decreases in the 15-month Tg inferior colliculus 
This Chapter is one of the first studies to provide in-depth anatomical quantification of 
individual synaptosomes and through the analysis identifies clear adaptations in the Tg model. 
The images were first taken on the SEM to validate the presence of synaptosomes in the 
samples (Figure 5.4). When contrasting with the literature, the high-power images seen in 
Figure 5.18 G&H are similar in size and shape to the examples imaged by (Ajito and Torimitsu, 
2002) using SEM and in the transverse sections imaged by (DiGiovanni et al., 2012) using 
transmission electron microscopy. Morphological analysis was then undertaken to identify if 
age and genotype caused remodelling of synaptosomal anatomy. Interestingly, synaptosomes 
were substantially reduced in size in the 15-month Tg groups of both hippocampus and IC, 
indicative of pressure on synapses to remodel. In addition, synaptosomes in IC were more 
circular in the 15-month Tg group, potentially suggestive of fewer synaptic inputs and 
integrated synapses, which has been observed as a key transitional point in transgenic AD 
mice development (Kashyap et al., 2019).  
The Tg model has been developed to express mutant human amyloid precursor protein and 
presenilin genes (Cohen et al., 2013), which cause a substantial increase in Aβ production along 
with a reduced ability to cleave these proteins. This leads to considerable levels of Aβ being 
present throughout the brain. Koffie et al. (2012) demonstrate that oligomeric Aβ is elevated 
at synapses and results in synapse shrinkage, which is commensurate with the results from this 
Chapter. This age-dependent pressure observed for synapses to remodel in the presence of 
Aβ suggests that targeting synaptosomes at early stages of the disease to rectify changes in 
synaptosome size could be critical.  
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5.4.7 –Age-dependent synaptophysin decreases in the Tg model across brain 
regions, with the largest differences in inferior colliculus 
The molecular biological approach of QRT-PCR was implemented to identify whether synaptic 
markers were affected on a transcriptional level that coincided with the physiological results. 
Other studies have identified decreases in GAD65 (Schwab et al., 2013), synaptophysin 
(Tampellini et al., 2010) and SV2a (Chen et al., 2018). In this Chapter, all synaptic markers 
demonstrated an age-dependent reduction in mRNA abundance (Figures 5.21, 23 & 24). Since 
all markers demonstrated a similar reduction suggests that there is likely to be a decrease in 
synapse density. Consistently, the 15-month Tg groups had the lowest levels of synaptic mRNA 
abundance, particularly in IC and hippocampus, which correlates with the mitochondrial 
dysfunction observed in the synaptosomes. This suggests that along with synaptic dysfunction, 
there is also a reduction in synaptic mRNA abundance. A study by Chen et al. (2018) showed 
that in patients with AD, there was a 41% reduction in SV2a binding sites compared to 
cognitively normal controls. These results are from patients at later stages of the disease, and 
when comparing with results from this section, it suggests that this begins at an earlier stage 
of the disease. Stockburger et al. (2016) show that SV2a is expressed in mitochondria and that 
the drug levetiracetam could be used to improve the symptoms of AD. This could be used as 
a future approach in line with the presented work to target potential metabolic mechanisms 
that could reverse observed synaptic dysfunction.  
5.4.8 – Technical limitations 
Inherent problems arise when studying the physiology of mitochondria, Brand and Nicholls 
(2011) summarised advantages and disadvantages of isolating mitochondria. Problems that 
had to be considered when isolating synaptosomes included, synaptosomes not operating 
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collectively with surrounding structures, damage when isolating synaptosomes and adding 
substrates to synaptosomes out of physiological context could affect interpretability, such as 
explaining the lack of Oligomycin response. However, these considerations do not discredit 
that there were differences between groups and unusual responses in the 15-month Tg group, 
which more than likely is having a negative effect within the living animal. 
Problems that arise when measuring proton leak include determining whether changes in 
membrane potential contribute to the changes detected in respiration.  This observation 
therefore hampers the interpretability of the findings as the exact mechanism causing the 
excessive proton leak in the 15-month Tg model was not determined. Future work would seek 
to implement a mitochondrial membrane potential assay as a measurement of membrane 
potential, to confirm the levels of proton leak were attributed to membrane inefficiency. Basal 
respiration, proton leak and maximal respiration are inter-dependent values, therefore when 
measuring them as independent values does not incorporate whether it was a common 
mechanism that caused the similar trends across the groups. However, this does not disregard 
differences between groups and that there is synaptic dysfunction.  
There were low numbers of viable samples in some of the physiological data and in all the 
molecular experiments, there was only time to perform experiments of three animals per 
group. These results will therefore be underpowered and hamper the interpretability of the 
findings. The low n numbers in the 15-month Tg IC and across molecular results are more than 
likely the reason why significant results have not been derived. Future experiments to increase 
the ‘n’ numbers for each experiment to improve the representability and the statistical power 
of the findings, may uncover further statistical significance.  
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Homogenising and undergoing high force centrifugation could have caused damage to 
synaptosome samples. In addition, synaptosomes separated from presynaptic nerve endings 
using centrifugation at high speeds will causes the synaptosomes to seal up and become 
particle like (Whittaker, 1969), which directly affects the interpretability of the morphological 
analysis of synaptosomes and the circularity measurements, but this could provide insight into 
why synaptosomes become smaller and more circular in the Tg groups. One could suggest 
that due to the lack of input, integration and induced stress causing damage to synaptosomes, 
would potentially render them more susceptible to separation from surrounding structures. 
5.4.9 – Conclusions 
This Chapter is the first research to provide molecular, anatomical and physiological evidence 
for age-dependent synaptic dysfunction in a transgenic rat model of AD. The pre-synaptic 
terminals (synaptosomes) undergo age-dependent dysfunction in the Tg model including an 
increased basal level of metabolism to accommodate normal functioning, increased maximal 
oxidative capacity and increased mitochondrial membrane inefficiency to undergo energy 
production. These results are supported by age-dependent anatomical changes in 
synaptosome morphology and molecular decreases in GAD65, SV2a and synaptophysin mRNA 
abundance in the Tg model. Taken together, these findings show for the first time that there 
is a level of synaptic dysfunction in the inferior colliculus, similar to that of the hippocampus 
in the TgF344-AD model that precedes neuronal loss. Overall, these findings demonstrate that 
the key auditory nucleus, the inferior colliculus, undergoes accelerated synaptic dysfunction in 
contrast to other regions of the brain. Therefore, the results provide a mechanistic link between 
hearing loss and early onset Alzheimer’s disease. This research uncovers new avenues of 
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investigation for future therapeutic tests, which could be instrumental in combatting the early 
development of the condition in humans.
214 | P a g e  
 
Chapter 6 – General Discussion 
6.1 – Summary of findings 
This thesis has revealed that two types of GAD67+ (putative GABAergic) neuron in IC can be 
classified based on the extent of Iba1 contacts on their soma. Furthermore, there are more 
GAD67+ somata present within the VCNIC than other sub-regions, and microglia have longer 
processes than other sub-regions. Moreover, microglia are more ramified in DCIC, and also 
colocalise with more putative glutamatergic synapses than other sub-regions. This suggests 
Iba1+ microglial processes are associated with IC synapses and the density of these is 
associated to the nature of local processing between sub-regions of IC. This means that in 
addition to what is known about neurons transmitting signals to the IC, that microglia influence 
the synaptic transmission differentially across the sub-regions, which could be informative to 
fundamental processing throughout different regions of the brain. 
Using fluorescent and chromogenic approaches produced evidence that neurons across CNIC, 
DCIC, LCIC, hippocampus and striatum do not undergo age-dependent reductions in density 
in the Tg model up to 18-months. This is in direct conflict with the key paper that characterised 
the Tg model (Cohen et al., 2013). This highlights a need for further research to characterise 
the Tg model before a concrete conclusion can be made. Activated microglial labelling was 
highest in white matter regions, but only demonstrated an age dependent increase in number 
in the Tg model, which broadly highlights that the Tg model systemic inflammatory response 
causes microglia to activate, and the fact that the response differed across subregions 
demonstrates that resident microglia respond differently. Astrocytic GFAP+ labelling 
substantially increased at 12-months in CNIC and hippocampus, while astrocyte morphology 
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in hippocampus underwent age-dependent increases in total ramifications and ramification 
density. 
Synaptic mitochondrial dysfunction was most prominent at 15-months in Tg hippocampus, 
with a similar trend of maximum respiratory capacity seen in IC. The morphology of 
synaptosomes decreased in size most markedly at 15-months in IC and hippocampus, 
indicating structural alterations to presynaptic proteins. Pre-synaptic markers GAD65, SV2a 
and synaptophysin all demonstrated trends in age-dependent reductions in the Tg model, 
similarly to Iba1, indicating general synaptic and microglial dysfunction at 15-months, that 
precedes loss of neurons. 
6.2 – Discussion of glia in IC, in health and dysfunction 
Before researchers can fully understand how microglia respond to pathology, an 
understanding must be developed regarding their function under healthy conditions. This 
thesis uses the sub regions of IC as a model for investigating microglial anatomy and their 
possible contributions to processing. The results from Chapter 3 demonstrate that microglia, 
under normal ‘ongoing’ conditions demonstrate profound sub regional differences. These 
findings therefore provide a basis for utilising physiological approaches to further understand 
the role microglia play in neuronal transmission, such as identifying differences in the types 
and composition of ion channels across the microglia. Following on from Chapter 3, Chapter 
4 shows that putative microglial-associated plaques at 12- and 18-month in the Tg model form 
predominantly in the CNIC caudo-medially, which could be due to the specific afferent sources 
and local processing, plus high density of GABAergic neurons therein. This could also reflect a 
role for the less ramified microglia found in VCNIC. In addition, Chapter 5 revealed a reduction 
in Iba1 gene expression at 15-months in the Tg model which could correlate with a reduced 
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number of microglia connections that promotes plaque formation. Gomez-Nicola and Perry 
(2015) suggest that microglial processes are involved in regulating synaptic transmission and 
sensing the microenvironment. Therefore, this may correlate to a different role for microglia 
in DCIC than in CNIC, which could be why there is an enhanced susceptibility to plaque 
formation. On the dorsal border of IC in Tg rats there is a clearly higher level of activated 
astrocytes than elsewhere in IC, and chronic activation is considered to exacerbate plaque 
development (Phatnani and Maniatis, 2015). However, the activated glia around plaques that 
appear in sub-regions are less densely packed under normal conditions. Therefore, one could 
suggest that a lack of sufficient local resident glia to mediate an effective response to local 
damage, could contribute to plaque formation and subsequent pathology. 
In Chapter 3, GFAP+ astrocytes were shown to be numerous around the borders of the IC, but 
lacking throughout the parenchyma. This labelling was also found around the borders of IC in 
Chapter 4, but was exacerbated in the Tg models, which suggests that the dense labelling of 
reactive GFAP+ astrocytes located at the borders may be exerting a neuroprotective role in 
‘ongoing’ conditions. However, when pathological conditions cause increased stress on the 
borders adjacent to the ventricle, there is a response that caused activation of glia. Microglia 
and astrocytes are neuroprotective cells (Bylicky et al., 2018) and suggests that a greater 
density of glia in normal conditions may also confer enhanced neuroprotection in these areas, 
such as DCIC and LCIC, thus decreasing the likelihood of developing plaques compared to 
other regions. From this position, one could suggest that underlying anatomical and functional 
differences of microglia and astrocytes in certain regions of the brain, renders them more 
susceptible to damage, as a result of not having the capability to produce the same level of 
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neuroprotection as other regions, which could be an extremely important aspect to 
understand regional AD development, such as the link between hearing loss and dementia.  
In Chapter 4, astrocytes were found to significantly increase in CNIC, but did not undergo age-
dependent morphological modifications similar to the hippocampus in the Tg model. 
Although there was a substantial increase in GFAP+ astrocyte labelling, the morphology of 
astrocytes in CNIC did not become more ramified or lead to extended length of arbours in the 
ageing Tg model. Therefore, this could infer that while there are similarities between IC and 
hippocampus in the Tg model the astrocytes exhibit divergent responses, related to local 
processing and potentially disparate phenotypes.  
6.3 – Suggestions for future investigations 
Future work may look to implement real time monitoring of microglia in IC, to observe the 
interactions they make with synapses and inhibitory neurons across sub regions and 
implement physiological measures of microglial functioning. The use of multi-photon 
microscopy (Hierro-Bujalance et al., 2018), and the accessible location of the IC in rodents, at 
the dorsal surface of the brain, between the cortex and cerebellum, may allow investigation of 
the highly ramified morphologies on Iba1+ microglia in DCIC and their putative contribution 
to synaptic processing. Measuring ‘resting’ microglia is a topic of particular interest, due to 
their activation in response to even minor stimuli (Guttenplan and Liddelow, 2019). Cell co-
culture approaches may also be of interest in addressing these issues (Nistor et al., 2011). 
Future work may also look to contrast different astrocyte markers, across the IC, both in young 
adults during normal processing and under pathological conditions. Preliminary work (not 
shown in this thesis), demonstrated that using the marker Aldh1L1 also did not uncover 
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astrocytes throughout the parenchyma. Hafidi and Galifianakis (2003) showed that the marker 
S100B revealed ‘astrocytes’ throughout the parenchyma, but S100B is a known marker of 
myelinated fibres (Steiner et al., 2007) and the IC is constituted heavily of myelinated fibres, 
also hampering the interpretability of this marker. 
Chapter 5 revealed a reduction in GAD65 gene expression at 15-months in the Tg model in 
whole IC homogenates, but GAD67+ somata in Chapter 3 were found in high numbers in the 
VCNIC, with fewer in CNIC and fewer still in DCIC and LCIC. This demonstrates the necessity of 
approaches that retain morphometric detail of the sample. While a loss of GAD65 in the 18-
months Tg group is interesting – it is imperative to localise where that change is manifest in 
IC, as this has profound implications for the interpretation of this finding. Future work should 
therefore also include immunohistochemistry with microscopy. 
Chapter 4 demonstrated no evidence for a loss of NeuN somata up to 18-months, which could 
be due to NeuN being a broad marker of post-mitotic neurons. Specifically targeting neuronal 
subtypes in the ageing Tg model could identify losses of certain subtypes and increases of 
others, potentially via phenotypic switching of gene expression. Inhibitory processing is more 
metabolically intensive than excitatory or neuromodulatory processing (Kann et al., 2014), and 
the results from Chapter 5 demonstrated reductions in basal metabolic rate in aged Tg, along 
with a reduction in GAD65 mRNA. This leads to the suggestion that altered inhibition, which 
is known to be reduced in aged Fisher 344 rats (Ouda and Syka, 2012) may be an interesting 
avenue of future investigations. This may be of particular interest in further understanding the 
sub-regional differences in glial response in IC. 
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6.4 – Overall summary 
Overall, the results of this thesis demonstrate that glial cells are important in processing 
throughout the sub regions of IC. These different sub-regions all have distinct functions, and 
this is the first study to subsequently demonstrate that among these IC regions, there are 
different sub-types of microglial cells. The neuronal pathways are already well established in 
IC and these results provide evidence that microglia contribute to this network, uncovering 
new avenues for the field to investigate in more depth how auditory signals are processed.  
In addition, the thesis provided evidence in IC and hippocampus of the Tg model up to 18-
months that there is no neuronal loss. However, there was an increase in the labelling of 
reactive astrocytes similar to hippocampus, which provides evidence for this integral nucleus 
within the auditory system to undergo similar AD related astrogliosis. Contrastingly, the 
morphology of the astrocytes in IC did not mirror the hippocampus. Therefore, by utilising 
future physiological approaches in line with these results could unearth interesting new areas 
of research regarding AD related glial responses, which could help in better understanding the 
link between hearing loss and AD.  
Finally, anatomical, physiological and molecular approaches corroborated results that 
demonstrated synaptic dysfunction between IC and hippocampus in the Tg rat model, at 
similar time-points to when human AD symptoms start to develop. Therefore, these results 
reveal potential targets for future therapeutics to try and prevent the early manifestation of 
mitochondrial dysfunction of synapses within the auditory pathway to slow down the 
development of AD symptoms.
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